Společnost Vishay Intertechnology uvedla automobilový optočlen VOMHA43A v novém pouzdře SOP-5 o šířce 3,6 mm. Nabízí CMTI 40 kV/µs a izolační napětí až 707 Vpeak.
AEC-Q102 Qualified Device Offers Industry-Best Minimum CMTI of 40 kV/µS and Maximum Repetitive Peak Isolation Voltage of 707 Vpeak
MALVERN, Pa., July 09, 2026 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced an automotive 1 MBd high speed optocoupler in a new SOP-5 package with a narrow width of 3.6 mm. Combining a comparative tracking index (CTI) of 400 with industry-leading minimum guaranteed common mode transient immunity (CMTI) of 40 kV/µS, the Vishay Semiconductors VOMHA43A is designed to deliver improved signal transmission quality and save space in applications requiring isolation voltages (VIORM) up to 707 Vpeak.
The AEC-Q102 qualified device released today is optimized for isolated data communication, fast signal switching, ground signal isolation, and logic voltage level shifting in automotive, industrial, home and building control, and telecom applications. In electric (EV), hybrid electric (HEV), and low speed electric (LSEV) vehicles, the optocoupler provides communication bus isolation for CAN, LIN, I²C, and SPI interfaces, as well as isolated drive circuit applications such as intelligent power module (IPM) drivers.
While previous SOP-5 packages offered a width of 4.4 mm, the narrower SOP-5 of the VOMHA43A requires less PCB space, while supporting stackable designs. The device’s minimum CMTI — which is more than double that of the closest competing device — provides enhanced robustness against electrical spikes and RF and EMI issues. And while competing devices offer maximum repetitive peak isolation voltages of 567 Vpeak, the optocoupler’s isolation voltage performance of 707 Vpeak meets the requirements of 400 V battery systems.
The VOMHA43A consists of a GaAlAs infrared emitting diode, optically coupled with an integrated photodetector and a high speed transistor. The photodetector is junction-isolated from the transistor to reduce miller capacitance effects. The optocoupler features an open collector output function that allows designers to adjust load conditions when interfacing with different logic systems, while a Faraday shield on the detector chip allows the device to reject and minimize high input to output common mode transient voltages.
The RoHS-compliant and halogen-free optocoupler operates over a temperature range of -40 °C to +125 °C and is pin to pin compatible with leading competing parts to provide a direct replacement and eliminate the need for electrical and mechanical redesigns.
Samples and production quantities of the VOMHA43A are available now, with lead times of six weeks.
Vishay manufactures one of the world’s largest portfolios of discrete semiconductors and passive electronic components that are essential to innovative designs in the automotive, industrial, computing, consumer, telecommunications, military, aerospace, and medical markets. Serving customers worldwide, Vishay is The DNA of tech.® Vishay Intertechnology, Inc. is a Fortune 1000 Company listed on the NYSE (VSH). More on Vishay at www.Vishay.com.
The DNA of tech® is a registered trademark of Vishay Intertechnology, Inc.
Vishay on Facebook: http://www.facebook.com/VishayIntertechnology
Vishay Twitter feed: http://twitter.com/vishayindust
Links to product datasheets:
http://www.vishay.com/ppg?80341 (VOMHA43A)
Link to product photo:
https://www.flickr.com/photos/vishay/albums/72177720334474258
For more information please contact:
Vishay Intertechnology
Peter Henrici, +1 408 567-8400 [email protected]
or
Redpines
Bob Decker, +1 415 409-0233 [email protected]
Vishay Intertechnology v 1. čtvrtletí zvýšila tržby o 17,3 % na 839,2 mil. USD a hrubá marže se zlepšila na 21 %. Ve 2. čtvrtletí čeká hrubou marži kolem 22 %.
Key Takeaways Vishay 3.0 aims to boost profitability through capacity expansion and higher exposure to fast-growing markets.VSH's Q1'26 revenues rose 17.3% to $839.2M, while gross margin improved to 21%, driven by stronger volumes.Vishay sees Q2 gross margin near 22%, helped by price increases and higher capacity utilization. Vishay Intertechnology, Inc.'s (VSH - Free Report) Vishay 3.0 strategy is designed to improve profitability by expanding manufacturing capacity, strengthening customer relationships and increasing exposure to faster-growing markets. While the company is still investing heavily, early results suggest that the strategy is beginning to support sustainable margin expansion.
Financial results for the first quarter of 2026 reflected encouraging progress. Revenues increased 17.3% year over year to $839.2 million, beating management's guidance. Gross margin improved to 21%, up from 19.6% in the previous quarter and 19% in the year-ago quarter. Operating margin also expanded to 2.6% from 1.8% in the fourth quarter of 2025, supported by stronger shipment volumes and improved factory utilization.
Demand has strengthened across industrial, automotive, aerospace and AI-related applications. Vishay Intertechnology reported a healthy book-to-bill ratio of 1.34, including an impressive 1.47 for semiconductors. Backlog increased 21% to $1.6 billion, providing strong revenue visibility and supporting higher capacity utilization in the coming quarters.
Vishay Intertechnology expects additional margin improvement in the second quarter. Revenues are projected between $875 million and $905 million, while gross margin is expected to reach roughly 22% despite higher metals and material costs. Recently implemented price increases should also contribute more meaningfully during the second and third quarters.
Although elevated capital spending on its new German 12-inch fab and other expansion projects may pressure free cash flow in the near term, these investments position Vishay Intertechnology to benefit from future demand growth. As capacity utilization rises and pricing actions take hold, Vishay 3.0 appears well-positioned to deliver sustainable margin expansion over the long run.
How Vishay Intertechnology Compares With Key Industry RivalsVishay Intertechnology's closest competitors, ON Semiconductor (ON - Free Report) and Diodes Incorporated (DIOD - Free Report) , are also working to improve margins through a richer product mix and manufacturing efficiency.
ON Semiconductor continues shifting its portfolio toward higher-margin silicon carbide (SiC), intelligent power and automotive solutions. In the first quarter of 2026, the company’s non-GAAP gross margin expanded by 30 basis points sequentially to 38.5%. This was primarily driven by increased manufacturing facility utilization (reaching 77% in the first quarter), enhanced operational efficiencies under its "Fab Right" strategy, and a richer product mix favoring higher-margin intelligent power products for AI data centers and automotive applications.
Diodes is also expanding its presence in automotive, industrial and AI power management applications. The company posted first-quarter 2026 revenues of $405.5 million, up 22.1% year over year, while its gross margin improved 30 basis points to 31.8%. Sequentially, Diodes’ gross margin expanded by 70 basis points, primarily driven by increased revenue contribution from higher-margin automotive and industrial segments and improved manufacturing facility utilization rates.
VSH’s Price Performance, Valuation and EstimatesShares of Vishay Intertechnology have skyrocketed 191.1% so far this year compared with the Zacks Computer and Technology sector’s 14.7% gain.
From a valuation standpoint, VSH trades at a forward 12-month price-to-sales ratio of 1.52, significantly below the sector average of 6.86. Vishay carries a Value Score of C.
Vishay Intertechnology Forward 12-Month P/S Ratio
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Vishay Intertechnology’s 2026 earnings is pegged at 75 cents per share, implying a robust improvement from the loss of 5 cents in 2025. The consensus mark of $1.54 per share for 2027 earnings calls for a 105% year-over-year surge. Estimates for 2026 and 2027 have been revised upward over the past 60 days.
Image Source: Zacks Investment Research
Vishay Intertechnology currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Akcie společnosti Vishay Intertechnology za měsíc klesly o 22,8 % kvůli obavám z výdajů na AI, realizaci zisků a ředění akcií. Tržby v 1. čtvrtletí 2026 vzrostly o 17,3 % na 839,2 mil. USD a backlog stoupl o 21 % na 1,6 mld. USD.
Key Takeaways VSH has fallen 22.8% in a month amid AI spending worries, profit-taking and dilution concerns.Vishay 3.0 is lifting results, with Q1 revenues up 17.3% and backlog rising 21% to $1.6B.VSH sees growth from AI, industrial, auto, aerospace, defense and healthcare end markets. Vishay Intertechnology, Inc. (VSH - Free Report) stock has come under intense selling pressure, declining 22.8% over the past month and significantly underperforming the broader Zacks Computer and Technology sector, which has gained 1.5% during the same period.
The weakness has not been limited to Vishay Intertechnology. Several leading semiconductor stocks, including Qualcomm Incorporated (QCOM - Free Report) , FormFactor Inc. (FORM - Free Report) and Marvell Technology, Inc. (MRVL - Free Report) , have also lost ground. Over the past month, shares of Qualcomm, FormFactor and Marvell Technology have fallen 3%, 3.6% and 8.4%, respectively.
VSH stock’s recent sell-off has been driven by three major reasons.
Firstly, investors have turned cautious on semiconductor stocks amid concerns that the massive artificial intelligence (AI) spending by hyperscalers may not generate returns quickly enough to justify current investment levels.
Secondly, many chip stocks surged sharply during early 2026, pushing valuations to elevated levels and encouraging institutional investors to lock in profits. Despite the recent sell-off, Vishay Intertechnology currently trades at a forward 12-month price-to-earnings (P/E) multiple of 36.35, a significant premium to the sector’s average of 24.56.
Vishay Intertechnology Forward 12-Month Price-To-Earnings Ratio
Image Source: Zacks Investment Research
Compared with other semiconductor peers, Vishay Intertechnology trades at a premium to QUALCOMM, while at a lower multiple than FormFactor and Marvell Technology. At present, Qualcomm, FormFactor and Marvell Technology trade at P/E multiples of 16.77, 42.23 and 46.42, respectively.
Thirdly, Vishay Intertechnology faced company-specific pressure after announcing on July 7, 2026 that its 2.25% convertible senior notes due 2030 had become convertible, raising concerns about potential future share dilution. Following the news, shares of the company fell 9.4% in a single day.
While these issues have weighed heavily on sentiment, they appear to overshadow a business that is showing improving fundamentals. With demand strengthening across several end markets and management executing its long-term strategy successfully, the recent decline could offer investors an attractive buying opportunity.
Vishay Intertechnology 3.0 Strategy Is Delivering ResultsThe company's multi-year Vishay 3.0 transformation is now translating into stronger operating performance. The strategy focuses on expanding manufacturing capacity, broadening the product portfolio, improving customer engagement and increasing technical support, enabling Vishay Intertechnology to capture more business across growing markets.
The benefits became visible in the first quarter of 2026. Revenues increased 17.3% year over year to $839.2 million, exceeding management's guidance. Growth was broad-based across every end market, every sales channel and all three major geographic regions. Volume increased 5.8%, supported by stronger customer demand, inventory replenishment and continued market-share gains.
Vishay Intertechnology also reported a healthy book-to-bill ratio of 1.34, including 1.47 for semiconductors, while the backlog expanded 21% to $1.6 billion, representing 5.7 months of sales visibility. These numbers indicate that demand continues to outpace shipments, providing a favorable setup for future revenue growth.
VSH’s Multiple Market Exposure Offers Several Growth DriversUnlike many semiconductor companies that rely heavily on a single end market, Vishay Intertechnology benefits from exposure to several fast-growing industries.
AI-related demand remains one of the strongest growth engines. The company continues receiving orders for high-voltage MOSFETs, polymer capacitors, current-sense resistors and magnetics used in AI servers, networking equipment and power management systems. Management expects AI-related revenues in 2026 to be well above last year's level, helped by expanding customer relationships and additional design wins.
Industrial demand is also improving rapidly. Customers are increasing spending on renewable energy, smart grids, factory automation, power transmission and AI infrastructure. Industrial revenues have now posted five consecutive quarters of sequential growth, supported by improving customer inventories and stronger capital spending. In the first quarter of 2026, revenues from the industrial segment increased 7% sequentially and 22% year over year.
Automotive remains another attractive opportunity. Rising electronic content in hybrid and electric vehicles continues to increase semiconductor demand. Vishay has become the leading resistor supplier for several next-generation EV platforms while also expanding design wins in battery management, ADAS, electronic power steering and powertrain systems. First-quarter revenues from the automotive segment increased 3% sequentially and 11% year over year.
The aerospace and defense segment is emerging as another meaningful growth driver as higher government defense spending supports increasing orders for resistors, capacitors and custom magnetics. In the first quarter, revenues from the aerospace and defense segment increased 14% sequentially and 17% year over year. Healthcare demand also remains healthy, supported by wearable devices, patient monitoring and implantable medical technologies. First-quarter revenues from the healthcare segment increased 5% sequentially and 11% year over year.
Capacity Investments Position VSH for the Next UpcycleVishay Intertechnology has spent heavily over the past several years to prepare for stronger industry demand. Capacity expansion projects include its new 12-inch semiconductor fabrication facility in Germany, additional production at Newport, RI, silicon carbide investments and expanded subcontractor partnerships.
Although these investments have temporarily pressured free cash flow, they position Vishay Intertechnology to respond faster than competitors as industry demand strengthens. Management expects the German fab to begin non-automotive production during mid-2027, while new silicon carbide products continue entering production to address fast-growing power semiconductor markets.
Importantly, management believes the current industry recovery is arriving just as these investments become operational, creating an opportunity for both higher revenues and expanding margins over the coming years.
Vishay Intertechnology’s Profitability to Continue ImprovingWhile VSH continues investing aggressively in capacity expansion, profitability is already improving. First-quarter 2026 gross margin expanded to 21% from 19% a year ago as higher shipment volumes offset ongoing material cost inflation. EBITDA margin improved to 9.3% from 7.6% in the year-ago quarter, while GAAP earnings returned to profitability at 5 cents per share from the year-ago quarter’s loss of 3 cents.
Management expects further improvement during the second quarter, guiding for revenues between $875 million and $905 million and gross margin around 22%. Pricing actions implemented earlier this year should gradually offset higher metal costs, while increasing factory utilization is expected to provide additional operating leverage.
The Zacks Consensus Estimate for 2026 and 2027 revenues indicates year-over-year growth of 16.7% and 10.4%, respectively. The consensus mark for 2026 earnings per share is currently pegged at 75 cents, calling for a robust improvement from a loss of 5 cents in 2025. Earnings estimates of $1.54 per share for 2027 indicate a 104.9% year-over-year increase.
Buy-the-Dip Strategy Looks Good for VSH StockThe recent sell-off appears to reflect short-term market fears rather than weakening business fundamentals. Concerns surrounding AI spending, profit-taking across semiconductor stocks and temporary dilution worries have overshadowed a business that is showing stronger demand, rising backlog, expanding margins and improving market share.
While near-term volatility may continue, Vishay Intertechnology appears well-positioned to benefit from the next semiconductor upcycle due to its expanded manufacturing capacity, diversified end-market exposure and improving execution under the Vishay 3.0 strategy.
Although the stock still trades at a premium valuation, that premium appears justified, given its consistent earnings growth and long-term prospects. For investors willing to look beyond current market sentiment, the recent pullback appears to present an attractive opportunity to buy a fundamentally strengthening semiconductor company.
Vishay Intertechnology sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Paylocity oznámila akvizici Aidora, softwaru nativního pro AI pro správu a compliance při čerpání volna, který je postaven na modelu přirozené jazykové interakce a má zrychlit HR procesy a snížit manuální práci. Firma neočekává materiální dopad na výsledky za první čtvrtletí ani fiskální rok 2027.
SCHAUMBURG, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Paylocity (NASDAQ: PCTY), a leading provider of HCM, Finance, and IT solutions, today announced the acquisition of Aidora, an AI-native leave management compliance software company built on a natural language interaction model that automates highly regulated leave processes.
Leave policies across federal, state, local, and company levels are getting more complex—driving increased administrative work, higher compliance risk, and rising expectations for timely, personalized support during key life events. Manual HR processes and disconnected systems only add to the problem, creating inefficiencies and inconsistent employee experiences.
Aidora expands Paylocity's leave management capabilities with an AI-native solution that saves HR teams time and provides employees a faster, clearer way to manage leave. For HR teams, AI handles the details—from eligibility to compliance, documentation, and payroll—all in one place. For employees, AI acts as a guide: answering questions, explaining options, and helping them navigate leave step by step. They can engage with it through a natural language interaction model, by voice or text.
“Leave management is one of the most complex and time-consuming processes HR teams deal with today,” said Toby Williams, President and CEO of Paylocity. “Aidora helps take that work off their plate by automating what has traditionally been manual, and giving HR teams more confidence in how they manage leave, while also providing a better employee experience.”
The acquisition reinforces Paylocity’s focus on embedding AI across its platform to create efficiency for HR teams and remove manual work that slows organizations down. It also extends Paylocity's value across its customer base—with particular impact for mid-market and enterprise employers navigating the most complex leave requirements.
Paylocity does not expect the acquisition of Aidora to have a material impact on first quarter or fiscal 2027 financial results. Paylocity will provide financial guidance in the normal course of business in its next earnings release.
About Paylocity
Headquartered in Schaumburg, IL, Paylocity (NASDAQ: PCTY) is an award-winning provider of HCM, Finance, and IT software solutions. Paylocity offers one unified, easy‑to‑use platform that helps businesses across HR, Finance, and IT streamline operations, manage spend and talent, and build culture and connection—with AI embedded directly into everyday workflows to save time, reduce manual effort, and support better decisions. Known for its unique culture and consistently recognized as one of the best places to work, Paylocity accompanies its clients on the journey to create great workplaces and help all employees achieve their best. For more information, visit www.paylocity.com.
Life Time otevřela nový Athletic Country Club v Brea Mall, svou 10. pobočku v Kalifornii a 4. v Orange County. Areál má téměř 123 000 čtverečních stop.
Highly anticipated North Orange County opening expands company's presence in strategic retail and mixed-use developments, including its seventh within the Simon® portfolio
Key Highlights:
Grand opening: Life Time Brea opens July 9, 2026, at Brea Mall, located at 1600 Brea Mall Road, Brea, CA 92821. Milestones: The club is Life Time's 10th location in California and 4th in Orange County. Mall Connection: This is the seventh Life Time located at a Simon center. Scale: The destination spans nearly 123,000 square feet, combining an 85,000-square-foot building with 38,000 square feet of outdoor amenities set on three acres. Resort-style Beach Club: A leisure pool with waterslides, a six-lane lap pool, cabanas, lounge chairs and an outdoor dining area and bar. Something for everyone – 90 days to 90 years: Five pickleball courts, rejuvenation suites including cold plunge, whirlpool, steam and sauna, a full-service LifeSpa, signature training including Alpha, GTX and the new CTR reformer class, LifeCafe and a Kids Academy. , /PRNewswire/ -- Life Time (NYSE: LTH), the nation's premier healthy lifestyle brand, has opened its highly anticipated Life Time Brea Athletic Country Club, in North Orange County, marking the 10th destination in California. Located at Brea Mall®, the new club expands Life Time's Orange County presence while reinforcing the company's role as a leading anchor within leading retail and lifestyle environments.
Life Time Brea opened its tenth California location and Fourth in Orange County at Brea Mall on July 9. The highly anticipated North Orange County opening expands company’s presence in strategic retail and mixed-use developments, including its seventh within the Simon® portfolio. Spanning nearly 123,000 square feet, including the 85,000-square foot club building and an additional 38,000-square-feet of outdoor spaces set on three acres, Life Time Brea is designed as a comprehensive healthy way of life destination featuring a resort-style beach club, exceptional programs and services, dynamic personal training, pickleball, recovery, luxury wellness amenities, dedicated spaces for work and social connection, and programming for every age from 90 days to 90 years.
"As our latest athletic country club development, Life Time Brea reflects the continued demand for Life Time's unique blend of wellness, social experiences and luxury amenities at premier retail destinations alongside exceptional partners like Simon," said Parham Javaheri, Executive Vice President, Chief Property Development Officer and President of Club Operations at Life Time. "Through the daily engagement we drive and the vibrant, health-conscious communities we cultivate, Life Time has become a powerful complement to today's most sought-after experience-driven destinations. We're excited to bring that same energy to Brea while helping people of all ages live healthy, happy lives."
Life Time's continued expansion within premier retail destinations reflects a broader shift toward experience-driven environments that encourage repeat visitation, foster community and support how people live, work and connect today.
Key highlights include:
Expansive workout floor and hybrid training spaces with hundreds of pieces of best-in-class strength and cardio equipment, free weights, functional training zones and access to highly certified personal trainers and assessments Dedicated boutique studios and group fitness spaces offering small- and large-group classes across barre, circuit-style, cardio, cycle, Pilates, strength and yoga formats, all led by certified, expert instructors. Also includes CTR (Core. Tone. Reform), Life Time's newest athletic-based training reformer class Integrated recovery and wellness spaces featuring LifeClinic Chiropractic care, stretching areas, water massage and cold therapy chairs, whole-body compression technology, percussion devices, metabolic testing and nutrition coaching Resort-style beach club experience with leisure and lap pools, waterslides, outdoor bar and dining area, and expansive lounge space with cabanas and lounge chairs Five pickleball courts – three climate-controlled indoor and two outdoor – for open play, lessons, clinics, leagues and social events Luxury men's and women's dressing rooms with wet suites featuring sauna, steam, warm spa and cold plunge, plus family changing rooms LifeSpa full-service salon and spa for hair, massage, skin and nails and rejuvenating services LifeCafe serving made-to-order drinks, smoothies, healthy meals and a full-service bar Kids Academy for children ages three months to 11 years, offering daily programming across movement, sports, arts, STEM and enrichment activities Complimentary work lounge providing flexible space to work before and after workouts "We're thrilled to welcome Life Time as an important milestone in the continued evolution of Brea Mall as a more dynamic, mixed-use destination," said Sundesh Shah, Simon's Senior Vice President, Specialty Development. "Life Time brings a best-in-class athletic country club experience that complements the way today's guests live, work, play and shop. This opening also reflects our strong, long-standing relationship with Life Time."
Brea joins other South California Life Time locations, including Laguna Niguel, Lakeshore-Irvine and Rancho San Clemente. It marks an exciting addition to the community with the Brea Mall's greater redevelopment efforts, bringing new jobs, supporting local economic growth, and providing residents with a premier destination that reflects the growing demand for health, wellness, and connected living.
Life Time Brea also connects members to the company's broader healthy way of life ecosystem, including unparalleled in-club experiences, expert coaching, the complimentary Life Time app featuring L•AI•CTM, digital wellness content, and access to national athletic events. Together, these offerings provide personalized, connected pathways to support long-term health and longevity.
Life Time Brea is located at 1600 Brea Mall Road, Brea, CA 92821. For more information, visit the club website, call 714-988-1950 or follow along on the club's Instagram.
For more information about Life Time, visit www.lifetime.life, follow on social media at Facebook, Instagram and LinkedIn, or download the complimentary Life Time App.
Asset: Life Time Brea Flythrough Video
Frequently Asked Questions:
What is Life Time Brea?
Life Time Brea is an athletic country club from Life Time located at Brea Mall. Spanning nearly 123,000 square feet across three acres, it offers a resort-style Beach Club, an expansive workout floor, boutique studios, pickleball, recovery and spa amenities, LifeCafe dining, a complimentary work lounge and kids programming.
When does Life Time Brea open?
Life Time Brea opens on July 9, 2026.
Where is Life Time Brea located? What's the contact info?
Life Time Brea is located at 1600 Brea Mall Road, Brea, CA 92821, as an anchor at Brea Mall. The club can be reached at 714-988-1950. Website. lifetime.life/brea
What amenities and classes does Life Time Brea offer?
Life Time Brea features a resort-style Beach Club with a leisure pool, waterslides, and a six-lane lap pool, five indoor and outdoor pickleball courts, and an LT Recovery Zone with HydroMassage, CryoLounge chairs, Normatec compression, and Hyperice therapy. Group fitness spans barre, cycle, Pilates, strength, and yoga, plus Life Time signature formats including Alpha, GTX, MB360, and the new CTR (Core, Tone, Reform) reformer class. The club also includes a full-service LifeSpa, LifeCafe dining and a Kids Academy for children ages three months to 11 years.
How do I become a member of Life Time Brea?
Membership information is available at the Life Time Brea club website or by calling 714-988-1950.
About Life Time
Life Time (NYSE: LTH) empowers people to live healthy, happy lives through its 195 athletic country clubs across the U.S. and Canada, the complimentary and comprehensive Life Time app featuring its L•AI•C™ AI-powered health companion, and more than 30 iconic athletic events. Serving people ages 90 days to 90+ years, the Life Time ecosystem uniquely delivers healthy living, healthy aging, and healthy entertainment experiences, a range of unique healthy way of life programs, highly trusted LTH nutritional supplements and more. Recognized as a Great Place to Work®, the company is committed to upholding an exceptional culture for its more than 50,000 team members.
DigitalOcean očekává za 2. čtvrtletí tržby 282,1 milionu USD, tedy meziroční růst o 29 %, a hlásí více než 800 milionů USD v remaining performance obligations. Firma říká, že nové kontrakty jsou navázané na inference a AI workloady.
The architectural landscape of cloud infrastructure is fracturing. For years, the market assumed legacy hyperscalers like Amazon NASDAQ: AMZN and Microsoft NASDAQ: MSFT would control the enterprise server space indefinitely, leaving smaller infrastructure providers to fight over budget-conscious developers.
DigitalOcean Today
$143.20 +2.73 (+1.94%)
As of 11:02 AM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$25.56▼
$187.50P/E Ratio62.37
Price Target$145.36
That paradigm shifted on June 7, 2026, as DigitalOcean Holdings NYSE: DOCN defied a broadly declining macroeconomic backdrop and rose by more than 10% following a highly bullish preliminary second-quarter earnings release. The price action signals something much deeper than an earnings beat. The market is witnessing a pivot as smaller independent cloud providers capture high-margin, enterprise-scale workloads.
Get DigitalOcean alerts:
Investors chasing this momentum should unpack the underlying data to separate the growth story from the temporary distortions of short covering and passive index accumulation, because when you look closely, you can observe how DigitalOcean is changing the tide in the enterprise artificial intelligence sector.
Reeling in Revenue: Accelerating Top-Line MetricsAnalyzing the second-quarter pre-announcement reveals the distinct drivers behind the sudden upside volatility. Management now forecasts second-quarter revenue of $282.1 million, a 29% year-over-year acceleration. This decisively eclipses Wall Street’s consensus estimate of $273.6 million and marks a steep re-acceleration from the 14% growth recorded in the second quarter of last year.
While the top-line beat is impressive, the forward-looking metrics are fundamentally resetting valuation models across the sector. DigitalOcean reported remaining performance obligations exceeding $800 million. Remaining performance obligations act as a reliable leading indicator of future revenue, representing contracted but unrecognized sales.
Adding $550 million to this pipeline in a single quarter is a feat of management, reflecting a greater than tenfold increase from the prior year. The weighted-average contract life has also extended from 1.6 years to over three years. By locking in long-term capital, DigitalOcean is preserving adjusted EBITDA margins despite executing heavy infrastructure spending.
Deep Water Infrastructure: The Enterprise AI PivotThe historic surge in contracted revenue requires a permanent re-evaluation of DigitalOcean's target demographic. Historically, the broader market categorized the business as a volume-driven host for small businesses or independent software developers. A low average revenue per user model traditionally struggles during periods of macroeconomic tightening, as smaller clients churn or downsize their hosting plans to survive.
Management explicitly attributes the recent $550 million pipeline jump to multiple nine-figure annual customer commitments strictly tied to inference and AI workloads. Nine-figure contracts are fundamentally incompatible with small business budgets. These agreements are the domain of highly funded enterprise AI labs and institutional research divisions. DigitalOcean is effectively pivoting from a budget-friendly hosting service to a heavyweight player in AI infrastructure.
To support these enterprise contracts, DigitalOcean deployed capital from a recent $800 million equity offering to secure an additional 20 megawatts of data center capacity for late 2027 and early 2028. This brings the total committed capacity to 155 megawatts. By focusing on purpose-built architectures, such as its proprietary inference routing software, DigitalOcean is winning strictly on total cost of ownership against the major hyperscalers, avoiding a margin-crushing race to the bottom on pricing.
Currents of Capital: Institutional Buy-In Vs. Insider ExitsUnderstanding the mechanics of the current price action requires looking under the hood at market sentiment and institutional capital flows. Options flow reflects a strong upside bias, with the volume put-to-call ratio dropping to 0.18 and total contract volume rising above 136% of the average daily volume.
Overall MarketRank™73rd Percentile
Analyst RatingModerate Buy
Upside/Downside3.6% Upside
Short Interest LevelHealthy
Dividend StrengthN/A
News Sentiment0.72 Insider TradingSelling Shares
Proj. Earnings Growth57.41%
See Full Analysis
This bullish derivatives activity is colliding directly with forced buying in the underlying equity. Short interest currently sits at approximately ~12% of the public float, translating to roughly 12.2 million shares shorted. With a days-to-cover ratio nearing four, the double-digit intraday climb is undoubtedly exacerbated by short sellers scrambling to close underwater positions. Institutional ownership commands ~50% of outstanding shares (down from around ~90%), creating a structural floor that successfully absorbed the dilution from the recent equity offering.
Despite the institutional accumulation, retail investors should consider internal structural headwinds. Over the trailing three months, insiders liquidated approximately $565.9 million in stock. The bulk of this distribution came from major shareholder Access Industries, along with multi-million-dollar sales from key executives. With zero open-market insider purchases during this period, internal leadership is clearly utilizing the elevated valuation to take profits.
Sailing Close to the Wind: At 57x Earnings?The fundamental momentum backing DigitalOcean is undeniable, and the expanding contracted revenue provides visibility through 2026. However, market mechanics and valuation multiples should still matter for investors entering at these levels.
DigitalOcean commands a premium trailing price-to-earnings ratio of ~57x. A valuation this rich leaves very little room for operational missteps, particularly in a high-interest-rate environment where the broader technology sector remains highly sensitive to changes in the cost of capital.
The recent addition of DigitalOcean to the Russell 1000 index has led to continued passive index accumulation, creating an artificial tailwind for the share price. Investors should first acknowledge that DigitalOcean is currently priced for perfection, and the heavy insider distribution suggests that early institutional backers have already made the easy money.
Dropping Anchor: Rigging the Deck for an AI PivotThe cloud computing narrative is undergoing a fundamental shift, revealing that nimble, cost-effective infrastructure providers can thrive alongside the trillion-dollar tech giants. DigitalOcean is proving that independent operators can successfully capture enterprise market share without sacrificing profitability. The pivot toward artificial intelligence infrastructure is entirely resetting the forward growth trajectory and shielding DigitalOcean from the high-churn risks typically associated with small business clients.
The underlying data support the bullish price action, driven by tangible contract expansions rather than speculative hype. Investors evaluating the infrastructure space might consider adding DigitalOcean to their watchlist as a high-growth alternative to mega-cap technology stocks, provided they have the risk tolerance for premium valuation multiples and post-squeeze volatility.
Should You Invest $1,000 in DigitalOcean Right Now?Before you consider DigitalOcean, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DigitalOcean wasn't on the list.
While DigitalOcean currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
H.B. Fuller ve 2. čtvrtletí zvýšila čisté tržby o 5,8 % na 950 milionů USD a upravené EBITDA o 9 % na 181 milionů USD díky cenám a lepší marži. Pro fiskální 2026 čeká růst tržeb i vyšší EBITDA.
Key Takeaways H.B. Fuller is prioritizing higher-value markets after its portfolio realignment and Flooring business sale. FUL grew Q2 revenues 5.8% as pricing, restructuring savings and mix lifted margins despite softer volumes. H.B. Fuller projects fiscal 2026 revenue growth and higher EBITDA, with cash flow weighted to the second half. H.B. Fuller Company (FUL - Free Report) is no longer just a broad specialty chemicals story. The investment debate now centers on whether a cleaner portfolio, stronger pricing discipline and medical expansion can support steadier margins.
That setup looks constructive, but not one-sided. Softer consumer-linked demand, flexible packaging weakness and automotive pressure still limit the near-term volume story.
How FUL Is Reshaping Its BusinessFollowing its fiscal 2025 realignment and the sale of the North America Flooring business, H.B. Fuller reports through three segments: Hygiene, Health & Consumable Adhesives, Engineering Adhesives and Building Adhesive Solutions.
The mix spans packaging, converting, hygiene, healthcare, transportation, electronics, clean energy, aerospace, appliances, roofing, building envelope, HVAC insulation and infrastructure. The strategic direction is clear. FUL is shifting toward more resilient and higher-value niches instead of relying mainly on raw volume growth.
H.B. Fuller Pricing Still Drives ResultsPricing remains the clearest support for the current thesis. In the fiscal second quarter, net revenues rose 5.8% year over year to $950 million, while organic revenues increased 2.6%, helped by pricing that more than offset slightly lower volume.
Margin execution was also stronger. Adjusted gross margin expanded 200 basis points to 34.2%, driven mainly by pricing execution and restructuring savings. Adjusted EBITDA rose 9% to $181 million, while adjusted EBITDA margin improved 70 basis points to 19.1%.
Why FUL Still Faces Demand FrictionThe weaker side of the story is volume. The Hygiene, Health & Consumable Adhesives unit saw strength in medical, tape and label and end-of-line packaging, but flexible packaging remained weak.
Engineering Adhesives also had mixed trends. Aerospace, electronics and general industries were stronger, but automotive declined by mid-single digits. These pressures leave earnings more dependent on price, mix, sourcing and cost control than on a broad-based volume recovery.
Avery Dennison Corporation (AVY - Free Report) gives investors another way to look at materials tied to packaging and labeling demand. RPM International Inc. (RPM - Free Report) , with exposure to specialty coatings, sealants and building materials, is also relevant for investors tracking construction-linked materials trends.
What H.B. Fuller Expects NextFor fiscal 2026, H.B. Fuller still expects net revenues to increase in the mid-single digits and organic revenues to rise in the low single digits. Foreign currency translation is expected to add 1-2% to revenues.
Management now expects adjusted EBITDA of $650-$675 million and adjusted earnings of $4.60-$4.90 per share. Operating cash flow is projected at $300-$325 million, with cash generation weighted to the second half of the year.
FUL Signals for Momentum and ValueThe bottom line is that FUL has a credible margin story, but it still needs to prove that pricing, restructuring and mix can offset uneven end-market demand. The proposed Advanced Medical Solutions acquisition adds another potential higher-margin growth platform, but it also brings integration and leverage considerations.
Shares of FUL have lost 7.2% so far this year against the industry’s 15.7% rise.
Image Source: Zacks Investment Research
FUL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The stock also has a VGM Score of A, with a Value Score of A, Momentum Score of A and Growth Score of C. That combination points to favorable value and momentum characteristics, while the Growth Score signals that growth questions have not fully disappeared.
Estimate revisions also remain supportive, with the current fiscal-year earnings estimate up 2.1% over the past four weeks. For investors, FUL looks best framed as a margin-and-mix execution story, not a simple volume recovery play.
H.B. Fuller rozšiřuje svůj záběr do zdravotnictví prostřednictvím plánované akvizice Advanced Medical Solutions, která má zvýšit adresovatelný trh o 15 miliard USD na 95 miliard USD. Ve druhém fiskálním čtvrtletí pomohlo stanovování cen zvýšit čisté výnosy o 3 % a hrubá marže vzrostla na 34,2 %.
Key Takeaways FUL is expanding into medical through the proposed Advanced Medical Solutions acquisition to widen its market.FUL saw aerospace rise 30% and electronics post double-digit gains, offsetting weaker automotive demand.FUL used pricing to lift margins despite higher raw material costs, though volume trends remain soft. H.B. Fuller Company (FUL - Free Report) gives investors a focused way to track changing demand in specialty materials. The company is not relying on one end market or one margin lever.
Its current setup rests on three connected trends: deeper exposure to regulated medical markets, solid demand in aerospace and electronics and pricing actions aimed at offsetting inflation and supply disruptions.
H.B. Fuller Pushes Deeper Into MedicalMedical is becoming a more important part of H.B. Fuller’s portfolio. The proposed acquisition of Advanced Medical Solutions would expand the company into tissue bonding adhesives, surgical tapes, dressings and biosurgical products.
The deal is expected to increase H.B. Fuller’s total addressable market by $15 billion to $95 billion. It also supports the company’s goal of reaching an adjusted EBITDA margin of more than 20% by 2028.
This matters because medical demand tends to be more procedure-driven and regulated than many industrial or consumer applications. That can make the business mix less tied to short-cycle demand swings.
3M Company (MMM - Free Report) remains a relevant comparison for investors watching materials innovation across healthcare, electronics and industrial applications. Its breadth shows why higher-specification materials businesses often attract attention when customers need reliability and regulatory know-how.
FUL Benefits From Aerospace and ElectronicsFUL’s growth is not coming from medical alone. In Engineering Adhesives, organic growth was roughly 5% excluding the exit from the lower-margin solar business.
Aerospace was up 30%, while electronics and general industries posted double-digit gains. Those areas are helping offset softness in automotive, where demand remained weaker across regions.
These trends point to the value of higher-performance niches. FUL’s adhesives are tied to applications where reliability, qualification and technical service matter.
Avery Dennison Corporation (AVY - Free Report) is another materials name investors may watch when tracking specialty materials demand. Like FUL, it gives investors exposure to markets where product performance and customer-specific solutions can shape growth.
H.B. Fuller Navigates an Inflation EraPricing remains central to the FUL story. In the second quarter of fiscal 2026, pricing increased net revenues by 3% and more than offset slightly lower volume.
Adjusted gross margin rose 200 basis points to 34.2%, helped by pricing execution and restructuring savings. Adjusted EBITDA increased 9% to $181 million, with adjusted EBITDA margin improving to 19.1%.
The operating backdrop remains unsettled. Nearly 90% of raw materials were higher in the fiscal second quarter versus the first quarter, and more than 50 force majeure events remained in place.
Management expects high-single-digit pricing in the second half. That gives FUL a margin-defense lever, but it also shows that input-cost pressure has not fully eased.
Why FUL Still Needs Better Volume TrendsThe trend story is not a clean cyclical rebound. Volume weakness remains a constraint, especially in more consumer-linked parts of the portfolio.
Flexible packaging stayed soft, and automotive declined by mid-single digits. Management’s fiscal 2026 framework also includes low- to mid-single-digit volume declines in the second half.
That keeps the investment case tied to mix improvement, pricing and restructuring rather than broad volume recovery. FUL can still improve margins, but stronger demand would make the growth profile more balanced.
The solar exit also creates noise in Engineering Adhesives comparisons. As that headwind laps, healthier niches may become easier to see, but the company still needs better volume confirmation.
FUL Screens Well for This Trend SetupThe bottom line is that FUL is participating in attractive specialty materials trends, but the stock still needs a firmer volume backdrop to turn margin resilience into a more decisive growth story.
Shares of FUL have lost 7.2% so far this year against the industry’s 15.7% rise.
Image Source: Zacks Investment Research
FUL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The stock also has a VGM Score of A, supported by a Value Score of A and Momentum Score of A. Those scores suggest the stock screens well for investors who focus on valuation and earnings-related momentum. The Growth Score of C keeps the signal more balanced, fitting a company with improving mix and pricing power but uneven end-market demand.
The setup is constructive, not risk-free. FUL’s medical expansion, aerospace and electronics exposure, and pricing execution give the stock useful support, while consumer softness, automotive pressure and input-cost volatility remain key areas to watch.
CleanCore Solutions uzavřela první projekt datového centra v západním Texasu s kapacitou 200 MW a potenciálem rozšíření nad 500 MW. Firma plánuje financovat jeho rozvoj mezi nyní a rokem 2029, přičemž 100 milionů USD má být financováno do 1. čtvrtletí 2027.
Company announces transaction for a 200-megawatt data center campus in West Texas with potential to expand to more than 500-megawatts
Alex Spiro to continue as Chairman of the Board of Directors and Tyler Hassen appointed as Chief Executive Officer
, /PRNewswire/ -- CleanCore Solutions, Inc. (NYSE American: ZONE) ("CleanCore" or the "Company") today announced it has closed a transaction for its first data center project in partnership with HST Technologies, Inc. ZONE will own more than 95% of the project, providing capital and share promote economics with development platform provider, HST. The Company plans to further expand its portfolio of AI infrastructure developments to support the growing demand for compute capacity and is excited about partnering with a leading, experienced project developer.
"As AI adoption increases rapidly and the demand for AI infrastructure continues to accelerate, we are actively focused on expanding our footprint of strategically located data center campuses," said Tyler Hassen, Chief Executive Officer of ZONE. "Closing our first data center project within weeks of signing our initial LOI reinforces the pace at which we're executing our strategy. We look forward to announcing upcoming projects in the coming weeks."
The transaction commits the company to funding the initial 200-megawatts of the West Texas data center campus between now and 2029 with $100 million expected to be funded by the first quarter of 2027. The project has the potential to expand to more than 500-megawatts by 2030, and the Company expects the financial performance of the project to be in line with market comparables.
About CleanCore Solutions, Inc.
CleanCore Solutions, Inc. (NYSE American: ZONE) is building the critical infrastructure that powers the AI economy. Through a growing pipeline of projects, ZONE aims to help meet the increasing demand for compute capacity, power, and digital infrastructure required by the world's leading AI companies.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements regarding the anticipated benefits, timing, development, financing, construction, operation, capacity, expansion and financial performance of the Company's data center project and any future data center projects; the Company's ability to fund capital contributions and commitments; the availability and cost of financing; the Company's plans to expand its portfolio of AI infrastructure developments; expectations regarding demand for AI infrastructure and compute capacity; anticipated future project announcements; the Company's strategic transition to AI infrastructure; and other statements that are not historical facts. Forward-looking statements are generally identified by words such as "anticipates," "believes," "expects," "intends," "plans," "may," "will," "could," "should," "estimates," "projects," "potential," "focused on," "aims," "expand," "expected," "look forward," and similar expressions.
These forward-looking statements are based on management's current expectations and assumptions as of the date of this press release and are subject to significant risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied. Such risks and uncertainties include, but are not limited to: the highly speculative and uncertain nature of the Company's anticipated AI critical infrastructure business; the Company's lack of operating history in the data center or computing infrastructure industry; the Company's limited experience in the data center and AI infrastructure industries; the Company's ability to successfully transition its business model from cleaning services; the ability of the parties to satisfy closing conditions and implement the transaction documents; the Company's ability to fund required capital contributions and commitments on anticipated timelines or at all; the availability, cost and terms of project-level, corporate or replacement financing; the significant capital requirements associated with data center development and the Company's limited current financial resources; construction, development, engineering, procurement, supply chain, utility, interconnection, power availability, permitting, zoning, land acquisition, site-control, environmental, operational and commissioning risks; the Company's ability to develop, bring online and expand data center projects on anticipated timelines, budgets, capacity levels or performance expectations; tenant, customer, colocation, power, utility and vendor demand, credit and performance risks; risks that expected financial performance, market comparables, revenues, EBITDA, profitability, returns, preferred returns, carried participation, promote economics or other economic benefits may not be achieved; risks associated with equity consideration, dilution, valuation, stock price volatility, liquidity, listing standards and securities-law compliance; the Company's dependence on HST Technologies, Inc. and other development, technology, operating, financing and construction partners; risks related to proprietary technology, platform licensing, cybersecurity, data security and business continuity; competition from established data center operators, hyperscale cloud providers and other market participants; changes in demand for AI infrastructure and compute capacity; changes in laws, regulations, utility tariffs, interconnection rules, government policy or market conditions affecting AI infrastructure, data centers, energy, power procurement or capital markets; the Company's ability to consummate a sale or disposition of its cleaning products business on favorable terms or at all; risks associated with the Company's transition away from its Dogecoin treasury strategy, including potential volatility in cryptocurrency markets and risks related to the disposition of digital asset holdings; conditions that raise substantial doubt about the Company's ability to continue as a going concern; and general economic, financial, capital market and industry conditions.
For a more complete discussion of risks and uncertainties, please refer to the Company's filings with the U.S. Securities and Exchange Commission ("SEC"), including the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All forward-looking statements are qualified in their entirety by this cautionary statement.
Flex a Cerebras rozšiřují výrobu superpočítačů CS-3 v Milpitasu, což má do roku 2026 zvýšit kapacitu zhruba sedminásobně. Cílí na rostoucí poptávku po AI infrastruktuře.
New manufacturing lines in Milpitas, California will support an anticipated 7x increase in production of Cerebras CS-3 systems as demand for high-performance AI infrastructure accelerates.
, /PRNewswire/ -- Flex and Cerebras Systems Inc. today announced an expanded manufacturing partnership to scale production of the Cerebras CS-3, one of the world's most advanced AI accelerator systems, at Flex manufacturing facilities in Milpitas, California. As demand for AI infrastructure accelerates, the collaboration reflects a significant expansion of advanced manufacturing capacity in the United States.
The expanded operation is expected to increase CS-3 production capacity by approximately 7x through 2026, supported by new production lines, expanded floor space, advanced test infrastructure, and additional skilled manufacturing talent based in California.
At a time when electronics manufacturing is often associated with overseas supply chains, this partnership demonstrates that some of the world's most sophisticated AI systems are being designed, assembled, integrated, and tested in the heart of Silicon Valley.
"The CS-3 is unlike any computer system ever built, and scaling its production requires an extraordinary manufacturing partner. Flex brings the technical depth, operational rigor, and manufacturing expertise needed to support that scale," said Dhiraj Mallick, COO of Cerebras. "People often think the entire AI manufacturing and packaging supply chain lives overseas, but everyday across the U.S., teams of American engineers and technicians are building state-of-the-art AI systems that power frontier AI workloads around the world."
The CS-3 is built on Cerebras' industry-leading wafer-scale engine architecture, featuring a processor physically larger than any conventional AI chip. The system integrates advanced liquid cooling, high-density power delivery, precision mechanical assembly, and tightly coordinated networking infrastructure into a platform designed for large-scale AI training and inference.
Manufacturing the CS-3 presents challenges rarely encountered in traditional server production. Each system requires specialized handling processes, custom tooling, precision calibration, and extensive system-level validation. Flex engineers worked closely with Cerebras to develop dedicated assembly flows, automated test stations, and new manufacturing methodologies tailored specifically to wafer-scale computing systems.
"The CS-3 does not resemble a conventional server or rack-scale compute platform," said Rob Campbell, President of Communication, Enterprise and Cloud at Flex. "Every stage of the manufacturing process—from mechanical integration to thermal validation and final system qualification—required deep collaboration between our engineering teams. We thank Cerebras for their partnership in demonstrating what American advanced manufacturing can achieve when two highly technical organizations work side by side."
To support the ramp, Flex is expanding dedicated manufacturing operations for Cerebras in Milpitas, with multiple new assembly and integration lines coming online through 2026. The footprint devoted to CS-3 manufacturing is expected to grow substantially this year as production accelerates to meet customer demand from AI model developers, cloud providers, and enterprise customers.
The expansion is also contributing to growth in high-skilled manufacturing roles across the region, including manufacturing, systems integration, quality, supply chain, and testing.
Inside the Milpitas facility, production operations span precision mechanical assembly, high-power electrical integration, liquid cooling installation, optical networking validation, and full-rack system qualification. To support growing demand, the site has expanded into a high-throughput manufacturing environment with parallel integration lines, enhanced burn-in and validation areas, additional automated test infrastructure, and increased warehouse and logistics capacity for critical components and finished systems. Tooling and fixtures will enable multiple CS-3 systems to move through integration and testing simultaneously, which is expected to significantly increase throughput while maintaining the rigorous quality and reliability standards required for large-scale AI deployments.
To learn more, please visit cerebras.ai/flex.
About Flex
Flex (Reg. No. 199002645H) is the manufacturing partner of choice that helps leading brands design, build, and manage products that improve the world. With a global footprint spanning 30 countries, Flex delivers advanced manufacturing and supply chain solutions, innovative products and technology, and lifecycle services that support customers from concept to scale. In the AI era, Flex is helping customers accelerate data center deployment by solving power, heat, and scale challenges through cutting-edge power and cooling technology and scalable IT infrastructure solutions. For information about Flex's intent to spin off its Cloud and Power Infrastructure portfolio, visit: https://flex.com/transaction-resources
About Cerebras Systems
Cerebras Systems (NASDAQ: CBRS) is building the fastest AI infrastructure in the world. Cerebras is a team of pioneering computer architects, computer scientists, AI researchers, and engineers of all types that have come together to make AI blisteringly fast through innovation and invention. Cerebras believes that when AI is fast, it will change the world. Cerebras' flagship technology, the Wafer-Scale Engine 3 (WSE-3) is the world's largest and fastest commercialized AI processor. Fifty-eight times larger than a leading GPU chip, the WSE-3 uses a fraction of the power per unit compute while delivering inference up to 15 times faster than leading GPU-based solutions as benchmarked on leading open-source models. Leading corporations, research institutes, and governments on four continents chose Cerebras to run their AI workloads. Cerebras solutions are available on premises and in the cloud.
Contacts
Flex Media & Press
Christie Haber
Senior Director, Commercial Marketing
(602) 245-1057
[email protected]
Flex Investors & Analysts
Michelle Simmons
Senior Vice President, Global Investor Relations and Public Relations
(669) 242-6332
[email protected]
Cerebras
[email protected]
Forward-Looking Statements
This press release contains forward-looking statements, including but not limited to: the anticipated 7x increase in production of CS-3 systems, multiple new assembly and integration lines coming online through 2026, the expected substantial growth this year in the footprint devoted to CS-3 manufacturing, and the expected significant increase in throughput of CS-3 systems while maintaining quality and reliability. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as "anticipate", "estimate", "expect", "project", "plan", "intend", "target", "aim", "believe", "may", "will", "should", "becoming", "look forward", "could", "can," "can have", "likely" and other words and terms of similar meaning. Forward-looking statements give our current expectations and projections relating to the information in this press release. Neither Cerebras, Flex, nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. The forward-looking statements included in this press release relate only to events and information as of the date hereof. Neither Cerebras nor Flex undertakes any obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected.
Meta Platforms klesá o 4,1 % poté, co Reuters uvedl, že letos může do AI infrastruktury utratit až 145 miliard USD. Firma chce do roku 2027 zdvojnásobit výpočetní kapacitu.
Meta Platforms Inc (NASDAQ:META) is sitting out the broader tech rally today, down 4.1% to trade at $578.19. An internal memo reviewed by Reuters indicated the company may spend up to $145 billion on AI infrastructure this year. The aim is to double computing capacity by 2027, and plans to begin manufacturing its 'Iris' chip in September.
META is now down 12.6% in 2026 and back below $600, with recent rallies turned away at a confluence of moving averages. Longer term, the shares are down nearly 21% in the last 12 months, carving a channel of lower highs.
Options bulls are steadfast. META's 10-day call/put volume ratio of 2.21 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) ranks higher than 86% of readings from the past year.
Echoing this, the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.51 sits in the 6th percentile of its annual range, which indicates a heavy preference for calls among short-term traders.
Meta spouští Muse Spark 1.1, svůj dosud nejsilnější model pro agentní a kódovací úlohy, a zpřístupňuje jeho API v public preview. Cílí tím na OpenAI a Anthropic.
Three months after unveiling its first artificial intelligence model under the leadership of AI chief Alexandr Wang, Meta is rolling out a major update as it attempts to compete with OpenAI and Anthropic in critical areas of the market.
Muse Spark 1.1, which Meta introduced on Thursday, represents its "strongest model for agentic and coding work yet," Wang said in an interview with CNBC. The initial Muse Spark model released in April was only available to "select partners" who could access the technology via a "private API preview."
Meta is making the new model's API available through a developer portal as part of a public preview, where users will be able to sign up and see instructions for integration. A Meta spokesperson said some early partners can already access the API, and new users "will be able to add themselves to a waitlist and be added from there over time." For now, Meta said it's limiting API access to its own properties rather than making it available on third-party platforms like the popular OpenRouter marketplace.
"This is going to be served on top of the computer infrastructure that we've built," Wang said.
It's Meta's second notable rollout for the Muse family this week. On Tuesday, Meta released Muse Image, originally code-named Mango, a model for creating images, as the company seeks to attract creators and advertisers to its offerings.
Meta CEO Mark Zuckerberg is coming under pressure from Wall Street to show a return on the company's massive and growing investment in AI infrastructure and development. While it's spending at the rate of its hyperscaler peers, Meta doesn't have a cloud infrastructure business (though it plans to start one), and it's failed to keep up with OpenAI, Anthropic and Google in developing popular models and AI applications.
watch now
Wang characterized pricing of the Muse Spark update as "very aggressive and attractive" compared with similar offerings from labs like Anthropic and OpenAI. He said every new API account will start with $20 in free credits. From there, the company will charge $1.25 per million tokens in input, and $4.25 per million tokens of output, he said.
"The goal is to really have attractive pricing that scales with immense consumption usage," Wang said.
He said Muse Spark 1.1 outperformed rival models in certain tasks involving the ability to interact with various third-party coding products and services.
Wang's Meta Superintelligence Labs, or MSL, trained Muse Spark 1.1 to excel in coding-related tasks because that ultimately improves the capabilities of AI agents that can autonomously perform multiple tasks like a fleet of human interns, he said.
"You kind of have to build coding capabilities as part of that in service of overall agentic capabilities," Wang said.
The tech industry's excitement about AI agents took off in the first half of 2026, in part due to the sudden popularity of OpenClaw, which developers could use to manage AI models that power supercharged digital assistants. Wang said Meta trained Muse Spark 1.1 "to be able to work well with all of the most popular harnesses that developers use today, and we felt that was the best approach for this model given our goal to maximize adoption."
Although Meta's previous AI strategy emphasized releasing its earlier Llama family of models to the open-source community, the company is now focusing on selling access to proprietary AI models.
Wang said that Meta is still "committed to open source" and that his MSL unit has a "variant of Muse Spark that is in development that we do intend to open source." He declined to say when the company would release it.
Wang added that he's been "dog-fooding" the latest Muse Spark model, and is excited about the technology's ability to be used as tool for improving personal health via tasks like searching the web, reading academic papers and accessing personal health-related data.
"It's one of these use cases that I think really encapsulates the needs of these agentic systems," Wang said of his AI and health experiments.
Wang said Meta is currently training a more powerful AI model, code-named Watermelon, but didn't say when it would be released. Muse Spark's code name was Avocado.
Dvě nedávné události s Boeingem 737 MAX na letech Southwest Airlines znovu přitahují pozornost k bezpečnostním rizikům Boeingu i aerolinek. BA je za posledních pět dní do 8. července o zhruba 0,67 % níže.
Two recent incidents regarding a Boeing 737 MAX aircraft have put Boeing Co. NYSE: BA stock back in the spotlight, and not in a good way. Both incidents occurred on Southwest Airlines NYSE: LUV jets. The timing is notable, landing just as Boeing works to reassure investors that its production and quality-control issues are behind it.
Boeing Today
$223.46 -1.50 (-0.66%)
As of 10:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$176.77▼
$254.35P/E Ratio108.36
Price Target$261.61
The first incident occurred on Southwest Flight WN139, which made an emergency return to Maui. The Boeing 737 MAX 8 was en route from Kahului to Las Vegas on July 5, 2026, when the crew reported a mechanical issue. Rather than continuing toward the mainland, the flight diverted to Honolulu.
Get Southwest Airlines alerts:
Passengers described a tense but orderly return, and the aircraft landed safely with no reported injuries. Southwest confirmed the diversion as a precaution, and the plane was inspected before returning to service.
A second, less-reported incident also involved a Southwest MAX 8. That flight, traveling between Denver and Dallas, diverted after the crew flagged a technical issue in mid-flight. Details are thinner, with limited official confirmation so far. Together, the two incidents highlight how quickly minor mechanical alerts can draw scrutiny, especially with a model still shadowed by its troubled history.
737 MAX Incidents Put Boeing Stock Back Under the MicroscopeThe company faced intense scrutiny after two fatal crashes involving the 737 MAX in 2018 and 2019, which led to a worldwide grounding of the aircraft. There's no indication that either recent event involved MCAS, the flight-control system tied to that earlier crisis.
This hasn’t turned into a sell-the-news event. BA is down only about 0.67% over the five days ending July 8. LUV is down about 3.01% over the same period. These new incidents, however, remind investors of the inherent risk in this sector.
One of those risks is the price of jet fuel, which is moving higher as U.S. President Donald Trump recently announced the U.S.-Iran ceasefire is over. For investors tracking BA and LUV, these incidents add a fresh variable to an already complex earnings picture heading into the back half of 2026.
Boeing's Production Recovery Still Faces Execution RisksBoeing's latest earnings paint a picture of a company gaining operational footing while still carrying real risk. Production discipline is the headline: 737 output has stabilized at 42 jets monthly, with plans to reach 47 this summer and eventually 52 once the new Everett North Line comes online.
Certification progress reinforces that momentum, with the 737-7/737-10 nearing final approval, the 777-9 advancing through FAA testing, and a supplier engine issue reportedly identified and being resolved. Higher MTOW approval on the 787-9/787-10 adds further flexibility.
Still, execution risk hasn't disappeared. A wiring nonconformance forced rework on 25 737s, pushing some deliveries into Q2. The 787 program faces its own delays, tied to seat certification and engine timing. Meanwhile, the Spirit AeroSystems integration remains a financial drag, expected to cost roughly $1 billion in cash this year.
Taken together, the stakes center on execution consistency. Boeing has a credible production ramp and certification runway ahead. That’s why the company can ill afford to deal with recurring quality lapses, particularly while integration costs threaten to undercut that progress. Investors will be watching whether operational discipline can outpace recurring one-off setbacks that still weigh on delivery timelines and cash flow.
Higher Fuel Prices Add Pressure to Airline StocksThe risk to Southwest and other airlines is not direct, but it’s nonetheless real.
Buyer behavior matters. Anecdotal evidence showed consumers actively sought out airlines and flights that didn’t use the 737 MAX after the 2018-2019 crashes. Southwest uses the 737 MAX extensively in its fleet, so the operational risk is real, albeit hard to quantify.
Southwest Airlines Today
LUV
Southwest Airlines
$49.47 +0.81 (+1.67%)
As of 10:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$28.98▼
$55.11Dividend Yield1.46%
P/E Ratio31.89
Price Target$49.58
That risk comes at a time when energy prices are on the rise, which means higher jet fuel prices at a time when the consumer is weak. Overall travel demand, including airline demand, has remained solid so far, despite sticky inflation and higher-for-longer interest rates that affect consumers at multiple levels.
Airlines such as Delta NYSE: DAL, which cater to a premium consumer, may not feel the impact as much as Southwest, which relies on a more budget-conscious consumer. That said, while consumers have options, Southwest has significant equity built with its customer base.
Energy prices will be the bigger short-term story for all the airline stocks, including Southwest. And due to the FIFA World Cup, Southwest and other airlines are likely to post good numbers this earnings season. Adding to the bull case, analysts have been raising their price targets for LUV despite the incidents.
If the investigation doesn’t reveal a systemic issue with the 737 Max, investors can remove that risk from their assessments of Southwest and Boeing. But in two sectors where the margin of error is slim, investors may want to exercise caution in the short term.
Should You Invest $1,000 in Southwest Airlines Right Now?Before you consider Southwest Airlines, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Southwest Airlines wasn't on the list.
While Southwest Airlines currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Citigroup dokončila první okamžitou mezinárodní platbu v USD s partnerskou bankou Siam Commercial Bank v Thajsku. SCB patří mezi 300 bank v síti Citi pro okamžité přeshraniční platby.
Citi Bank logo appears in this illustration taken December 1, 2025. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo Purchase Licensing Rights, opens new tab
NEW YORK, July 9 (Reuters) - Citigroup said it completed its first instant international payment in dollars with a partner bank, Thailand's Siam Commercial Bank.
Make sense of global markets with the Trading Day newsletter. Sign up here.
Phillip Securities Thailand, a client of SCB, made an instant transfer of funds in dollars from a Citigroup account in the UK to a Siam Commercial Bank account in Thailand during the U.S. July 4 holiday weekend, Citigroup said in a statement.
SCB is among the 300 banks integrated with Citi's international instant payments network that serves multinational clients at Citi's Services division.
Citi's Head of Payments Debopama Sen said she sees rising client interest in instant international transfers between accounts in different banks.
Instant international transfers through tokenized deposits within Citigroup accounts held by companies are close to $1 billion daily. Citigroup’s global payments division processes around $6 trillion daily across 180 countries.
Reporting by Tatiana Bautzer; Editing by Lincoln Feast.
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Tatiana Bautzer is a U.S. banking correspondent at Reuters in New York. She previously covered banks in Brazil, breaking news on deals by major global corporations, initial public offerings and bankruptcies. She has also delved into corruption scandals at Brazilian conglomerates and business disputes between billionaires. Prior to joining Reuters in 2015, Bautzer worked for business magazines Exame and Istoe Dinheiro and newspapers Valor Economico and O Estado de S. Paulo. She previously served as international correspondent for Valor Economico in Washington, D.C., covering multilateral institutions and trade. Bautzer holds a B.A. in Journalism and an MBA from the University of Sao Paulo.
Zoom uvedl samostatnou AI recepční pro existující telefonní systémy bez nutnosti Zoom Phone. Nabízí nonstop obsluhu, více než 10 jazyků, přepis hovorů, plánování schůzek a směrování hovorů.
SAN JOSE, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ: ZM) today announced a standalone offering for Zoom Virtual Agent (ZVA) Receptionist, enabling organizations to add an AI-powered front desk to their existing phone system without requiring Zoom Phone, helping organizations improve customer responsiveness, extend business availability, and capture more opportunities.
For many businesses, inbound calls are opportunities to win a customer, book an appointment, or strengthen an existing relationship. Yet according to research, 71% of consumers find calling a business more stressful than the issue they're trying to resolve, and 50% say they would switch to a competitor after a single bad experience.
With Zoom Virtual Agent Receptionist, organizations can provide fast, always-available customer assistance through natural, conversational AI that answers calls, assists customers, and routes inquiries around the clock. With support for more than 10 languages, built-in live transcription, appointment scheduling, and intelligent call routing, Zoom Virtual Agent Receptionist helps businesses deliver responsive customer experiences while enabling employees to focus on the conversations that matter most.
“Businesses shouldn’t have to replace their phone system to benefit from AI,” said Chris Moss, general manager of Zoom Phone. "Every inbound call is an opportunity to serve a customer or nurture a prospect. With the standalone Zoom Virtual Agent Receptionist offering, organizations can quickly add an AI-powered front desk to their existing systems, helping them answer more calls, respond faster, and stay available around the clock.”
Extending AI Receptionist capabilities beyond Zoom Phone
Originally introduced as part of Zoom Phone, Zoom Virtual Agent Receptionist is now available across existing business phone systems, making it easier for organizations to adopt AI without changing their communications infrastructure.
Answer and greet every caller with natural, conversational AI in multiple languages.Resolve common customer needs by answering business questions, scheduling appointments, and providing after-hours support.Connect customers to the right person with intelligent call routing and seamless handoff when human assistance is needed. Organizations can now add an AI-powered front desk without changing their existing phone system, making it easier to improve customer responsiveness while preserving existing technology investments and avoiding major migrations.
Whether supporting a retail store, healthcare practice, law office, or growing small business, Zoom Virtual Agent Receptionist helps ensure every caller receives timely, professional assistance while enabling employees to remain focused on serving customers.
Helping organizations capture every opportunity.
Since every inbound call has the potential to generate new business, appointments, or revenue, responsiveness is key to maintaining a competitive edge. During busy periods, after hours, or when employees are focused on helping customers in person, businesses often struggle to respond as quickly as customers expect.
By bringing AI receptionist capabilities to existing phone systems, Zoom is helping organizations improve responsiveness, extend business availability, and create better first impressions without disrupting the technology they already trust.
Available now
Standalone Zoom Virtual Agent Receptionist is available for purchase online beginning today, starting at $29.99 USD per month/100 minutes, or $24.99 USD per month/100 minutes with annual billing. To learn more, visit Zoom.com.
Organizations can also explore Zoom Virtual Agent Receptionist through a free trial program available to both new and existing customers.
About Zoom
Zoom (NASDAQ:ZM) is a system of action for modern work, turning live collaboration into completed results. From entrepreneurs to global enterprises, customers choose Zoom to seamlessly collaborate, communicate, and drive outcomes across meetings, phone, contact center, and more — all with the built-in assistance of Zoom AI. Founded in 2011, Zoom is headquartered in San Jose, CA. For more information, visit zoom.com.
Verizon bude pro nově vyráběná vozidla BMW Group pro USA poskytovat konektivitu 5G Standalone a LTE. Jde o první vozy napojené na jeho celostátní nabídku 5G Standalone pro Connected Vehicles.
July 09, 2026 08:00 ET | Source: Verizon Communications, Inc.
At a glance:
Verizon will provide 5G Standalone and LTE connectivity directly to BMW Group vehicles in the U.S., delivering exclusive telematics support for the BMW Connected Drive system in newly manufactured vehicles The deal stems from Verizon’s long-term partnership with KDDI, which supplies its proprietary Global Communications Platform to BMW Group and global connected services to OEMs in various other industries NEW YORK and DALLAS, July 09, 2026 (GLOBE NEWSWIRE) -- Verizon Business and KDDI today announced a collaboration with BMW Group uniting Verizon’s world-class 5G and LTE networks, KDDI’s expansive Global Communications Platform, and BMW Group’s superior automotive engineering for a second-to-none connected-vehicle experience.
Verizon now provides telematics connectivity for new BMW, MINI, and other BMW Group vehicles manufactured for the U.S. market. This collaboration delivers cellular connectivity directly to BMW Group vehicles, enabling BMW Connected Drive and other digital infotainment, remote, app and telematics services.
“Verizon is committed to delivering seamless connectivity for customers. Our collaboration with BMW Group and KDDI prioritizes innovation and capability to advance the connected experience for drivers across the U.S.,” said Kyle Malady, CEO, Verizon Business.
This major launch stems from Verizon’s long-standing relationship with KDDI, who provides IoT services through its Global Communications Platform to Original Equipment Manufacturers (OEMs) in demanding industries. KDDI’s platform enables a programmable connected experience for BMW Group, giving the automaker complete control of the connectivity and data packets flowing reliably and securely through Verizon’s state-of-the-art 5G network. The service is available for all newly manufactured BMW Group vehicles in the United States.
“At KDDI, we are honored to support BMW Group’s next generation connected vehicle services with our Global Communications Platform,” said Satoshi Oishi, President & CEO, KDDI America Inc. “With over two decades of experience in connected car telecommunications, we understand the critical importance of performance and reliability. Together with BMW Group and Verizon, we are committed to delivering an exceptional connected driving experience to customers across North America.”
These vehicles are the first to be connected to Verizon’s nationwide 5G Standalone for Connected Vehicles offering using its 5G core and 3GPP Release 16 industry standards for 5G standalone.
Visit LinkedIn for more information about KDDI and its connected-vehicle subsidiary KDDI Spherience.
Visit Verizon’s connected-vehicle website to learn more about our services and capabilities or to reach out to a Verizon Business sales representative.
This announcement was originally published by Verizon. Read the original press release.
McDonald’s vidí mistrovství světa FIFA 2026 jako šanci zvýšit zapojení zákazníků a návštěvnost restaurací. V USA, Kanadě a u Arcos Dorados chystá marketing spojený s turnajem během turnaje.
Key Takeaways McDonald's sees the 2026 FIFA World Cup as a chance to deepen engagement and lift restaurant traffic.McDonald's plans event-linked marketing across the U.S., Canada and Arcos Dorados during the tournament.McValue, McCafe and menu innovation may help convert World Cup attention into more restaurant visits. McDonald’s Corporation (MCD - Free Report) is navigating a challenging consumer backdrop from a position of strength. In the first quarter of 2026, global comparable sales increased 3.8%, while systemwide sales grew 6% in constant currency. The company also gained market share across nearly all of its top 10 markets, underscoring the effectiveness of its value-led strategy. As the FIFA World Cup unfolds across North America, McDonald's has an opportunity to build on that momentum by using one of the world's largest sporting events to deepen customer engagement and support restaurant traffic.
FIFA Supports McDonald's Customer Engagement StrategyMcDonald's has maintained a relationship with the FIFA World Cup for more than three decades, but the 2026 tournament carries added strategic significance as matches are being hosted across the United States, Canada and Mexico. Management stated that its U.S. and Canadian businesses, together with Arcos Dorados, have a robust marketing calendar tied to the event, reflecting the company's intent to capitalize on heightened consumer attention during the tournament.
The World Cup complements McDonald's broader growth strategy rather than serving as a standalone initiative. The company continues to pair compelling value with culturally relevant marketing and menu innovation to drive customer traffic. Its recently enhanced McValue platform, featuring under-$3 menu items and expanded meal deals, strengthens its affordability proposition, while the nationwide rollout of the new McCafe beverage platform broadens consumption occasions beyond traditional meal times. Together, these initiatives likely position McDonald's to translate event-driven consumer engagement into incremental restaurant visits.
However, weak consumer sentiment, elevated gas prices and continued pressure on lower-income customers remain concerns. Nevertheless, McDonald’s emphasis on disciplined execution and its enhanced McValue platform bodes well. If McDonald’s successfully integrates its FIFA activation with its value, marketing and menu strategies, the tournament could help reinforce customer engagement and support sales momentum through the remainder of 2026.
MCD’s Price Performance, Valuation & EstimatesShares of McDonald’s have dropped 2.8% in the past year compared with the industry’s fall of 4.3%. In the same time frame, other industry players, including Starbucks Corporation (SBUX - Free Report) , have gained 12%, while Dutch Bros Inc. (BROS - Free Report) lost 2.1%.
MCD Stock’s One-Year Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, MCD trades at a forward price-to-sales (P/S) multiple of 6.75, above the industry’s average of 3.38. Then again, other industry players, such as Starbucks and Dutch Bros, have P/S ratios of 2.98 and 4.88, respectively.
MCD’s P/S Ratio (Forward 12-Month) vs. Industry
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MCD’s 2026 earnings per share has declined from $13.07 to $12.93 in the past 60 days.
EPS Trend of MCD Stock
Image Source: Zacks Investment Research
The company is likely to report strong earnings, with projections indicating a 6% year-over-year increase in 2026. Conversely, industry players like Dutch Bros are likely to project a rise of 22.4% in 2026 earnings. Starbucks is likely to witness growth of 12.7% year over year in fiscal 2026 earnings.
MCD’s Zacks RankMCD stock currently has a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Teva získala exkluzivní globální práva na komercializaci biosimilárního kandidáta k Ocrevusu od Polpharma Biologics po regulačním schválení. Pokryje intravenózní i subkutánní formu v USA, Evropě, Brazílii, Kanadě, Austrálii, na Novém Zélandu, v Izraeli a Turecku.
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both intravenous and subcutaneous formulations. Agreement advances Teva’s Pivot to Growth strategy by expanding its biosimilars pipeline through strategic collaborations.Agreement reflects both companies’ commitment to broadening access to biologic medicines.
TEL AVIV, Israel and ZUG, Switzerland, July 09, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities.
“This agreement reflects our focus on pushing high-quality biologics to the finish line efficiently and at scale,” said Anjan Selz, Chief Executive Officer of Polpharma Biologics International AG. “Teva brings reach, discipline and real commercial strength to our strategic collaboration. Combining its global footprint with our technical and development capabilities creates a clear path to getting this medicine to patients who need more treatment options.”
Under the terms of the agreement, Polpharma Biologics retains full responsibility for the development and manufacturing of the biosimilar candidate. Teva will be responsible for regulatory submissions and, upon approval, commercialization of the intravenous and subcutaneous formulations in the United States, Europe, Brazil, Canada, Australia, New Zealand, Israel and Turkey.
“This agreement is aligned with Teva’s Pivot to Growth strategy and our focus on expanding our biosimilars pipeline. With our global commercial footprint and deep expertise in complex medicines, we are well positioned to help bring this biosimilar candidate to patients,” said Yolanda Tibbe, Vice President, Global Head of Biosimilars at Teva.
This strategic agreement reinforces both organizations’ commitment to broadening access to biologic medicines while promoting the long-term sustainability of healthcare systems.
About ocrelizumab
Ocrelizumab is a humanized monoclonal antibody designed to target CD20-positive B cells, which are believed to play a role in the autoimmune activity associated with multiple sclerosis. Ocrevus® (ocrelizumab) is indicated for the treatment of relapsing forms of multiple sclerosis and primary progressive multiple sclerosis. In the U.S., the intravenous formulation is marketed as Ocrevus®, while the subcutaneous formulation is marketed separately as Ocrevus Zunovo® (ocrelizumab and hyaluronidase-ocsq). In the EU, both formulations carry the single brand name Ocrevus®.
About Multiple Sclerosis
Multiple sclerosis is a chronic, unpredictable and progressive disease of the central nervous system, which includes the brain and spinal cord. In MS, the loss of myelin, the protective sheath surrounding nerve fibers, disrupts the transmission of electrical signals to and from the brain, leading to a wide range of symptoms.
MS affects people differently. Symptoms can fluctuate, with periods of worsening (relapses) followed by partial or full recovery (remission). Over time, some patients may also experience a gradual progression of disability.
Common symptoms include fatigue, weakness, numbness or tingling, walking difficulties, spasticity, dizziness, and vision problems, among others.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.
About Polpharma Biologics
Polpharma Biologics International AG is a biopharmaceutical company focused on development and manufacturing of biosimilars for supply to global markets. We manage the entire value chain: from product selection and investment allocation, through program execution to asset monetization, ensuring fast progress from idea to launch in strong collaboration with our global partners.
Our international team of senior experts has proven experience in program leadership, regulatory strategy, CMC integration, device development, clinical oversight, and quality assurance. Working with trusted CDMOs and CROs, we deliver end-to-end biosimilars, from cell line to finished product, across a range of major therapeutic areas. Our commercial partners ensure access for patients to these medicines worldwide.
Our mission is to accelerate access to biologics. To fulfill that mission, we maintain a robust, expanding pipeline of biosimilars in development. www.polpharmabiologics.com
Media Contact – Polpharma Biologics
Stephanie Deitzer
Lead Transformation & Communications
Polpharma Biologics International AG [email protected]
+41 78 600 53 59
Teva Cautionary Note Regarding Forward-Looking Statements
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully execute our collaboration agreement with Polpharma Biologics for the commercialization of its biosimilar candidate to ocrelizumab, upon regulatory approval; our ability to successfully compete in the marketplace, including our ability to develop and commercialize additional pharmaceutical products; our ability to successfully execute on our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the first quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned “Risk Factors” and “Forward-looking statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
1 Ocrevus® and Ocrevus Zunovo® are registered trademarks of Genentech, Inc. and/or F. Hoffmann-La Roche Ltd.
Sony oznámila, že od roku 2028 ukončí fyzické herní disky a přejde na digitální distribuci. Firma tím chce reagovat na preference zákazníků a snížit náklady.
This is a fair market value price provided by Massive. Learn more.
52-Week Range$19.32▼
$30.34Dividend Yield0.53%
Price Target$22.00
Sony Corp. NYSE: SONY announced plans to discontinue its physical gaming discs starting in 2028. According to the company, the move is being made to coincide with consumer preferences. That sentiment is backed up by Take-Two Interactive NASDAQ: TTWO , which announced that its latest version of Grand Theft Auto will be available exclusively in a digital format.
SONY hasn’t moved much since the announcement, and for good reason. The issue of physical discs doesn’t address the larger threat that’s facing the gaming industry as a whole.
Get Sony alerts:
For updates on that front, investors will have to wait for the company’s earnings report, which is due in early August.
Memory Costs Remain Sony's Biggest Gaming HeadwindThe short-term reaction to the phase-out news was predictable. The decision will lead to cost savings, which investors love. It also has the potential to improve margins.
But it does nothing to address the memory issue, which will still be front and center for Sony and other gaming companies, such as Microsoft NASDAQ: MSFT. Microsoft has recently announced company-wide layoffs of up to 4,800 workers. However, most of those displaced will come from its gaming division, which is struggling with higher memory costs for its Xbox.
Sony faces those issues with its PlayStation console, but on a much greater scale. Sony's PlayStation 5 currently dominates in market share with an estimated 75 million active units globally. That’s a stark contrast to the 30 million units sold across the Xbox Series ecosystem.
That means the company faces a memory issue that’s literally twice as large as that of Microsoft and even more so than that of Take-Two.
Sony's Move Away From Discs Raises Ownership ConcernsSony’s decision, on top of Take-Two's move, is a shot across the bow at a company like GameStop NYSE: GME, which still generates a significant share of its revenue from physical gaming hardware, including discs. But that’s been a known issue for years. GameStop has closed over 1,300 stores in the last two fiscal years due to dwindling demand for physical games.
The real backlash is coming from collectors and physical media loyalists who have now lost the ability to resell, lend, or buy used games. Eliminating discs ties ownership more tightly to platform accounts/servers. The argument is that the absence of physical discs eliminates the second-hand market and gives consumers no alternative to the PlayStation Store. That means after 2028, Sony will be the only arbiter over what a game costs and how long users can use it.
On one level, the concerns hold some merit. If Sony decides to delist a title, gamers who don’t own the physical disc could lose access entirely. Even if they have a physical disc, the functionality will be limited to that version.
Those concerns are coming to a head in a lawsuit by a Dutch law firm, which is seeking $457 billion dollars in damages. The “Fair PlayStation” campaign addresses the “Sony tax,” which refers to the 30% commission that Sony levies on all products sold through its stores.
Plus, the announcement comes shortly after Sony raised the price of its disc-edition PlayStation to $649.99 from $549.99—a not-so-subtle way to nudge consumers to higher-margin digital sales. It may be a coincidence, but the optics give the critics some validity.
However, the real erosion of consumer ownership rights is mostly an argument dressed in nostalgia's clothing. No privacy rights are being lost, and Sony’s larger point is correct. More gamers are simply choosing to download the updated version of a game.
SONY Stock Analysis: Technical Signals Point to Limited UpsideSONY is down about 17% in 2026. The good news is that it looks like it’s formed a bottom at just under $20 per share. The concern is that the upside may be limited without better momentum.
The Sony analyst forecasts on MarketBeat show a consensus price target of $22, which leaves less than 4% by way of upside. Assuming earnings growth of around 10% in the next 12 months, the company’s annual dividend looks safe and may increase. But the yield of 0.5% may not be enough to keep investors interested.
The daily chart supports a case for cautious optimism, but with a big asterisk. Shares have climbed off their recent low to about $21, and the MACD line has crossed above its signal line, a bullish signal that often precedes further near-term gains. That said, the stock remains well below its 200-day simple moving average of $24.05, a level SONY hasn't reclaimed since December 2025.
That gap between improving short-term momentum and a still-declining long-term trend line is exactly why the upside looks capped. A bounce off support isn't the same as a confirmed reversal, and bulls likely need a close above the 200-day average before the broader downtrend is truly broken.
Should You Invest $1,000 in Sony Right Now?Before you consider Sony, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sony wasn't on the list.
While Sony currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Rackspace Technology a Palantir představují rámec pro provoz AI v regulovaných firmách, který má pomoci bezpečně nasadit AI do produkce. Rackspace uvádí, že má už zhruba 400 certifikací Palantir.
SAN ANTONIO and MIAMI, July 09, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a global enterprise AI infrastructure and solutions provider, and Palantir Technologies Inc. (NASDAQ: PLTR) today announced an operating model framework to help regulated and sovereign enterprises own and operate AI in production. The framework, delivered through Rackspace, combines Palantir Foundry and AIP with Rackspace’s governed private cloud, sovereign cloud, on-prem infrastructure, certified FDEs, and managed operations for customers that require control over data, security, governance, deployment location, and operational outcomes.
The framework is built for markets such as healthcare systems protecting patient records, financial institutions running on regulated data, energy operators with air-gapped infrastructure, and sovereign organizations that cannot move data across borders. For these customers, AI deployment is guided by a few fundamental, non-negotiable questions: Who owns the data? Where should the data live? And can their models be used to build someone else's business? For these customers, where governance, compliance, and security are non-negotiable, AI in production calls for both a platform and a governed operator. Palantir provides the AI operating layer; Rackspace provides the infrastructure, certified engineers, and managed operations to run that layer where the customer’s mission, data, and obligations live.
"While most regulated enterprises have an AI strategy, they often lack the operating model to put AI into production safely and at scale. This effort by Rackspace closes that gap," said Gajen Kandiah, Chief Executive Officer of Rackspace Technology. "Rackspace brings the governed infrastructure, the Palantir-certified engineers, the managed operations, and the accountability for outcomes in the environments where our customers actually live. This is deploy and operate, not deploy and leave. This is how organizations with the most demanding requirements move AI into production at scale."
“Sovereign AI requires more than access to a model. It requires an operating layer that lets enterprises govern data, enforce permissions, route models, audit actions, and deploy capability where the mission lives,” said Alex Karp, Co-Founder and Chief Executive Officer of Palantir Technologies. “This framework brings Palantir Foundry and AIP together with Rackspace’s infrastructure and delivery capabilities for mission-critical environments.”
Since the companies’ initial February 2026 announcement, the partnership has built measurable momentum. Rackspace has scaled to approximately 400 Palantir certifications across sales, engineering, delivery, and operations, including a large global cohort of Palantir-certified forward deployed engineers (FDEs) to serve demand across healthcare, financial services, energy, and mid-market. The first joint deployment closed in <2 months with Rackspace FDEs deploying AI-enabled workflows on Palantir Foundry inside a U.S.-based solar tracking manufacturer to deliver a 94% reduction in their quote cycle time.
Rackspace is also committing to deploy Foundry and AIP across more than 70% of its own back-office operations under the Rackspace OneOS program. In doing so, Rackspace runs its own business on the same governed stack it operates for customers, retaining full control of its data and models rather than ceding them to a third party.
Under the framework, Rackspace serves as a preferred operator for on-premise, private cloud, and sovereign Palantir deployments across critical infrastructure in both the public and private sectors, and for enterprises that demand the same control governments require – with Palantir Foundry and AIP as the data + AI platform layer of the governed enterprise AI stack that Rackspace has been assembling throughout 2026. The two companies will work together to acquire and serve customers in healthcare, financial services, energy, private equity, and the mid-market. The collaboration also aims to stand up large-scale private cloud and sovereign deployments, where Rackspace and Palantir FDEs work side by side inside customer environments. Across these motions, Rackspace will provide the governed infrastructure, certified forward-deployed engineers, and managed operations that take Palantir Foundry and AIP into production. The result is a new category of partnership and operating model delivered by Rackspace designed for regulated enterprises to deploy AI in production.
To learn more visit: https://www.rackspace.com/enterprise-ai/partners/palantir
About Rackspace Technology
Rackspace Technology® (NASDAQ: RXT) is the operator of the full enterprise AI stack from governed private cloud to AI inference and agents in production. With an Outcomes-as-a-Service model built on secure infrastructure, data foundations, and forward-deployed engineering, Rackspace delivers business results for regulated and mission-critical industries where governance, sovereignty, and uptime are non-negotiable. Learn more at www.rackspace.com.
About Palantir Technologies
Foundational software of tomorrow. Delivered today. Additional information is available at palantir.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, the parties’ expectations regarding the amount and the terms of the contract and the expected benefits of Palantir's software platforms and Rackspace’s governed infrastructure and delivery capabilities. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond the parties’ control. These risks and uncertainties include the ability to meet the unique needs of customers; the failure of Palantir's platforms and Rackspace’s governed infrastructure and delivery capabilities to satisfy customers or perform as desired; the frequency or severity of any software and implementation errors; Palantir's platforms’ reliability; and customers' ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings Palantir and Rackspace make with the Securities and Exchange Commission from time to time. Except as required by law, Palantir and Rackspace do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.
AstraZeneca klesla v ranním obchodování o 9,55 % poté, co Wainua selhala v klíčové studii fáze III u srdečního onemocnění. Firma uvedla, že test nesplnil primární cíl.
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 9.55% in early trading, wiping £19 billion from the company's valuation, after its Wainua drug failed a closely watched Phase III trial in a form of heart disease.
The drop propelled the stock to the top of the FTSE 100 losers' list.
The CARDIO-TTRansform trial, run with US partner Ionis, tested Wainua in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), a progressive and often fatal condition in which misfolded protein builds up in the heart.
The study did not meet its primary endpoint of reducing cardiovascular deaths and recurrent cardiovascular events over 140 weeks compared with placebo.
AstraZeneca said adding Wainua to today's standard of care, which included a stabiliser treatment for most patients, provided no statistically significant benefit.
In a prespecified subgroup of patients receiving Wainua on its own, fewer events were observed and the result was nominally significant, though no treatment effect was seen in patients already on stabiliser therapy.
The trial was the largest ever run in ATTR-CM, enrolling 1,432 patients across 130 sites in 20 countries.
Full data will be presented at the European Society of Cardiology Congress in August.
Sharon Barr, head of biopharmaceuticals research and development at AstraZeneca, said that although the trial missed its primary objective, the results support greater scientific understanding of treatment approaches for the hundreds of thousands of patients living with the disease worldwide.
The readout was one of three major Phase III catalysts hanging over the stock in the second half, alongside the SERENA-4 trial of breast cancer drug camizestrant and the AVANZAR lung cancer study of Datroway.
Citi, which has a buy rating on the shares, had modelled peak Wainua sales in ATTR-CM of around $6.2 billion, with a 59% probability of success, making it the highest-conviction of the three readouts.
The bank estimated in May that a failure of CARDIO-TTRansform would knock around 2.8% off its discounted cash flow valuation, equivalent to roughly £5.20 off its £181 fair value estimate.
Notably, Citi argued at the time that the roughly 10% fall in AstraZeneca shares from their pre-results highs already exceeded the combined 7% downside it attributed to the failure of all three trials.
Even in a scenario where all three readouts disappointed, the bank calculated a bear-case valuation of £168, still 23% above where the shares were then trading.
The broker's bull case, assuming success across all three, pointed to a valuation of around £204.
Today's sell-off suggests the market is pricing in a harsher read-across, with investors likely reassessing the risk attached to the remaining SERENA-4 and AVANZAR readouts later this year.
Citi has consistently described AstraZeneca as having the best growth and best pipeline in European pharma, with $46 billion of risk-adjusted peak pipeline sales and ten Phase III readouts due in 2026.
Wainua is already approved in more than 20 countries for the polyneuropathy of hereditary transthyretin-mediated amyloidosis, a separate nerve-damage indication unaffected by today's result.
Micron plánuje investovat až 3 miliardy USD do posílení amerického dodavatelského řetězce polovodičů. Součástí je také 500 milionů USD pro GlobalWafers a desetiletá dodávka křemíkových waferů.
Investment supports GlobalWafers’ U.S. wafer manufacturing expansion and other strategic investments for long-term supply assurance July 09, 2026 08:30 ET | Source: Micron Technology, Inc.
BOISE, Idaho, July 09, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced plans to invest up to $3 billion to strengthen the U.S. semiconductor supply-chain ecosystem and enable the critical semiconductor manufacturing footprint needed for future technology innovation. The investment reflects Micron's commitment to securing a reliable U.S. supply of critical manufacturing materials, enhancing supply assurance, improving long-term planning flexibility, and supporting the growing demand for advanced memory and storage solutions driven by artificial intelligence and other data-intensive applications.
As part of Micron’s planned investment into the U.S. supply chain, the company will provide GlobalWafers Co., Ltd. with $500 million in strategic financing support to advance the development and manufacturing capabilities of its GlobalWafers America 300mm raw silicon wafer manufacturing facility in Sherman, Texas. The companies will also enter into a 10-year supply agreement that will provide Micron with access to significant raw silicon wafer capacity to support its long-term manufacturing plans and bolster the critical semiconductor manufacturing ecosystem in the United States.
"Securing a reliable supply of critical input materials is essential to supporting Micron’s long-term growth and technology roadmap," said Ben Tessone, senior vice president and chief procurement officer at Micron Technology. "Micron’s strategic investment in the U.S. semiconductor ecosystem and GlobalWafers' raw silicon wafer manufacturing facility reflects our commitment to strengthening supply assurance, deepening collaboration with key suppliers, and supporting the expansion of the semiconductor supply chain and manufacturing infrastructure in the United States. Together, these efforts help build a more resilient supply chain that can support future innovation and growing demand for advanced memory solutions."
"Micron has long been an important partner of GlobalWafers, and we are honored to further deepen our strategic collaboration and jointly support the stable supply of critical materials for the semiconductor industry. GlobalWafers is currently the only raw silicon wafer supplier participating in the CHIPS for America Program that is capable of locally producing advanced 300mm wafers in the United States," said Doris Hsu, Chairperson and CEO of GlobalWafers. "Through this close collaboration with Micron, we are not only continuing to meet market demand for high-quality semiconductor wafers, but also helping to strengthen local manufacturing capabilities and supply chain resilience, working hand in hand with Micron to support the continued growth of the U.S. semiconductor ecosystem."
Beyond manufacturing expansion and long-term supply commitments, Micron and GlobalWafers intend to explore collaboration on next-generation wafer technologies and process innovations to support future semiconductor manufacturing requirements.
The proposed transaction remains subject to definitive agreements, customary approvals and closing conditions.
U.S. Secretary of Commerce Howard Lutnick:
“Micron’s pledge of $3 billion to strengthen the U.S. semiconductor supply chain and expand domestic manufacturing capabilities is making the United States stronger in a sector that is vital to our economy and our technological leadership,” said Commerce Secretary Howard Lutnick. “When great companies invest in America, build in America, and bet on American workers, we create the conditions for our country and companies to succeed.”
U.S. Trade Representative Ambassador Jamieson Greer:
“Memory chips are vital to the infrastructure we depend on, from satellites and cars to medical devices and defense systems. President Trump’s trade agenda is safeguarding these critical industries by incentivizing companies to build, invest, and innovate on American soil. Micron’s additional investment of $3 billion will further expand our domestic manufacturing footprint, creating more jobs, enhancing our supply chain resilience, and strengthening our semiconductor ecosystem.”
U.S. Sen. John Cornyn:
“Micron’s $500 million investment in GlobalWafers is great news for North Texas and the Lone Star State’s semiconductor industry,” said Sen. Cornyn. “This project will not only expand the GlobalWafers facility in Sherman but also help create new jobs and strengthen our nation’s chip manufacturing capabilities, and I look forward to seeing these positive developments in Texas’ Silicon Prairie.”
U.S. Rep. Pat Fallon:
“Consistent, reliable access to critical materials is essential for the U.S. to maintain a robust and resilient supply chain here at home,” commented Congressman Pat Fallon (TX-04). “This is welcome news that Micron has announced a major investment in the silicon wafer manufacturing facility here in Sherman, TX. Not only is this announcement a testament to the fact that North Texas continues to attract critical economic development, but it is also a major step forward towards shoring up domestic semiconductor manufacturing. This facility is a benefit both to Texas’ Fourth District and U.S. national security.”
Sherman Mayor Shawn Teamann:
"The city of Sherman’s central role in the domestic semiconductor ecosystem has transformed our city into the hub of the North Texas 'Silicon Prairie,' with billions of dollars in investment and thousands of new jobs,” said Sherman Mayor Shawn Teamann. “Micron’s commitment to support GlobalWafers’ expansion is a huge step forward for the U.S. semiconductor industry, the State of Texas, and our growing, historic city. We’re thrilled to have a world class company like Micron investing in the future of this great nation, right here in Sherman."
About Micron Technology, Inc.
Micron Technology, Inc. is an industry leader in innovative memory and storage solutions, transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership and manufacturing and operational excellence, Micron delivers a rich portfolio of high-performance DRAM, NAND and NOR memory and storage products. Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence (AI) and compute-intensive applications that unleash opportunities — from the data center to the intelligent edge and across the client and mobile user experience. To learn more about Micron Technology, Inc. (Nasdaq: MU), visit micron.com.
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding demand growth, investment amounts and timing, and development of the U.S. semiconductor supply chain. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially. Please refer to the documents Micron files with the Securities and Exchange Commission, specifically its most recent Form 10-K and Form 10-Q. These documents contain and identify important factors that could cause actual results to differ materially from those contained in these forward-looking statements. These certain factors can be found at https://investors.micron.com/risk-factor. Although Micron believes that the expectations reflected in the forward-looking statements are reasonable, Micron cannot guarantee future results, levels of activity, or achievements. Micron is under no duty to update any of the forward-looking statements after the date of this press release to conform these statements to actual results.
Micron zvyšuje plánované investice v USA na více než 250 miliard USD do roku 2035 a v Clay ve státě New York dokončil první betonáž více než čtvrtletí dříve, než byl původní plán.
Micron raises its planned U.S. investment to more than $250 billion through 2035 and celebrates a construction milestone at what will be the largest semiconductor manufacturing site in U.S. history July 09, 2026 08:45 ET | Source: Micron Technology, Inc.
CLAY, N.Y., July 09, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced it is accelerating its planned U.S. fab and technology investments and increasing its expected spend to more than $250 billion through 2035, driven by surging demand for memory in the AI era.
Micron anticipates that the increase in investments will support its long-term goal of producing 40% of its DRAM in the U.S. while creating additional good-paying direct and indirect jobs. The expanded investment reflects Micron’s confidence in its technology leadership and continued demand for its leading-edge memory products.
The announcement comes as Micron celebrates the first concrete pour milestone at its Clay, New York site, which occurs more than one quarter ahead of the original plan and marks the transition from site preparation to vertical construction. As announced earlier today, Micron also plans to invest up to $3 billion to develop the domestic semiconductor supply chain ecosystem in support of its U.S. manufacturing footprint.
Today, Micron Chairman, President and CEO Sanjay Mehrotra will host the concrete pour, joined by supplier partners and federal, state and local leaders, including U.S. Secretary of Commerce Howard Lutnick, New York Governor Kathy Hochul, Small Business Administration Administrator Kelly Loeffler, U.S. Chief Technology Officer Dr. Ethan Klein, Onondaga County Executive Ryan McMahon, U.S. Congressman John Mannion, U.S. Congresswoman Claudia Tenney, and Town of Clay Deputy Supervisor Joe Bick.
"As America celebrates its 250th anniversary, data and memory are foundational to the modern economy — and Micron is increasing our U.S. investments to more than $250 billion through 2035 to meet that moment," said Sanjay Mehrotra, Micron Chairman, President, and CEO. "I want to thank President Trump, Secretary Lutnick, Governor Hochul, Senator Schumer, County Executive McMahon, and our partners across government and the community for their leadership. Reaching this milestone ahead of schedule reflects the speed and determination behind this project. Micron is proud to bring the world's most advanced memory manufacturing to Central New York, strengthen the domestic semiconductor supply chain and help secure America's technology leadership for generations to come."
A Media Snippet accompanying this announcement is available by clicking on this link.
“President Trump has made it clear that America is where you should build your business and the world is responding rapidly. Today, Micron pours the foundation on its massive semiconductor campus in upstate New York and increases its American investment commitment to $250 billion, creating nearly 100,000 jobs and providing leading-edge memory supply here in the United States,” said Commerce Secretary Howard Lutnick. “The Trump economic model clearly shows there has never been a better time to invest in the United States.”
"Today's milestone marks another major step for Micron in Central New York, and what makes it even more remarkable is that we're here in July — months ahead of schedule — pouring the concrete foundation,” said Governor Kathy Hochul. “This is the largest private investment in New York State history, and it's already delivering for New Yorkers, our state economy, and our local businesses. With up to 50,000 jobs on the horizon, we are building the future of American memory manufacturing right here in Central New York, and we are building it fast."
Rapid progress in Central New York
Less than six months after breaking ground in January 2026, Micron has completed key early site work and is transitioning to vertical construction. Micron recently selected Bechtel to partner on the engineering, procurement and construction for the first New York fab. Jacobs, the architectural and engineering design partner, and Gilbane Building Company, the preconstruction and site infrastructure contractor, will also join the celebration.
To date, Micron, in partnership with Gilbane on the early site works phase, has directed approximately $675 million — more than half of the total awarded value to date — to New York-based contractors, suppliers, and subcontractors, including companies from Syracuse, Liverpool, Rome, Rochester, Watertown, Buffalo, and Binghamton. More than 80% of the workers on site to date have been New York residents, reflecting the project's impact on upstate New York businesses and communities.
Building the facility will require thousands of skilled craft professionals at peak construction, creating opportunities for union trades, apprentices, local training program graduates, specialty contractors and suppliers. With up to four fabs, Micron’s New York project is the largest private investment in state history and is expected to generate 50,000 jobs in New York, including 9,000 direct Micron jobs.
Building America's memory across the United States
The New York project is the cornerstone of Micron's U.S. investment plan. Micron is also making rapid progress in Idaho, with first wafer output expected in mid-calendar 2027 for the first fab and late calendar 2028 for the second. Earlier this year in Virginia, Micron launched initial production of its 1α (1-alpha) DDR4 technology, supporting customers’ long lifecycle product needs in auto, industrial, medical, aerospace and defense markets.
Together, these projects are expected to create more than 90,000 jobs and advance U.S. economic and national security goals. As Micron makes these investments, the company will remain disciplined in its approach and responsive to the market environment to appropriately align its supply plans.
“This milestone in Central New York shows Micron’s U.S. manufacturing strategy moving from planning to meaningful local impact,” said Manish Bhatia, Micron Executive Vice President of Global Operations. “As we build the capacity, workforce and supplier base needed for the AI era, we are creating opportunities for New York businesses, skilled trades and communities to grow with us. What we are building here will contribute to a thriving semiconductor hub in Central New York, complementing Micron’s existing sites in Idaho and Virginia.”
Investing in the Central New York Community
In honor of America's 250th anniversary, Micron recently announced a $250 million investment in Trump Accounts to reach one million children and families. The company will offer a one-time $250 seed deposit for eligible children in the communities where it operates, including Central New York, as well as an employee match benefit. To date, Micron has also committed more than $50 million to community priorities across Central New York, supporting workforce development, STEM education and other training needs, veterans’ initiatives, housing, transportation, and childcare.
Photos from the event will be available after 3 p.m. ET here.
Kelly Loeffler, Administrator of the U.S. Small Business Administration:
"Micron's massive investment in Central New York – part of a $250 billion investment nationwide – is exactly the kind of bold, American-made commitment that President Trump's agenda was designed to unleash. When a company of Micron's scale puts down roots, it has a powerful effect across our economy – not only by creating 50,000 new jobs and thousands of new work orders for local job creators, but also by strengthening small businesses across America who depend on leading-edge semiconductor technology to fuel every vital industry, from defense to energy. SBA is proud to support the small manufacturers, contractors, and local businesses that will grow alongside Micron's fab as the company advances this Administration’s mission to rebuild American industrial dominance.”
U.S. Chief Technology Officer Dr. Ethan Klein:
"The Trump Administration is committed to achieving unrivaled American leadership in AI, microelectronics, and the full semiconductor supply chain — and milestones like this one show we are turning that commitment into reality. Micron's $250 billion U.S. investments in leading-edge memory manufacturing and R&D will directly power the next generation of American innovation, and we are proud to see that future taking shape right here on American soil."
U.S. Senator Charles E. Schumer:
“Micron’s first concrete pour marks concrete progress towards bringing America’s largest semiconductor manufacturing facility to life right here in Central New York! Micron’s chips are in demand more than ever, and their Central New York project and the 50,000 jobs it’ll create put New York on the global map for advanced chip production. Micron’s total $250 billion U.S. investment is transformative for manufacturing in America and New York. I delivered a $6.1 billion CHIPS grant and billions more in Investment Tax Credit assistance from my CHIPS & Science Law to make this historic project possible. Today, we celebrate a new chapter for American chip manufacturing with Upstate New York leading the way.”
U.S. Congresswoman Claudia Tenney:
“I know how important Micron's investment is to this community — and today's milestone makes that investment tangible. Pouring the first concrete ahead of schedule is a testament to what American workers and American ingenuity can accomplish when Washington opens the path for industry to succeed. By expanding the Advanced Manufacturing Investment Credit through the One Big Beautiful Bill and championing the Working Families Tax Cut Act, Congress has sent a clear signal that the United States is committed to long-term technological leadership and supporting the next generation. Micron's $250 billion investment in making leading-edge memory in the U.S. will create good-paying jobs and strengthen our national security.”
U.S. Congressman John Mannion:
"Pouring the first concrete at Micron's Clay fab — ahead of schedule — is proof that this project is delivering for Central New York. From championing Green CHIPS in the state legislature to fighting for federal investment in Congress, I have been proud to help lay the groundwork for what will become the largest semiconductor manufacturing site in U.S. history, and part of a $250 billion Micron investment across the country. This is an investment in the thousands of workers, families, and businesses of Central New York who will build this facility and help secure America's dominance in the global semiconductor industry for generations to come."
Onondaga County Executive Ryan McMahon:
"Today's milestone is a proud and defining moment for Onondaga County, Central New York, and the country. Pouring the first concrete at Micron's historic New York campus is proof of what this community can achieve when we set ambitious goals, work together, and refuse to slow down. Reaching this milestone months ahead of schedule reflects the grit of the people of Central New York — and the strength of the partnership we have built with Micron. This project to build leading-edge memory locally will reshape the trajectory of our region for generations, and today reminds us that when Onondaga County comes together with purpose, we don't just meet expectations — we exceed them."
Matt Nesbitt, President, Central & Northern New York Building Trades:
“The Central and Northern New York Building and Construction Trades Council could not be more excited for the monumental event today. We are poised and ready for the challenge of building the largest construction project in the history of New York State. The invaluable partnership that our council has forged with Micron to prepare for this historic project is about to be on full display as we build one of the largest chip manufacturing facilities in the United States.”
Justin Driscoll, President & CEO, New York Power Authority:
“Today’s milestone at Micron’s Clay site reflects the growing momentum behind this transformative project. NYPA low-cost power allocations played a vital role in attracting this once-in-a-generation investment that will strengthen New York’s economy, create tens of thousands of good jobs, and cement New York’s role as a global leader in advanced manufacturing.”
David Anderson, President, NY Creates:
"Micron’s announcement that construction is already moving ahead of schedule is exciting for Central New York and for the future of domestic semiconductor manufacturing. This milestone represents tangible progress on a transformational project that will strengthen America’s memory chips leadership and the related supply chain, create thousands of high-tech careers, and generate lasting economic impact across the region. At the same time, NY Creates is proud to partner with Micron on our High NA EUV Lithography Center and the Industrial Manufacturing Technician (IMT) Apprenticeship Program, which advance the capabilities and talent needed to further strengthen the nation’s innovation ecosystem.”
Rob Simpson, Chief Executive Officer, CenterState CEO:
“This is one more important milestone in the foundation we are building for our region's economic resurgence and our country's national security. We are grateful to Micron for their continued partnership and investment in our region and excited to carry this message forward to the global semi-conductor supply chain — Central New York is quickly becoming one of the most important centers for memory and chip manufacturing in the world."
About Micron Technology, Inc.
Micron Technology, Inc. is an industry leader in innovative memory and storage solutions, transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership and manufacturing and operational excellence, Micron delivers a rich portfolio of high-performance DRAM, NAND and NOR memory and storage products. Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence (AI) and compute-intensive applications that unleash opportunities — from the data center to the intelligent edge and across the client and mobile user experience. To learn more about Micron Technology, Inc. (Nasdaq: MU), visit micron.com.
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding expected acceleration and expansion of construction projects, target U.S.-based DRAM production, anticipated research and development expansion, expected timing of first wafer output, planned manufacturing, supply chain and community investments, job creation and workforce expansion, and expected economic and community impacts. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially. Please refer to the documents Micron files with the Securities and Exchange Commission, specifically its most recent Form 10-K and Form 10-Q. These documents contain and identify important factors that could cause actual results to differ materially from those contained in these forward-looking statements. These certain factors can be found at https://investors.micron.com/risk-factor. Although Micron believes that the expectations reflected in the forward-looking statements are reasonable, Micron cannot guarantee future results, levels of activity, or achievements. Micron is under no duty to update any of the forward-looking statements after the date of this press release to conform these statements to actual results.
Zillow spustil Zillow Pro, prémiové členství pro realitní makléře, které jim umožní zvát klienty ke spolupráci přímo na platformě a získat přehled o jejich aktivitě. Součástí jsou také nástroje My Agent a „Likely to List“ s podporou AI.
Agents can now invite buyers and sellers they already know to collaborate with them on Zillow, unlocking insights and tools to help create more personalized client experiences and more business
, /PRNewswire/ -- With 235 million average monthly unique users1 and 70% of actual buyers and sellers in the U.S. on Zillow® today,2 most of a real estate agent's past clients are already browsing homes on Zillow, often without a clear path to take the next step. If agents could see those signals and act on them, they could show up at the right moment with the right information, giving buyers and sellers the guidance they need when they need it. And when agents are better connected to the clients they've already built relationships with, everyone wins — agents grow their business and consumers get a more responsive, more personal experience throughout their search.
Zillow has launched Zillow Pro℠, its premium membership for any and all real estate agents. It lets agents invite buyers and sellers they are working with to collaborate on Zillow, unlocking insights and tools for more personalized client experiences.
My Agent is a collaboration tool that brings agents into the shopper's Zillow experience. When a consumer accepts an invitation to My Agent, agents get real-time insight into what that shopper is browsing, saving and searching in their area.
"Likely to List" is a Zillow Pro premium feature powered by AI that helps agents spot properties in their existing Follow Up Boss database that may be coming to market soon, giving agents a reason to reconnect with past contacts who may be interested in selling.
Agents and shoppers can message or book a tour together on Zillow listings in their local market, staying connected without ever leaving their Zillow search.
A premium Agent Profile gives agents a differentiated presence on Zillow, with custom branding, photos and video. Zillow has launched Zillow Pro℠, its premium membership for any and all real estate agents, nationwide to make this possible. The membership equips agents with exclusive tools built to help them meet clients where they already are — on Zillow — and work together seamlessly. Agents can invite any buyer or seller in their network to collaborate with them on Zillow, and once that contact accepts, agents get visibility into their Zillow activity along with the tools to help them know when and how to best reach out. Nearly 20,000 agents have already used Zillow Pro in its beta version, and buyers working with agents who have a membership are 80% more likely to meet with their agent face-to-face and 50% more likely to move forward in their search.3
In a housing market where sales are on track for another flat year and mortgage rates are once again near 6.5%, agents are competing harder for every transaction. The relationships an agent builds over years are foundational to their business. But being kept in mind across a large client base is hard, and most agents have no way of knowing when someone in their network starts getting serious about a move. That closed door is where opportunities are lost.
"Real estate runs on relationships, and we see time and again the agents who win are the ones who show up at the right moment with the right information," said Cynthia Taylor, senior vice president of product at Zillow. "Now any agent can have the tools and visibility to do that across their entire business. This is our commitment to helping agents get more out of the platform where their clients are browsing, dreaming and planning."
It starts with My Agent, a collaboration tool that brings agents into the shopper's Zillow experience. When a consumer accepts an invitation to My Agent, agents get real-time insight into what that shopper is browsing, saving and searching in their area. That intelligence helps agents deliver more timely and relevant outreach by using Follow Up Boss® automatic prioritization and tailored message suggestions. Consumers who connect through My Agent convert at more than four times the rate of those with inferred relationships.4
Shoppers, in turn, see their agent across Zillow listings in their local market as they search and can easily message or book a tour with their agent, staying connected without ever leaving their Zillow search.
"The client wants to be on Zillow. Everybody is on Zillow," said Lisa Ryan, vice president of agent services at Exquisite Properties in San Antonio. "Zillow Pro membership allows us to be more intentional with keeping that relationship and nurturing it as well."
No other platform can deliver the combination of a world-class customer relationship management (CRM) system with insights from the largest online audience of home shoppers in the country. With a Zillow Pro membership, any agent — whether they advertise on Zillow or not — can extend My Agent invitations to any contact in their Follow Up Boss database.
Listing agents get a meaningful edge with the new "Likely to List" tag, a Zillow Pro premium feature. Powered by AI, Likely to List helps agents spot properties in their existing Follow Up Boss database that may be coming to market soon, giving agents a reason to reconnect with past contacts who may be interested in selling.
Powerful tools for branding, outreach and day-to-day workflow round out the agent's tool kit. A premium Agent Profile gives agents a differentiated presence on Zillow, with custom branding, photos and video. AI automatically surfaces the most engaged contacts, generates personalized outreach and gives agents instant context on a contact's history so they always know who to call and how to help. In supported MLS markets, agents can also search listings, share properties with buyers and track engagement without leaving Follow Up Boss — with their branding on every listing link they send. Combining these tools in a Zillow Pro membership, agents get a complete system for staying visible, informed and connected with clients.
Along with Zillow PreviewSM and Zillow ShowcaseSM, as well as consumer tools like its AI mode, Zillow is building a richer and more connected experience for everyone in the transaction. Buyers move from browsing to action, sellers reach the right buyers earlier and agents have the tools to guide their clients from preparation through closing.
Agents can learn more and get started at zillowpro.com.
About Zillow Group:
Zillow Group, Inc. (Nasdaq: Z and ZG) is reimagining real estate to make home a reality for more and more people.
As the most visited real estate app and website in the United States, Zillow connects hundreds of millions of consumers with innovative technology, trusted agents and loan officers, and seamless digital solutions. With industry-leading tools and resources, Zillow supercharges real estate professionals so they can grow their businesses and deliver exceptional client experiences. For renters and housing providers, Zillow offers not only a robust marketplace but a set of end-to-end products and services to streamline applications, leases, payments and more.
Zillow's ecosystem spans the entire home journey — from dreaming and shopping to renting, buying, selling and financing.
Zillow Group's affiliates, subsidiaries and brands include Zillow®, Zillow Premier Agent®, Zillow Home Loans®, Zillow Rentals®, Zillow® New Construction, Trulia®, StreetEasy®, Out East®, HotPads®, Follow Up Boss®, ShowingTime®, dotloop® and Zillow® Closing.
1 Zillow data, full-year 2025.
2 Zillow Group monthly unique visitors divided by "real estate" unique visitors (as defined by Comscore) for December 2025.
3 Based on Zillow internal analysis comparing matched contacts with and without a My Agent Relationship.
4 Internal analysis suggests this reflects the higher intent of buyers who actively confirm an agent relationship, rather than the relationship status itself driving conversion.
Eli Lilly na AAIC 2026 představí data, podle nichž krevní test P-tau217 dosáhl silného potvrzujícího výkonu srovnatelného s amyloidním PET při záchytu patologie Alzheimerovy choroby u kognitivně nepostižených jedinců.
Analyses across Kisunla (donanemab-azbt) trials providing further insights into the benefit-risk profile from long-term extension data
New data compares the diagnostic performance of P-tau217 blood tests with amyloid positron emission tomography (PET) in cognitively unimpaired Alzheimer's disease
Research spanning diagnostics, long-term treatment, disease biology, and patient-centered outcomes reflects Lilly's 35-year commitment to Alzheimer's disease science
, /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it will present 16 abstracts at the 2026 Alzheimer's Association International Conference (AAIC), July 12-15 in London. Three oral presentations anchor the scientific program, with 13 poster presentations spanning imaging science, health economics, real-world prescribing evidence, and patient-centered outcomes, reflecting Lilly's 35-year commitment to answering open questions in Alzheimer's disease.
Key Presentations at AAIC 2026
New Clinical Evidence on Kisunla (donanemab-azbt)
On July 15, a Developing Topics Session, Donanemab in Early Symptomatic Alzheimer's Disease: Evidence to Address Clinical Questions, will present new insights from TRAILBLAZER-ALZ 6 and the TRAILBLAZER-ALZ 2 long-term extension. Findings include new data on safety through modified titration and corticosteroid pretreatment as well as long-term extension evidence on biomarkers and the potential durability of clinical benefit.
Advancing Diagnostics
Also on July 15, Samantha Burnham, Ph.D., senior research scientist, Eli Lilly and Company, will present data showing P-tau217 blood biomarker assays demonstrated strong rule-in performance comparable to amyloid PET for identifying Alzheimer's disease pathology in cognitively unimpaired individuals. Though blood biomarker tests and amyloid PET agents are not currently indicated for use in cognitively unimpaired individuals, the results generate support for a potentially scalable, accessible alternative to specialized imaging in the future.
Advancing Scientific Methodology
On July 13, as the organizer of the Featured Research Session, Lars Raket, Ph.D., Eli Lilly and Company, will deliver an oral presentation on external controls versus internal extrapolation in the TRAILBLAZER-ALZ 2 long-term extension (Room N10). The analysis addresses a key methodological question in Alzheimer's disease research: how long-term outcomes are measured and interpreted in clinical trials, reflecting Lilly's commitment to the scientific rigor that underpins credible long-term evidence generation.
A full list of abstracts appears below. Presentations will be available at www.lilly.com following their scheduled release times.
Abstract Title
Presenter
Presentation
Type/#
Details (Date, Time,
Location, Session Time)
Kisunla (donanemab-azbt)
External Controls vs. Internal
Extrapolation in the
TRAILBLAZER-ALZ 2 Long-
Term Extension
Lars Raket
Featured
Research
Session
7/13/2026
Room: N10
Session: 9-10:30 a.m.
Donanemab in Early
Symptomatic Alzheimer's
Disease: Evidence to
Address Clinical Questions
Nick Fox,
Emel Serap
Monkul Nery,
Hong Wang,
Erin Doty
Developing
Topics Session
7/15/2026
9-10:30 a.m.
Interim Analysis of the
United Kingdom
Donanemab Controlled
Access Programme: Early
Patient Characteristics and
Prescribing Patterns
Krista Schroeder
Poster
7/12/2026
Poster #8953
7:30 a.m.-4:15 p.m.
Exhibit Hall
Diagnostics
Blood Biomarker Assays
Demonstrate Strong Rule-in
Performance for Identifying
Cognitively Unimpaired AD
Samantha
Burnham
Oral
7/15/2026
Room: S11
Session: 8-8:45 a.m.
Baseline amyloid and tau
PET characteristics in early
Alzheimer's Disease: Results
from the TRAILRUNNER-ALZ
3 PET Addendum
Ilke Tunali
Poster
7/15/2026
Biomarkers: Neuroimaging,
8 a.m.- 3 p.m.
Exhibit Hall
Evaluation of Diffusion
Tensor Imaging biomarkers
in phase 2 PROSPECT-ALZ
study of Ceperognastat in
early symptomatic
Alzheimer's disease
Regional tau PET Extent to
estimate pathological
volume, capture tau
heterogeneity, and detect
treatment response in
clinical trials
Vikas Kotari
Poster
7/11/2026 and 7/14/2026
Biomarkers: Neuroimaging,
7:30 a.m.-4:15 p.m.
*Will also be presented at
AIC ahead of AAIC*
Cross-sectional evaluation of
diffusion tensor imaging
endpoints using three
clinical trials in Alzheimer's
disease
Diana Otero
Poster
7/13/2026
Biomarkers: Neuroimaging,
7:30 a.m.-4:15 p.m.
Exhibit Hall
Health Economics and Outcomes Research (HEOR)
Drivers of Increased
Healthcare Utilization and
Medicare Payments During
Cognitively Unimpaired
(Preclinical) Alzheimer's
Disease Progression
Zachary Sheff
Poster
7/12/2026
Poster #441
7:30 a.m.-4:15 p.m.
Exhibit Hall
Neurocognitive, Biomarker,
and Health Outcomes in
Those at Risk for Alzheimer's
Disease Symptoms:
ANCHOR-AD Study Design
Nalin Payakachat
Poster
7/14/2026
Poster #9036
7:30 a.m.-4:15 p.m.
Exhibit Hall
Incident institutionalization
rates among Medicare
beneficiaries with
Alzheimer's disease or mild
cognitive impairment
Zachary Sheff
Poster
7/12/2026
Poster # 7262
7:30 a.m.-4:15 p.m.
Exhibit Hall
Risk Algorithms to Predict
Elevated Plasma P-tau217
Status: A Cross-sectional
Analysis
Nalin Payakachat
Poster
7/12/2026
Poster # 2141
7:30 a.m.-4:15 p.m.
Exhibit Hall
Natural Language Processing
(NLP) Algorithms to Identify
Intracerebral Hemorrhage
>1 cm and Amyloid-Related
Imaging Abnormalities
(ARIA) in US Electronic
Medical Records
Krista Schroeder
Poster
7/15/2026
Poster # 8947
7:30 a.m.-4:15 p.m.
Exhibit Hall
About Alzheimer's Disease
By 2030, an estimated 78 million people worldwide are projected to have Alzheimer's disease, rising from approximately 55 million today, from those living with the earliest changes associated with the disease, to those experiencing profound memory loss.¹ The disease begins silently, often decades before any change in memory or thinking, with the accumulation of amyloid plaques in the brain,2 progressing through stages of increasing memory loss, behavioral changes, and growing dependence on caregivers.3
Nearly 4 in 5 Americans say they would want to know if they had Alzheimer's disease before experiencing symptoms or before symptoms interfere with their daily activities.4
About Kisunla® (donanemab-azbt)
Kisunla is currently approved as an amyloid-targeting treatment for people with mild cognitive impairment as well as people with mild dementia stage of early symptomatic Alzheimer's disease with confirmed amyloid pathology. Kisunla is a humanized monoclonal antibody that targets and reduces insoluble N-truncated pyroglutamate amyloid beta plaques, a defining feature of Alzheimer's disease, and is administered as an intravenous infusion every four weeks. Kisunla can cause serious side effects, including ARIA and infusion-related reactions. Apolipoprotein E ε4 (ApoE ε4) homozygotes have a higher incidence of ARIA, including symptomatic and serious ARIA, and testing for ApoE ε4 status should be performed prior to initiating treatment. Carriers of one or two copies of the ApoE ε4 gene may be at higher risk of developing Alzheimer's disease and experiencing ARIA. Patients should discuss any safety concerns with their healthcare providers.
INDICATION AND SAFETY SUMMARY WITH WARNINGS
Kisunla® (kih-SUHN-lah) is used to treat adults with early symptomatic Alzheimer's disease (AD), which includes mild cognitive impairment (MCI) or mild dementia stage of disease.
Warnings - Kisunla can cause Amyloid-Related Imaging Abnormalities or "ARIA." This is a common side effect that does not usually cause any symptoms, but serious symptoms can occur. ARIA can be fatal. ARIA is most commonly seen as temporary swelling in an area or areas of the brain that usually goes away over time. Some people may also have spots of bleeding on the surface of or in the brain and infrequently, larger areas of bleeding in the brain can occur. Although most people do not have symptoms, some people have:
Headache Dizziness Nausea Difficulty
walking Confusion Vision changes Seizures Some people have a genetic risk factor (homozygous apolipoprotein E ε4 gene carriers) that may cause an increased risk for ARIA. Talk to your healthcare provider about testing to see if you have this risk factor.
You may be at higher risk of developing bleeding in the brain if you take medicines to reduce blood clots from forming (antithrombotic medicines) while receiving Kisunla. Talk to your healthcare provider to see if you are on any medicines that increase this risk.
Your healthcare provider will do magnetic resonance imaging (MRI) brain scans before and during your treatment with Kisunla to check you for ARIA. You should carry information that you are receiving Kisunla, which can cause ARIA, and that ARIA symptoms can look like stroke symptoms. Call your healthcare provider or go to the nearest hospital emergency room right away if you have any of the symptoms listed above.
There are registries that collect information on treatments for Alzheimer's disease. Your healthcare provider can help you become enrolled in these registries.
Warnings - Kisunla can cause serious allergic and infusion-related reactions. Do not receive Kisunla if you have serious allergic reactions to donanemab-azbt or any of the ingredients in Kisunla. Symptoms may include swelling of the face, lips, mouth, or eyelids, problems breathing, hives, chills, irritation of skin, nausea, vomiting, sweating, headache, or chest pain. You will be monitored for at least 30 minutes after you receive Kisunla for any reaction. Tell your healthcare provider right away if you have these symptoms or any reaction during or after a Kisunla infusion.
Other common side effects
Headache Tell your healthcare provider right away if you have any side effects. These are not all of the possible side effects of Kisunla. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.
Before you receive Kisunla, tell your healthcare provider:
About all medicines you take, including prescription and over-the-counter medicines, as well as vitamins and herbal supplements. Especially tell your healthcare provider if you have medicines to reduce blood clots from forming (antithrombotic medicines, including aspirin). About all of your medical conditions including if you are pregnant, breastfeeding, or plan to become pregnant or breastfeed. Kisunla has not been studied in people who were pregnant or breastfeeding. It is not known if Kisunla could harm your unborn or breastfeeding baby. How to receive Kisunla
Kisunla is a prescription medicine given through an intravenous (IV) infusion using a needle inserted into a vein in your arm. Kisunla is given once every 4 weeks. Each infusion will last about 30 minutes.
Learn more
For more information about Kisunla, call 1-800-LillyRx (1-800-545-5979) or go to kisunla.lilly.com.
This summary provides basic information about Kisunla. It does not include all information known about this medicine. Read the information given to you about Kisunla. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Kisunla. Your healthcare provider is the best person to help you decide if Kisunla is right for you.
DN CON BS APP
Kisunla® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Frequently Asked Questions
How accurate are blood tests for diagnosing Alzheimer's disease? What is P-tau217 and how is it used in Alzheimer's disease diagnosis? How effective is Kisunla in slowing Alzheimer's disease progression? What was presented at the Alzheimer's Association International Conference (AAIC) 2026? About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. P-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about Kisunla (donanemab-azbt) as a treatment for people with early symptomatic Alzheimer's disease and as a potential treatment for patients with cognitively unimpaired Alzheimer's disease and other conditions and reflects Lilly's current beliefs and expectations. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of drug research, development, and commercialization. Among other things, there is no guarantee that planned or ongoing studies will be completed as planned, that future study results will be consistent with study results to date, that Kisunla will receive additional regulatory approvals, or that Kisunla will be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
References
Alzheimer's Disease International. 2026 Dementia statistics. https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/. Accessed 24 June 2026. Sperling RA, Donohue MC, Rissman RA, et al. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. J Prev Alzheimers Dis. 2024;11(4):802–813. Alzheimer's Association. Stages of Alzheimer's. www.alz.org/alzheimers-dementia/stages. Accessed 24 June 2026. Alzheimer's Association. 2025 Alzheimer's disease facts and figures. Alzheimers Dement. 2025;21(5):3708–3821. Refer to: Gina Goodenough; [email protected] (Media)
Michael Czapar; [email protected] (Investors)
Akcie ServiceNow v první polovině roku klesly o 36 %, protože trh se obává dopadu agentické AI na SaaS. Firma ale hlásí 22% meziroční růst předplatného tržeb v 1. čtvrtletí 2026.
ServiceNow (NOW 1.09%) stock dropped 36% in the first half of the year, according to data provided by S&P Global Market Intelligence. The market has been worried about the impact of agentic artificial intelligence (AI) on software-as-a-service (SaaS) stocks like ServiceNow, but ServiceNow is pushing back with its own AI platform.
Out with SaaS, in with AI? ServiceNow is a major player in organizational management, with more than 8,800 clients who rely on it to manage their workflows. Its platform is embedded into these clients' databases, unifying and automating various workplace processes.
When agentic AI first came out on a major scale a few months back, SaaS stocks plunged. The market has been worried about how SaaS companies will fare if clients can get the same value through AI agents that can be customized to do the same thing.
Image source: Getty Images.
ServiceNow has been ahead of the curve, and it launched its Control Tower product just over a year ago. The Control Tower acts, as the name implies, as a single point connecting all of the client's AI agents and platforms, as well as the rest of the organization. And it uses AI to analyze how it all works and provide insights. After all, even if AI agents can take care of the work of some employees, companies still need to set up, monitor, and manage them. And since it's also based in AI and machine learning, it's continually upgraded to improve along with advances in technology.
At least for now, the response has been positive, and ServiceNow hasn't seen a disruption in its business. It reported a 22% year-over-year increase in subscription revenue in the 2026 first quarter, and management is guiding for similar growth in the second quarter and for the full year.
Today's Change
(
-1.09
%) $
-1.17
Current Price
$
106.61
Is ServiceNow stock priced to buy? At the current price, ServiceNow stock trades at 64 times trailing 12 months. That's a hefty price tag, but it's actually a lot lower than it's been over the past few years. In fact, it's just off its lowest P/E ratio ever as it starts to climb back higher. Investors have been willing to pay a high premium for the stock, since it has a strong economic moat as the platform of choice for a large percentage of the country's top companies.
That kind of valuation can hardly be called a bargain, especially in the changing AI landscape, but it could still be a defensive play as more workflow goes toward AI, and investors could feel comfortable taking a small position right now.
USA plánují v roce 2026 utratit za obranu 1 bilion USD a v roce 2027 žádají zhruba 1,5 bilionu USD, což by byl největší meziroční nárůst v historii. Z toho mohou těžit Lockheed Martin a RTX díky obřím zakázkám a dlouhodobým kontraktům.
The U.S. plans to spend $1 trillion for defense in 2026, and the 2027 funding request stands at about $1.5 trillion, which would mark the largest year-over-year increase ever if approved. Rising military spending comes amid rising geopolitical tensions, including the U.S.-Iran and Ukraine-Russia conflicts. The U.S. is also looking to modernize the military and bolster the defense industrial base and has allocated capital for space-based missile defense initiatives.
Defense contractors should benefit from growing order books and long-term contracts that provide insight into future earnings. Against this capital-intensive backdrop, defense stocks Lockheed Martin (LMT 1.21%) and RTX Corporation (RTX 0.17%) stand out as beneficiaries due to their strong positions in the industry. Here's what investors need to know.
Image source: Getty Images.
Lockheed Martin's growing platform makes it a defense spending winner Lockheed Martin is a behemoth in the defense industry, boasting a backlog exceeding $186 billion from long-term government contracts. The company has a broad portfolio of offerings, anchored by its flagship F-35 Lightning II jet fighter program, which provides a strong moat that translates into predictable, long-term revenue.
Its F-35 program is projected to cost $2.1 trillion during its 94-year lifecycle and generate roughly a third of Lockheed's revenue. The size and stability of this long-term program help buffer Lockheed's earnings against economic recessions and market volatility and lock in long-term revenue from both jet sales and aftermarket services, including maintenance, repairs, upgrades, and pilot training.
Today's Change
(
-1.21
%) $
-6.38
Current Price
$
521.58
In addition to the F-35, Lockheed holds a strong position in high-altitude missile defense, serving as the sole prime contractor for the Terminal High Altitude Area Defense (THAAD) weapon system. In late June, the U.S. government formally awarded it a contract for as much as $35 billion over seven years to quadruple the production of its THAAD interceptors.
In another major move, on July 6, Lockheed Martin signed an agreement to acquire Ultra Maritime Solutions for $3.45 billion, giving it a strong foothold in the rapidly growing undersea weapons market. Lockheed acquired the company from Advent International and now controls key undersea defense technologies, including sonobuoys for submarine detection, torpedo defense systems, and uncrewed underwater vehicles.
As military spending ramps up, Lockheed Martin is a top defense contractor that stands to benefit. Its position provides it with steady, predictable revenue that powers steady long-term growth. The company has raised its dividend for 23 consecutive years and yields about 2.6%, making Lockheed a top pick for investors looking to capitalize on growing global defense budgets.
RTX combines defense upside with commercial aerospace stability RTX Corporation boasts an even more impressive backlog of $271 billion, up 25% during the past year. RTX's business spans commercial aerospace and defense, operating three segments: Raytheon, Pratt & Whitney, and Collins Aerospace. As a result, RTX has a more diverse portfolio than pure-play military contractors, balancing defense awards with commercial contracts. Like Lockheed, RTX benefits from its huge backlog that ensures long-term revenue consistency years down the road.
Through Pratt & Whitney, RTX provides aircraft propulsion systems for both commercial aircraft and Lockheed Martin's F-35 Lightning II Joint Strike Fighter, generating high-margin recurring aftermarket revenue. Through Raytheon, the company manufactures the Patriot air defense system, advanced missiles, naval and land radars, and directed-energy weapons. The segment accounts for $109 billion of its enormous backlog.
Today's Change
(
-0.17
%) $
-0.33
Current Price
$
194.58
The company is seeing robust demand for its air defense systems, and on July 7, it announced it would partner with European manufacturers in Germany and the Netherlands to double the global production capacity for its Stinger surface-to-air missiles. In addition, in late June, it announced a $1.1 billion contract modification to replenish American stockpiles and arm allied nations with tactical missiles.
RTX's large backlog ensures rising earnings in the years ahead, and the company stands to benefit from growing military budgets and long-term demand for aftermarket services through its aerospace business, making it another top defense stock for investors to consider scooping up today.
Reliance za posledních šest měsíců vzrostla o 23,2 % díky rekordním čtvrtletním objemům a akvizicím. V 1. čtvrtletí prodala zhruba 1,673 milionu tun, meziročně o 2,7 % více.
Reliance, Inc.’s (RS - Free Report) shares have rallied 23.2% in the past six months. The company has also outperformed the Zacks Mining - Miscellaneous industry’s 2.8% growth over the same time frame.
The rally was driven by strong first-quarter results, including record quarterly tons sold, with shipments outperforming industry trends and significant acquisitions.
Image Source: Zacks Investment Research
Let’s take a look at the factors that are driving RS stock.
RS Gains From Record Shipments and AcquisitionsReliance reported first-quarter 2026 tons sold of roughly 1.673 million, up 9.4% sequentially and 2.7% year over year, marking its 13th consecutive quarter of outperforming industry shipment trends.
The company continues to benefit from strong demand in non-residential construction, driven by public infrastructure, heavy civil construction, data centers, energy infrastructure and manufacturing projects.
Through its AMI Metals subsidiary, Reliance secured major Department of Homeland Security border wall contracts that are expected to support revenue growth. Demand also remained healthy across automotive toll processing, semiconductors, defense, shipbuilding, industrial machinery and nuclear-related markets, particularly those tied to small modular reactor programs.
Reliance continues to strengthen its growth profile through acquisitions that expand its geographic footprint, product offerings and value-added processing capabilities. Earlier acquisitions, such as Metals USA, Tubular Steel, Best Manufacturing, Ferguson, All Metals, Fry Steel Company and Merfish United, enhanced its service center network and higher-margin product mix.
Recent acquisitions, including Rotax, Admiral Metals, Nu-Tech Precision Metals, Southern Steel Supply, Cooksey Iron & Metal Co. and American Alloy, further increase its presence in attractive U.S. growth markets.
The company ended the quarter with $249.7 million in cash and cash equivalents, up from $216.6 million sequentially, supported by record shipment volumes and strong profitability.
Some better-ranked stocks in the Basic Materials space are CSW Industrials, Inc. (CSW - Free Report) , Idaho Strategic Resources, Inc. (IDR - Free Report) and Albemarle Corporation (ALB - Free Report) . CSW, IDR and ALB carry a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for CSW’s current-year earnings stands at $12.52 per share, implying a 20.6% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average surprise being 3.8%. Shares of the company have plunged around 15.1% in the past six months.
The Zacks Consensus Estimate for IDR’s current-year earnings is pegged at $1.52 per share, implying a 33.3% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average surprise being 68.7%. Shares of IDR have plunged around 33.8% in the past six months.
The Zacks Consensus Estimate for ALB’s current-year earnings is pegged at $13.15 per share, indicating a 1,764.6% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average surprise being 74.5%. Shares of IDR are down around 23.6% in the past six months.
MARA uzavřela dohodu o koupi energeticky napájeného pozemku v Texasu s přístupem až k výkonu 2 GW. Po plném zprovoznění má kapacita MARA vzrůst na zhruba 4,8 GW.
Expands MARA's digital infrastructure platform with access to approximately 2 GW of power capacity
HIF to retain minority ownership in the project
Thousands of jobs expected for Texas
MIAMI, FL and HOUSTON, TX, July 09, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) (“MARA”), a leading energy and digital infrastructure company, and HIF USA LLC (“HIF”), a leading energy and sustainable fuels company, today announced that they have entered into a definitive agreement under which MARA will acquire from HIF a large-scale powered land site in Matagorda County, Texas, approximately 90 miles southwest of Houston. HIF will continue its advanced fuels development plans on other sites.
The site encompasses more than 1,200 acres and is expected to provide access to up to an initial 1 GW of grid capacity by October 2027 and up to 2 GW by April 2028. The site is well positioned to support next-generation, efficient digital infrastructure development, and has already received interest from potential High-Performance Computing (“HPC”) tenants. MARA intends to develop the site through its previously announced partnership with Starwood Digital Ventures as a large-scale digital infrastructure campus capable of supporting high-performance computing workloads, as well as flexible compute operations, including Bitcoin mining. Upon execution of a lease with an HPC tenant, HIF will retain a minority ownership interest in the project.
The transaction enables HIF to unlock value from infrastructure assets while maintaining participation in the site’s future development and supporting its broader advanced fuels strategy.
Upon full energization, the site is expected to more than double MARA's potential power capacity to approximately 4.8 GW across its portfolio (including the anticipated close of MARA’s previously announced agreement to acquire Long Ridge Energy & Power), further strengthening MARA's position as a developer and operator of large-scale digital infrastructure.
“This transaction advances our strategy of securing strategically located infrastructure assets capable of supporting high-performance compute and bitcoin workloads,” said Fred Thiel, MARA's chairman and CEO. “As demand for digital infrastructure continues to grow, we believe sites with access to reliable, scalable power will become increasingly valuable. This acquisition meaningfully expands our long-term development pipeline and strengthens our ability to support high-performance compute and maximize the value of that power over time. We look forward to working with our partners at the site to deliver on the project buildout and drive long-term value for all our stakeholders.”
Renato Pereira, CEO of HIF USA, said, “We are pleased to welcome MARA to our long-term partnership with Matagorda County, accelerating our commitment to economic investment and jobs for Texans. The development of this digital infrastructure serves as a powerful economic anchor to strengthen Matagorda County and create local career opportunities for a prosperous future. We have given Notice to Proceed for construction on the switchyard to connect the site to the grid. We continue work on our advanced fuels facilities on other sites we control in Texas and worldwide to provide new sources of secure energy supply to meet rapidly growing global demand.”
Site Development Details
Phased construction of the digital infrastructure campus is expected to begin in 2026, contingent upon regulatory approvals.
By combining MARA's expertise in securing and managing large-scale power loads, Starwood Digital Ventures' world-class experience developing and operating data centers, and HIF's history in Matagorda, MARA believes the site is well positioned to support future digital infrastructure opportunities and create long-term value for customers, local communities, and shareholders.
MARA has a proven track record of investing in the communities where it operates while supporting grid reliability and local economic growth. To date, MARA has invested more than $1.2 billion in Texas. MARA intends to continue investing significantly to develop a premier digital infrastructure campus that is expected to support thousands of construction and permanent full-time jobs upon completion.
About MARA
MARA (NASDAQ: MARA) deploys digital energy technologies to advance the world’s energy systems. Harnessing the power of compute, MARA transforms excess energy into digital capital, balancing the grid and accelerating the deployment of critical infrastructure. Building on its expertise to redefine the future of energy, MARA develops technologies that reduce the energy demands of high-performance computing applications, from AI to the edge.
About HIF Global
HIF Global is a world leading e-Fuels company developing large scale infrastructure projects to recycle captured CO₂ and produce synthetic fuels for existing engines. The name HIF reflects the company’s mission: to produce Highly Innovative Fuels that contribute to global energy security. HIF already produces e-Fuels at its HIF Haru Oni facility in southern Chile and is developing large scale projects in the United States, Uruguay, Brazil, Australia, and Chile. For more information, visit www.hifglobal.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. All statements, other than statements of historical fact, included in this press release are forward-looking statements. The words “may,” “will,” “could,” “anticipate,” “expect,” “intend,” “believe,” “continue,” “target” and similar expressions or variations or negatives of these words are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements include, among other things, statements related to the occurrence of any event, change or other circumstance that could give rise to the exercise of any return or forfeiture right under, the purchase agreement entered into in connection with MARA’s acquisition of the site; MARA’s planned development of the site as a digital infrastructure campus; the expected power capacity (including as a result of the agreement to acquire Long Ridge Energy & Power), scalability and performance of the site; the anticipated ability to commercialize the site’s power capacity for high-performance compute and bitcoin workloads; the number of construction and other jobs anticipated to be created; and the anticipated benefits of the transaction to MARA. Such forward-looking statements are based on management’s current expectations about future events as of the date hereof and involve many risks and uncertainties that could cause MARA’s actual results to differ materially from those expressed or implied in these forward-looking statements. Subsequent events and developments, including actual results or changes in MARA’s assumptions, may cause MARA’s views to change. Readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including uncertainties related to market conditions, the risk that the transaction disrupts MARA’s current plans and operations or diverts management’s attention from its ongoing business, the effect of the announcement of the transaction on the ability of MARA to retain and hire key personnel and maintain relationships with others with whom it does business, the effect of the announcement of the transaction on MARA’s operating results and business generally and the other factors discussed in the “Risk Factors” section of MARA’s most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) and the risks described in other filings that MARA may make from time to time with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and MARA specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise, except to the extent required by applicable law.
MARA Company Contact:
Telephone: 800-804-1690
Email: [email protected]
DraftKings spustí 13. července v Albertě online sázky a kasino, čímž rozšíří svou přítomnost v Kanadě na druhou provincii. Současně tam nabídne i značku Golden Nugget Online Gaming.
BOSTON--(BUSINESS WIRE)--DraftKings Inc. (Nasdaq: DKNG) today announced plans to launch its top-rated online sportsbook and casino, along with its Golden Nugget Online Gaming brand, in Alberta on July 13. Alberta will become the second Canadian province and the 34th jurisdiction across North America where DraftKings Sportsbook is available. With the launch, DraftKings Casino will be available in five U.S. states and Golden Nugget Online Gaming casino in four U.S. states, with both brands available in Alberta and Ontario in Canada.
Ahead of the official launch, DraftKings will host a watch party for the World Cup on July 11 at the Wildhorse Saloon in Calgary. The event is part of DraftKings' broader initiative that has brought fans across North America closer to the excitement of the tournament through a series of watch parties in Los Angeles, Dallas, Miami and Hoboken. Each event has featured live match viewing, giveaways and interactive activations designed to create memorable fan experiences.
“We’re thrilled to launch DraftKings Sportsbook and DraftKings Casino, as well as Golden Nugget Online Gaming in Alberta and continue expanding our presence in Canada,” said Greg Karamitis, Executive Vice President and General Manager of Sports at DraftKings. “Alberta is home to a passionate sports fan base, and we’re excited to bring customers across the province our industry-leading sports betting and online casino experiences. Launching during one of the biggest moments in global sports, with the World Cup taking place across North America, makes this an especially exciting time to welcome Albertans to DraftKings.”
To celebrate the launch in Alberta, DraftKings employees will volunteer with Food Banks Alberta and present a $150,000 donation to the organization. The funding will purchase over 40,000 pounds of essential food items to be distributed through Food Banks Alberta's network of member food banks, ensuring resources reach communities both large and small throughout Alberta. This donation will help provide essential food support, including high demand items like fruits and vegetables and baby formula to individuals and families facing hunger, while strengthening local food banks' ability to meet growing demand.
Eligible customers in Alberta will have access to DraftKings’ comprehensive suite of sports betting and online casino offerings. From same-game parlays, live in-game wagering, and special odds boosts on DraftKings Sportsbook to thousands of casino games, including fan-favorite titles like “Wheel of Fortune – Triple Extreme Spin,” exclusive slot titles, as well as progressive jackpots across Golden Nugget Online Gaming and DraftKings Casino, DraftKings delivers one of the industry’s most robust and engaging entertainment experiences.
DraftKings leads the industry in responsible engagement by promoting customer awareness and use of budget and control tools and resources like deposit limits, cool off periods, and self-exclusion to help customers have a fun source of entertainment with a brand they can trust.
The DraftKings Sports and Casino app and Golden Nugget Online Gaming casino app are available to be downloaded today for iOS and Android here and here. Customers can review DraftKings’ Responsible Engagement tools here. For additional problem gambling support or services, Alberta customers can visit GameSense or ABiGaming.ca, or contact the GameSense Info Line at 1-833-447-7523.
About DraftKings
DraftKings Inc. is a digital sports and gaming company created to be the Ultimate Host and fuel the competitive spirit of sports fans with platforms that range across daily fantasy, regulated gaming, prediction markets and digital media. Headquartered in Boston and launched in 2012 by Jason Robins, Matt Kalish and Paul Liberman, DraftKings is the only U.S.-based vertically integrated sports betting operator. DraftKings’ mission is to make life more exciting by responsibly creating the world’s favorite real-money games, betting experiences and event contracts trading. DraftKings Sportsbook is live with mobile and/or retail sports betting operations pursuant to regulations in 30 states, Washington, D.C., Puerto Rico, and Ontario, Canada. The Company operates iGaming pursuant to regulations in five states and in Ontario, Canada under its DraftKings brand and pursuant to regulations in four states and in Ontario, Canada, under its Golden Nugget Online Gaming brand. DraftKings also owns Jackpocket, the leading digital lottery courier app in the United States. DraftKings’ daily fantasy sports platform is available in 44 states, Washington, D.C., and certain Canadian provinces. DraftKings' wholly-owned subsidiary GUS III LLC (d/b/a DraftKings Predictions) also operates DraftKings Predictions, offering federally regulated event contracts under CFTC oversight. DraftKings is both an official sports betting and daily fantasy partner of the NHL, PGA TOUR and WNBA, as well as an official daily fantasy partner of NASCAR, an official sports betting partner of the NBA and an authorized gaming operator of MLB. In addition, DraftKings owns and operates DraftKings Network, a multi-platform content ecosystem. DraftKings is committed to delivering responsible engagement tools and resources, while focusing on integrity and customer education.
ATF zařadila BolaWrap 150 od Wrap Technologies mezi prostředky k omezení, nikoli jako střelnou zbraň ani zbraň. Firma říká, že to posiluje její pozici na trhu veřejné bezpečnosti.
NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- via NetworkNewsWire (“NNW”) — Wrap Technologies Inc. (NASDAQ: WRAP) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.
To view the full publication, “Federal Ruling Changes Economics of Nonlethal Law Enforcement,” please visit: https://ibn.fm/SQDXI
American law enforcement is in the middle of a legal and cultural reckoning over use of force. Courts are demanding more from officers before they reach for traditional weapons, and the Supreme Court’s unanimous 2025 ruling in Barnes v. Felix has made that demand structurally unavoidable: Every use-of-force decision must now be evaluated against the full context of the encounter, not just the moment it occurred. That legal shift is creating real procurement demand for tools that give officers options earlier in an encounter, before the situation reaches the force threshold that generates liability.
Wrap Technologies Inc. builds exactly those tools, and last week the company received a ruling from the Bureau of Alcohol, Tobacco, Firearms and Explosives (“ATF”) that may be the single most consequential development in its commercial history: ATF Ruling 2026-2 formally classified the BolaWrap(R) 150 as an instrument of restraint — not a firearm, not a weapon — under both the Gun Control Act and the National Firearms Act. The ruling strengthens Wrap Technologies’ position among other tech leaders operating in the global public-safety space.
About Wrap Technologies Inc.
Wrap Technologies is a global leader in innovative public safety technologies and non-lethal tools, delivering cutting-edge technology with exceptional people to address the complex, modern-day challenges facing public-safety organizations.
WRAP’s complete public-safety portfolio includes the non-lethal BolaWrap(R) 150 device, Wrap Reality(R) immersive training platform, WrapVision(TM) body-worn camera system, WrapTactics(TM) training programs, and next-generation C-UAS solutions such as PAN-DA and the 1KC Kinetic Anti-Drone Cassette, all of which supports the company’s mission to provide safer, scalable and cost-effective technologies for public safety, defense and critical infrastructure markets.
With a growing demand for non-lethal tools and techniques to create time, distance and tactical advantage in noncriminal calls, Wrap’s BolaWrap 150 incorporates a multisensory distraction of sight and sound as a first response, followed by a non-lethal restraint if further escalation is required. This approach reduces the risk of injury to officers, subjects, and the community.
Wrap’s BolaWrap 150 solution is intended to provide law enforcement with a safer choice for nearly every phase of a critical incident. This innovative, patented device deploys a multi-sensory, cognitive disruption to expand the pre-escalation period and gives officers the advantage and critical time to manage non-compliant subjects before resorting to higher-force options. The BolaWrap 150 is not pain-based compliance. It does not shoot, strike, shock or incapacitate; instead, it helps officers strategically operate pre-escalation on the force continuum, reducing the risk of injury to both officers and subjects. Used by more than 1,000 agencies across the United States and in 60 additional countries, BolaWrap is backed by training certified by the International Association of Directors of Law Enforcement Standards and Training (“IADLEST”), reinforcing Wrap’s commitment to public safety through cutting-edge technology and expert training.
WrapReality(TM) VR is a fully immersive training simulator to enhance decision-making under stress.
As a comprehensive public-safety training platform, it provides first responders with realistic, interactive scenarios that reflect the evolving challenges of modern law enforcement. By offering a growing library of real-world situations, WrapReality is intended to equip officers with the skills and confidence to navigate high stakes encounters effectively, which we believe leads to safer outcomes for both responders and the communities they serve.
WrapVision is an all-new body-worn camera and evidence management system built for efficiency.
Designed for efficiency, security, and transparency to meet the rigorous demands of modern law enforcement, WrapVision captures, stores and helps manage digital evidence, ensuring operational security, regulatory compliance and enhanced video picture quality and field of view.
The WrapVision camera, powered by IONODES, boasts streamlined cloud integration and final North American assembly, with a critical made-in-America roadmap projected for early 2026. This track helps ensure data integrity and helps eliminate critical concerns over unauthorized access or foreign surveillance risks.
NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP
For more information about Wrap Technologies, visit the company’s website at www.Wrap.com.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness.
NNW is where breaking news, insightful content and actionable information converge.
For more information, please visit www.NetworkNewsWire.com
Please view full terms of use and disclaimers on the NNW website applicable to all content provided by NNW, wherever published or re-published: http://www.nnw.fm/Disclaimer
NetworkNewsWire
New York, NY
www.NetworkNewsWire.com
212.418.1217 Office [email protected]
NetworkNewsWire is powered by IBN
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.
Dceřiná společnost Centene, Meridian Health Plan of Illinois, získala v Illinois čtyřletou smlouvu na pokračování programu HealthChoice Illinois Medicaid, která má začít 1. ledna 2027.
, /PRNewswire/ -- Centene Corporation (Centene) (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing services for the HealthChoice Illinois Medicaid managed care program. The four-year contract is expected to begin January 1, 2027, through 2030.
Meridian logo "Centene has a long track record serving Medicaid and dually eligible Medicaid-Medicare members in Illinois," said Chief Executive Officer Sarah M. London. "This award reflects Meridian's strong local partnerships and focus on delivering coordinated, high-quality care while connecting people to the support they need beyond the clinical setting. We value our partnership with the state and look forward to continuing to expand access and strengthen outcomes across Illinois."
Meridian is one of six managed care organizations selected by HFS to deliver access to high-quality managed care services to approximately 2.4 million Medicaid-eligible Illinoisans statewide. As of May 2026, Meridian serves more than 596,000 Medicaid enrollees through the HealthChoice Illinois Medicaid program. Under the new contract, Meridian will continue providing managed care for Medicaid enrollees, including access to integrated primary, maternal, and behavioral health care.
"We are honored to be chosen again by the Illinois Department of Healthcare and Family Services to continue delivering access to high-quality, whole person care through proven performance and building on our strategy to address barriers to care," said Meridian Plan President and Chief Executive Officer Cristal Gary.
In addition to ensuring its members get the medical care they need through its clinical and population health programs, Meridian's whole-person approach also focuses on improving well-being by working with community-based partners to address gaps in social drivers that impact health outcomes. Meridian is recognized for its work with the highest possible 5-star rating in the latest 2024 HealthChoice Illinois Report Card in three critical areas: Access to Care, Living with Illness, and Women's/Children's Health.
Building on nearly 20 years of experience serving Illinois communities, Meridian will continue providing comprehensive, coordinated care for some of the state's most vulnerable populations while advancing programs that address social drivers of health across all 102 counties.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/.
About Meridian Health Plan of Illinois
Meridian Health Plan of Illinois, Inc. and its family of health plans provide government-sponsored managed care to families, children, seniors, and individuals with complex medical needs. This includes Meridian's Medicaid and Medicare-Medicaid plans, and YouthCare HealthChoice Illinois. YouthCare is a specialized program designed to address the healthcare needs of Illinois Department of Children and Family Services (DCFS) youth in out-of-home placement and former youth in care. Meridian connects members to care and offers comprehensive services to support lifelong health and wellness. Meridian is a company of Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives. Learn more at ILmeridian.com.
All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "predict," "intend," "seek," "target," "goal," "potential," "may," "will," "would," "could," "should," "can," "continue," and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our expected future operating or financial performance, changes in laws and regulations, market opportunity, expectations concerning pricing actions, competition, expected contract start dates and terms, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions. All forward-looking statements included in this press release are based on information available to us on the date hereof. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events, or otherwise, after the date hereof. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables, and events including, but not limited to: our ability to design and price products that are competitive and/or actuarially sound; our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical costs; rate cuts, insufficient rate changes or other payment reductions or delays by government payors affecting our government businesses; the effect of social, economic, and political conditions, geopolitical events and state and federal policies, including the amount and terms of state and federal funding for government-sponsored healthcare programs, including as a result of changes in U.S. presidential administrations or Congress; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder, including the timing and terms of renewal or modification of the Enhanced Advance Premium Tax Credits (eAPTCs) or program integrity initiatives that could have the effect of reducing membership or profitability of our products; unanticipated increased healthcare costs, including due to changes in consumer and provider behaviors, inflation and tariffs; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that could impact revenue and future growth; competition, including for providers, broker distribution networks, contract reprocurements and organic growth; our ability to adequately anticipate demand and timely provide for operational resources to maintain service level requirements in compliance with the terms of our contracts and state and federal regulations; our ability to comply with the terms of our contracts and state and federal regulations and our ability to effectively oversee our third-party vendors to comply with the terms of their contracts with us and state and federal regulations; our ability to manage our information systems effectively; disruption, unexpected costs, or similar risks from business transactions, including acquisitions, divestitures, and changes in our relationships with third-party vendors; impairments to real estate, investments, goodwill and intangible assets; changes in senior management, loss of one or more key personnel or an inability to attract, hire, integrate and retain skilled personnel; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; our ability to effectively and ethically use artificial intelligence and machine learning in compliance with applicable laws; changes in macroeconomic conditions, including inflation, interest rates and volatility in the financial markets; negative public perception of the Company and the managed care industry; uncertainty concerning government shutdowns, debt ceilings or funding; tax matters; disasters, climate-related incidents, acts of war or aggression or major epidemics; changes in expected contract start dates and terms; changes in provider, broker, vendor, state, federal and other contracts and delays in the timing of regulatory approval of contracts, including due to protests and our ability to timely comply with any such changes to our contractual requirements or manage any unexpected delays in regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare or other customers); the difficulty of predicting the timing or outcome of legal or regulatory audits, investigations, proceedings or matters including, but not limited to, our ability to resolve claims and/or allegations on acceptable terms, or at all, or whether additional claims, reviews or investigations will be brought; challenges to our contract awards; cyber-attacks or other data security incidents or our failure to comply with applicable privacy, data or security laws and regulations; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the terms of our contracts and the undertakings in connection with any regulatory, governmental, or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price, or accretion for acquisitions or dispositions; losses in our investment portfolio; restrictions and limitations in connection with our indebtedness; a downgrade of our corporate family rating, issuer rating or credit rating of our indebtedness; the availability of debt and equity financing on terms that are favorable to us and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission (SEC). This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition, and results of operations, in our filings with the SEC, including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative (SG&A) costs.
Společnost Aehr Test Systems získala od klíčového zákazníka v oblasti křemíkové fotoniky další výrobní objednávku na plně automatizovaný systém FOX-XP pro wafer-level burn-in. Systém má podpořit vysokosériovou výrobu pro AI optické propojky a hyperscale datová centra.
FREMONT, CA / ACCESS Newswire / July 9, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced it has received an additional follow-on production order from its lead silicon photonics customer for a fully automated FOX-XP® wafer-level burn-in (WLBI) system. The system will support high-volume production burn-in of silicon photonics devices used in AI optical interconnect and hyperscale data center applications.
The order includes Aehr's turnkey FOX-XP multi-wafer WLBI system configured to test up to nine 300mm wafers in parallel together with the fully automated FOX WaferPak® AutoAligner™, enabling automated, high-volume production burn-in with hands-free operation when integrated with an automated wafer handler.
The customer is developing advanced silicon photonics devices used in next-generation optical interconnects and optical I/O architectures for hyperscale AI and cloud data centers and advanced packaging of AI processors and high-performance computing (HPC) devices. These silicon photonics devices enable dramatically higher bandwidth and lower power communication between AI processors, memory, switches, and networking equipment, addressing one of the industry's most significant bottlenecks as AI infrastructure continues to scale. Industry leaders across the AI ecosystem have increasingly identified silicon photonics and optical I/O as key enabling technologies for future AI clusters, rack-scale computing, and chip-to-chip communications to permanently replace copper interconnects that are approaching their practical performance and power limits.
This customer took delivery of its first FOX-XP with fully automated WaferPak Aligner production system in fiscal 2026. The system has now been successfully installed and demonstrated fully automated, hands-free operation integrated with the customer's automated wafer handling equipment and an automated guided vehicle for 300mm wafer FOUP movement. This represents an important production milestone as the customer ramps up manufacturing of its silicon photonics products.
"The successful installation and production qualification of our first fully-automated system with this customer represents another important milestone in our long-term relationship with them," said Gayn Erickson, President and CEO of Aehr Test Systems. "Demonstrating fully hands-free production operation with our integrated FOX-XP platform and automated wafer handling validates not only our technology, but also our ability to support customers as they transition from engineering qualification into high-volume manufacturing.
"We are very pleased to receive this additional follow-on production order early in our new fiscal year. We believe this order reflects the customer's continued confidence in Aehr's FOX-XP platform and represents an encouraging start to fiscal 2027. As AI infrastructure evolves toward optical interconnects and optical I/O, we believe Aehr is well-positioned to support customers that require cost-effective, high-throughput WLBI and stabilization."
Demand for silicon photonics continues to accelerate as hyperscale AI infrastructure expands. Major technology companies and AI infrastructure providers are increasingly adopting optical interconnect technologies to overcome the bandwidth, latency, and power limitations of traditional electrical interconnects. Industry forecasts anticipate significant growth in silicon photonics deployments over the coming years as optical communication moves closer to AI processors and ultimately onto processor packages through optical I/O architectures.
Aehr's FOX-XP platform is designed for high-power wafer-level test and burn-in of advanced semiconductor devices, including silicon photonics integrated circuits, AI processors, power semiconductors, memory devices, sensors, and other leading-edge semiconductor technologies. The FOX-XP system enables parallel burn-in and test of up to nine wafers simultaneously and, when combined with the FOX WaferPak AutoAligner, provides a fully automated production solution that significantly reduces handling time while improving throughput, repeatability, and manufacturing efficiency. The platform utilizes Aehr's proprietary FOX WaferPak Contactors, allowing full-wafer electrical contact and burn-in before singulation to identify infant mortality failures, improve long-term reliability, and lower overall manufacturing costs.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including advanced artificial intelligence (AI) processors, silicon photonics, data and telecommunications infrastructure, electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, and solid-state memory and storage are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr's expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, future requirements and orders of Aehr's new and existing customers; Aehr's ability to receive orders and generate revenue in the future, as well as Aehr's beliefs regarding the factors impacting the foregoing, including the growth of the markets referred to herein; Aehr's ability to integrate Incal efficiently; and the timing and extent to which the acquisition is accretive. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr's recent Form 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
Baker Hughes získal tři zakázky pro Cheniereův Sabine Pass LNG, včetně zařízení pro Train 7 a modernizace plynových turbín. Projekt má přidat přes 6 MTPA kapacity.
Contracts awarded by Bechtel and Cheniere to supply primary liquefaction equipment, including main refrigerant compressors and gas turbines, for the first phase of the Sabine Pass Expansion ProjectTechnology packages support an additional nameplate capacity of over 6 million tons per annum (MTPA) for Train 7 and boil-off gas re-liquefaction unitServices award provides fleet-wide gas turbine upgrades to enhance power, driving LNG production
HOUSTON and LONDON, July 09, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Thursday three substantial awards for Cheniere’s Sabine Pass LNG facility in Cameron Parish, Louisiana. The awards, booked in the second quarter, comprise orders from Bechtel Energy Inc. (Bechtel) and Cheniere to supply liquefaction equipment for Train 7 and for a boil-off gas re-liquefaction unit, as well as an award for fleet-wide gas turbine technology upgrades.
The equipment orders for Phase 1 of the Sabine Pass expansion project include seven PGT25+ G4 gas turbines driving 15 centrifugal compressors, enabling approximately 6 million tons per annum (MTPA) of additional LNG production capacity.
Additionally, Baker Hughes will deliver upgrades across the entire fleet of installed aeroderivative PGT25+ G4 gas turbines at the Sabine Pass facility over a four-year period. These upgrades will help to increase the power output of the turbines to enhance LNG production capabilities, helping deliver efficiency across the facility’s current approximate 30 MTPA capacity. These upgrades, together with Train 7 and the boil-off gas re-liquefaction unit, are expected to add over 6 MTPA of capacity at Sabine Pass.
The expansion and upgrade of the Sabine Pass LNG terminal support growing global demand for natural gas in energy and industrial applications, helping to deliver affordable energy supply.
“These comprehensive technology solutions, from advanced liquefaction equipment to lifecycle services, help our customers expand LNG production and meet growing energy demand,” said Baker Hughes Chairman and CEO Lorenzo Simonelli. “Our differentiated portfolio of equipment, technologies and services enables us to deliver comprehensive solutions that help customers accelerate project execution, enhance reliability and unlock long-term value.”
“We are pleased to continue our decades-long collaboration with Baker Hughes, a key partner in the development of Sabine Pass into one of the largest LNG facilities in the world,” said Cheniere Chairman, President and CEO Jack Fusco. “These equipment orders, lifecycle services and technology upgrades are critical to facilitate further optimization and efficiency upgrades throughout the Cheniere platform.”
About Baker Hughes
Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward – making it safer, cleaner and more efficient for people and the planet. Visit us at bakerhughes.com.
Cognizant oznámil plán rozšířit pracovní sílu certifikovanou pro Frontier na 5 000 Frontier Certified Engineers a 10 000 Frontier Business Operators. První kohorta má být připravena ve 4. čtvrtletí 2026.
Cognizant's Frontier workforce model to create the human infrastructure that turns AI investment into enterprise outcomes Backed by decades of running technology and operations at enterprise scale, Cognizant's human capital operating model embeds outcome-owning Frontier talent inside client operations Cognizant Frontier talent operates across any cloud, any model to help close the gap between AI capability and enterprise results , /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading AI Builder and technology services provider, today announced it was committing to scaling its Frontier-certified workforce, the human and operational infrastructure enterprises need to convert AI capability into measurable business results, to 5,000 Frontier Certified Engineers and 10,000 Frontier Business Operators.
Cognizant's people investment will yield its first cohort, which will be both Frontier-assessed and deployment-ready, by fourth quarter, 2026. Cognizant also plans to augment its own Frontier talent pipeline through annual direct hires of Frontier-native talent from American and global universities.
This human capital investment is focused on solving an urgent problem facing enterprises today: most organizations have spent more on AI than on any technology in a generation, and most have little to show for it. Cognizant measures the gap between what AI can deliver and what enterprises actually realize at $4.5 trillion. That gap is not a compute problem. It is a people and process problem, and it will not be closed by provisioning more infrastructure. The required investment is skilling and deploying more Frontier-ready talent into client-oriented delivery to help clients realize a return on their technology investment.
"Closing the AI outcome gap demands talent who not only understands a client's industry deeply but can also reimagine the way work is structured and take end-to-end responsibility for delivering results in collaboration with clients, on any model or cloud the client selects," said Cognizant CEO Ravi Kumar S. "That is what a Frontier workforce does. By taking accountability for outcomes rather than stopping at technology deployment, we can help clients accelerate measurable results while managing risk. Cognizant's industry context and experience position us uniquely to unlock the value that has remained out of reach during this shift toward outcome-based delivery and a new chapter in human capital."
Cognizant's Frontier workforce is model- and cloud-agnostic by design. Its teams build an organization's unique context into whatever stack the client has already chosen, across a partnership footprint that spans Anthropic, OpenAI, Microsoft, Google, AWS, NVIDIA, Salesforce, and ServiceNow. The result is durable capability designed for enterprise ownership and portability across environments, otherwise known as solutions that are geared towards the problems being experienced by our client, not the closest thing a proprietary platform can accomplish.
"AI has exposed 93% of jobs to change, and the associated labor value remains untapped because the workforce architecture built for a pre-AI world cannot capture it. So we rebuilt the architecture for the world we are in now," said Cognizant Chief People Officer, Kathy Diaz. "Industry domain depth is a core strength of Cognizant, and we bring enterprise-scale experience across technology, processes and operations. We know how to take these powerful frontier tools and turn them into real business value, and we are training our workforce to do it at scale."
Cognizant Chief Learning Officer, Thiru Arohi said: "We are developing a new professional identity for the AI era. We are investing in the infrastructure behind this identity: the Academy, the assessment architecture, the certification pathway, and the talent pipeline from campus to senior practitioner. What we are scaling is not headcount, but a workforce capable of closing the outcome gap that no model, platform, or deployment engineer can close alone."
This Frontier model is anchored in six principles: interdisciplinary capability; a direct linkage to customer value; building, deploying, or working alongside agents as routine; end-to-end accountability; delivery through a small operational pod; and a single, unified Cognizant experience for the client. The workforce will be organized as a single premium job family of seven roles across two complementary tracks, Frontier Certified Engineers and Frontier Business Operators:
Frontier Certified Engineers: Frontier Certified Engineers architect and build agentic systems, engineer the retrieval and context layers that keep those systems grounded in domain reality, and orchestrate multi-agent pipelines into live production, remaining accountable for every system they deploy, including ongoing monitoring, tuning and improvement cycles that follow go-live. They are where industry domain expertise, full-stack AI engineering and production accountability converge in a single practitioner. They enter a client environment already fluent in its regulatory constraints, operational failure modes and business logic, and use that fluency to determine not just what AI can do, but what it should do, and how it must be governed to be trusted in alignment with client requirements. Frontier Business Operators: Frontier Business Operators are responsible for delivering operational outcomes in collaboration with client stakeholders in environments where the workforce is simultaneously human and digital, managing agent fleets and human teams against a committed outcome, in real time, with no separation between the two. Their edge is not technical configuration; it is the judgment that comes from having run the operations floors, claims pipelines, and service workflows that AI agents are now being asked to take on. They know how to feed every exception and override back into agent calibration, so the system is continuously refined to improve reliability over time. What sets these roles apart from being forward deployed engineers is permanence, accountability and something that cannot be trained overnight: Cognizant's deep industry domain expertise and the hard-won experience of an AI builder running enterprise operations at scale. The model is already live — a two-person Engineer-and-Operator pod recently reimagined a large food service company's account-management workflow into seventeen production AI agents, reclaiming roughly eleven hours per account manager each week while cutting handoff cycles by about 60 percent and nearly tripling their revenue per engagement.
Underpinning the commitment is a model built to scale and to reach the client. Cognizant stands up local capacity inside client clusters so certified pods deploy close to the work they own, while its global capability centers supply the talent base behind them. The elevation funnel narrows at each stage: from a broad base of AI-fluency skilling across hundreds of thousands of associates, through structured AI-Bridge programs to 40,000 in Frontier certification, credentialed directly by the frontier-model companies, including GitHub Copilot, Google Gemini, Anthropic's Claude, and OpenAI's Codex. Today's announced investment will expand Cognizant's SkillSpring™ capacity, deliver AI-fluency and responsible-AI training across the workforce, and fund embedded client engagements worldwide.
For enterprises, the payoff is measured where it matters most: AI investment converted into business results, delivering value from the technology stack they already run, with accountability through an AI builder firm that lasts well beyond go-live. In committing to the people who deliver those outcomes, Cognizant is making a strategic bet that the defining edge of the AI era will be human and operational, and positioning its clients to pursue the financial return from their technology investment which has eluded them. That is the future of AI: not just capability, but outcomes that endure.
About Cognizant
Cognizant (Nasdaq: CTSH) is an AI Builder and technology services provider, bridging the gap between AI investment and enterprise value by building full-stack AI solutions for our clients. Our deep industry, process and engineering expertise enables us to build an organization's unique context into technology systems that amplify human potential, drive tangible outcomes and keep global enterprises ahead in a fast-changing world. See how at www.cognizant.ai or @cognizant.
Otsuka ICU Medical LLC oznámila investici více než 500 milionů USD do rozšíření výroby infuzních roztoků v Austinu, včetně výstavby nové továrny a modernizace stávajícího závodu. Cílem je posílit odolnost dodavatelského řetězce a urychlit vývoj produktů bez DEHP v Severní Americe.
This expansion of IV solutions manufacturing will help enhance supply-chain resiliency, support portfolio development and advance non-DEHP innovation for the North American IV solutions market.
Joint venture announces over $500M IV solutions manufacturing expansion in Austin, TX Expansion aimed at improving IV solutions supply resiliency and quality, and accelerating non-DEHP new product development in North America via fully automated technology First major milestone toward fulfilling the commitments of the joint venture finalized in May 2025 between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc. , /PRNewswire/ -- Otsuka ICU Medical LLC today announced plans for an over $500 million expansion to its US IV solutions manufacturing through a new facility and significant upgrades to its existing operations in Austin, Texas. The expansion is expected to enhance long-term supply resiliency and accelerate new product development while positioning the portfolio to support evolving non-DEHP legislation across the North American IV solutions market.
The project will leverage Otsuka Pharmaceutical Factory, Inc.'s long-standing expertise in IV container development and manufacturing quality to support Otsuka ICU Medical LLC's advancement of non-DEHP IV solutions for the North American market. As part of this initiative, Otsuka ICU Medical LLC will expand its existing 700,000-square-foot Austin manufacturing site with a new 500,000-square-foot facility in Austin to support greater operational flexibility and future innovation across IV solutions and specialty pharmaceutical segments.
This expansion is the first major milestone toward delivering on the commitments made by the joint venture between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc., a subsidiary of Otsuka Pharmaceutical Factory, Inc., finalized in May 2025. It reflects the partnership's strategic focus on bolstering North American IV solutions manufacturing and innovation, while complementing existing efforts to obtain long-term FDA approval of select overseas Otsuka manufacturing sites to supplement North American supply as needed.
"This expansion reflects our commitment to long-term growth in a clinically essential market," said Yoshifumi Fujimoto, chief executive officer of Otsuka ICU Medical LLC. "By strengthening our US manufacturing footprint, expanding non-DEHP capabilities, and introducing innovation, we are enhancing supply reliability for North American customers while positioning ourselves to better support future regulatory and legislative requirements."
The North American IV solutions market remains highly concentrated, and recent supply chain disruptions—driven by natural disasters and infrastructure constraints—have highlighted the importance of resilient, geographically diversified production. At the same time, healthcare providers are preparing for an evolving regulatory environment, including the transition toward non-DEHP IV solutions containers. This expansion is designed to address both needs: strengthening supply resiliency while supporting future portfolio innovation and market readiness.
Media Contact:
Harrison Richards, ICU Medical, Inc.
949-366-4261
[email protected]
About Otsuka ICU Medical LLC.: Otsuka ICU Medical LLC is a joint venture between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc., subsidiary of Otsuka Pharmaceutical Factory, Inc., formed to strengthen the resiliency, reliability, and innovation of IV solutions supply in North America. Combining global manufacturing scale with strong North American production and distribution capabilities, Otsuka ICU Medical LLC supports caregivers with high-quality IV solutions designed to help deliver safe, consistent patient care. For more information, visit www.otsukaicumed.com.
About Otsuka Pharmaceutical Factory, Inc. (OPF): OPF is the original company from which the Otsuka Group has grown. The management vision of OPF is "the best partner in clinical nutrition worldwide", and as a leading company in IV solutions in Japan has been developing, manufacturing, and selling IV solutions for 80 years. Today, in addition to IV solutions, OPF provides a variety of products that contribute to solving issues in the healthcare setting. For more information, visit https://www.otsukakj.jp/en/.
About Otsuka Pharmaceutical Factory America, Inc. (OPFA): OPFA operates across healthcare and life sciences markets engaging in the research, development, technology transfer, manufacture, and sale and importation of pharmaceuticals, IV solutions, medical devices and functional food products. The company also oversees the management and strategic operations of its U.S. subsidiary, Otsuka ICU Medical LLC, and related business activities.
About ICU Medical: ICU Medical, Inc. (Nasdaq: ICUI) offers clinically essential medical devices that connect patients and caregivers through life-enhancing, innovative technology and services that provide meaningful clinical value. The organization's robust portfolio features medical delivery systems and consumable products for infusion therapy, emergency medicine, general and regional anesthesia, home care, NICU/PICU, oncology, pain management, and respiratory care. More information about ICU Medical, Inc. can be found at www.icumed.com.
Simply Good Foods ve 3. čtvrtletí vykázala tržby 357,0 mil. USD a čistou ztrátu 52,0 mil. USD. Zároveň snížila výhled celoročních tržeb na 1,345 až 1,355 mld. USD.
DENVER, July 09, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial results for the thirteen and thirty-nine weeks ended May 30, 2026. Third Quarter Summary: (1) Net sales of $357.0 million versus $381.0 million Net loss of $52.0 million versus net income of $41.1 million Loss per diluted share of $0.58 versus earnings per diluted share of $0.40 Adjusted Diluted EPS (2) of $0.42 versus $0.51 Adjusted EBITDA (3) of $57.2 million versus $73.9 million Updating Fiscal Year 2026 (4) Outlook: Net sales expected to range between $1.345 and $1.355 billion, or a decline of roughly 7% to 6% year-over-year Gross margins expected to decline approximately 375 basis points year-over-year Adjusted EBITDA expected to range between $220 and $225 million, or -21% to -19% year-over-year “Our third quarter results reflect initial steps against the turnaround priorities we outlined last quarter.
Marex Group Limited se dohodla na koupi společnosti Bright Point International, aby rozšířila své clearingové podnikání v Asii a Tichomoří a získala přístup na čínské trhy. Transakce přidá asi 800 mil. USD klientských zůstatků.
LONDON, July 09, 2026 (GLOBE NEWSWIRE) -- Marex Group Limited (‘Marex’ or the ‘Group’; NASDAQ: MRX), the diversified global financial services platform, today announces it has agreed to acquire Bright Point International (‘BPI’), an Asian focused clearing business, to further expand its footprint across the Asia Pacific region and provide access to the markets in China.
BPI is a Singapore-based multi-asset clearing business with strong Asia Pacific and China-linked client relationships, adding scale, client balances and regional expertise to Marex. BPI provides its clients with access to commodities and financial products, including FX, index futures and options and digital asset derivatives. The acquisition will add approximately $800m in client balances and over 70 employees across Singapore, Hong-Kong, China, Norway and the United Kingdom.
The deal is subject to regulatory approval and is expected to complete by late 2026 or early 2027.
Thomas Texier, Group Head of Clearing, commented: “BPI is a well-established business with an experienced and high-quality team. This deal will drive additional revenues by adding clients and increasing client balances and is also expected to provide material synergies from the internalization of some clearing activities. Importantly, it will also enhance our ability to service clients in Asia with a broader range of services from the Marex platform and provide existing Marex clients with an improved access to Chinese markets.”
Kenny Mah, Group CEO of BPI said: “Today's announcement marks an exciting new chapter for BPI. Joining Marex represents a significant opportunity to accelerate our growth, broaden the solutions we can offer our clients and provide our people with access to a truly global platform. We share a common commitment to integrity and client service, and I am confident that together we will be even better positioned to support our customers in an increasingly dynamic marketplace.”
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including the expected acquisition of BPI and the closing of the transaction as well as expected benefits from the acquisition. In some cases, these forward-looking statements can be identified by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions.
These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the risks discussed under the caption "Managing our Risk" in our Annual Report on Form 20-F for the year ended December 31, 2025, filed with the Securities and Exchange Commission (the "SEC") and our other reports filed with the SEC. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.
About Marex: Marex Group Limited (NASDAQ:MRX) provides market access, infrastructure services and essential liquidity to clients across global commodity and financial markets. The Group provides comprehensive breadth and depth of coverage across four services: Clearing, Agency and Execution, Market Making and Hedging and Investment Solutions. It has a leading franchise in many major metals, energy and agricultural products, with access to more than 60 exchanges. Marex has over 3,400 active clients, including some of the largest commodity producers, consumers and traders, banks, hedge funds and asset managers. With more than 50 offices worldwide, the Group has over 3000 employees across Europe, Asia and the Americas. For more information visit www.marex.com.
Google se odvolává proti indickému verdiktu, který mu nařídil zaplatit 31 600 USD za porušení ochranné známky v reklamním systému. Firma tvrdí, že rozhodnutí poškodí spotřebitele i digitální reklamní trh.
Visitors walk near a logo of Google at Bharat Mandapam, one of the venues for AI Impact Summit, in New Delhi, India, February 17, 2026. REUTERS/Bhawika Chhabra/File Photo Purchase Licensing Rights, opens new tab
SummaryCompaniesGoogle counts India as a key growth market for search, adsCourt said Google ad platform was allowing trademark breachGoogle says ruling has major consequences for digital ad marketNEW DELHI, July 9 (Reuters) - Google (GOOGL.O), opens new tab has challenged an Indian court ruling that it infringed on a company's trademark rights by allowing rivals to use its name as an advertising keyword, arguing the decision will hurt consumers, documents reviewed by Reuters show.
The May decision could reshape the online ads market in a country where Google last year earned $4.1 billion in gross advertising revenue but where it is also facing a raft of antitrust cases and court battles.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
To ensure their ads are promoted by Google and target the right customers, companies bid on keywords that online consumers type into the search engine.
Indian bathroom fittings maker Hindware, however, accused its rivals of purchasing keywords related to its brand on the Google ads platform, so that their websites appear at the top of searches when consumers typed in "Hindware".
The Delhi High Court ruled against Google in the case, ordering it to pay damages of $31,600 and other litigation costs.
In its 4,761-page challenge, which is not public but was reviewed by Reuters, Google said the decision makes India the "sole outlier" among global jurisdictions "with serious consequences for the digital advertising industry, online consumer choice, and competitive markets."
Researchers have observed that consumers may search for a brand in order to identify and assess alternatives, Google wrote in the July 7 filing, arguing the ruling will effectively grant trademark owners a "monopoly over advertising space to the detriment of consumers."
In a response to a Reuters request for comment, Google confirmed it is appealing the order, which it said "diverges from established legal precedents in India". It added that its ads policies reflect standard practices that enable competition.
Google India's appeal will be heard in the coming days.
GOOGLE SELLING SOMETHING IT DOESN'T OWN, JUDGE SAYSIf upheld, Indian lawyers and tech experts say the original ruling will have wide-ranging ramifications for how the online ads market operates.
Indian matchmaking service Shaadi.com, for example, said that it would change the economics of online ads for millions of businesses that were suffering when their competitors bid on their name and Google took a fee.
Justice Mini Pushkarna noted in the decision in May that Google could not be permitted to shrug off responsibility after making a tool available that leads to trademark infringement.
"Google has attempted to sell something that it simply does not own," Pushkarna wrote.
Google's appeal rejects the position that it has infringed on trademarks, arguing that "a keyword is merely used as an internal and backend trigger to display an ad" and is simply "making advertising space available".
Google also faces antitrust cases in India as well as legal challenges over AI training and stricter-than-ever content takedown regulations that began applying to tech companies from February.
Reporting by Aditya Kalra; Editing by Joe Bavier
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Aditya Kalra is the Company News Editor for Reuters in India, overseeing business coverage and reporting stories on some of the world's biggest companies. He joined Reuters in 2008 and has in recent years written stories on challenges and strategies of a wide array of companies -- from Amazon, Google and Walmart to Xiaomi, Starbucks and Reliance. He also extensively works on deeply-reported and investigative business stories.
Moderna logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
CompaniesJuly 9 (Reuters) - Moderna (MRNA.O), opens new tab said on Thursday it has secured a European Commission contract to supply its respiratory syncytial virus vaccine to six countries in the region.
Here are the details:
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The agreement gives the participating countries - Austria, Denmark, Ireland, Luxembourg, Norway and Portugal - access to up to 24 million doses of the vaccine over as many as four years, the company said.
The vaccine, mRESVIA, will be supplied in a ready-to-use, single-dose pre-filled syringe, making administration easier for healthcare professionals, Moderna said.
The company had a similar joint procurement framework agreement with the European Commission for COVID-19 vaccines last year.
mRESVIA is authorized in the European Union to prevent lower respiratory tract disease caused by RSV in adults.
RSV is a common respiratory virus that causes seasonal infections such as the flu and is a leading cause of pneumonia and death in infants and older adults.
Moderna has four approved mRNA vaccines for respiratory infections, including a combined influenza and COVID-19 vaccine authorized in Europe.
Reporting by Christy Santhosh in Bengaluru; Editing by Leroy Leo
Our Standards: The Thomson Reuters Trust Principles., opens new tab
IBM rozšířila platformu IBM Bob o multiagentní funkce, vestavěnou analytiku nákladů a předpřipravené pracovní postupy pro modernizaci IBM Z, IBM i a Javy. Firma říká, že nové nástroje mají zrychlit vývoj a zpřesnit řízení AI ve velkých podnicích.
Latest IBM Bob Updates Help Enterprises Deliver Production-Ready Software Fast IBM Bob is Built to Optimize the Cost of AI-Driven Development Beyond the Model IBM Bob Now Offers Pre-Built, Customizable Enterprise Workflows for IBM Z, IBM i, Plus Java Modernization , /PRNewswire/ -- Today, IBM (NYSE: IBM) announced major updates to IBM Bob, its agentic software development platform, including new multi-agent capabilities, built-in AI cost and use analytics, and pre-built, specialized workflows for modernizing enterprise systems.
Now that organizations are using AI to write massive amounts of code, their software development challenges have moved to other parts of the process with 85% of DevSecOps professionals surveyed agreeing that AI has shifted the bottleneck from writing code to reviewing and validating it.1 IBM Bob is architected to bring AI capabilities wherever software engineering work happens. Rather than limiting AI to a single development interface for isolated tasks, Bob provides a unified foundation for teams to coordinate across the software development lifecycle.
For example, engineers at Jack Henry, a leading financial services and banking technology provider, were facing challenges maintaining and evolving a large RPG codebase as its application portfolio expanded in size and complexity. "Using IBM Bob," explained Kevin Sligar, Chief Technical Architect at Jack Henry. "Our developers are able to accelerate RPG development workflows, improve code quality, and gain deeper insights into decades of accumulated system knowledge while gaining efficiency in enhancement efforts."
Many enterprise engineers are manually choosing models, trying to balancing cost versus performance, and still ending up with inconsistent outcomes and unpredictable spend. Bob can now optimize across the execution system, not just model selection. Bob matches models to tasks, coordinates AI execution across agents, and provides organizations with visibility into productivity, quality, performance, and cost through the newly launched Bobalytics, to help enterprises optimize AI at scale.
"Bob is the platform enterprise customers have been asking for," said Neel Sundaresan, GM, Automation and AI, IBM. "The bar for enterprise AI is no longer a better coding assistant. It's an end-to-end agentic development partner that works inside any system development teams already use, with the governance, security, and cost controls enterprises require. We built Bob to solve the problems enterprises actually have, and the updates we're announcing today are the foundation for everything that comes next."
Engineering teams also encounter unique challenges as they move beyond code generation and apply AI to larger, more complex work like updating legacy applications or modernizing IBM Z, IBM i, and Java environments.
Blue Pearl, a cloud solutions and consulting services company, has successfully used IBM Bob for this type of complex project. "We introduced IBM Bob to a legacy modernization program, an effort originally projected to take nine months with 14 engineers was completed in just three days," said Saireshan Govender, Group CEO of Blue Pearl. "The most powerful outcome wasn't the speed – it was the combination of operational efficiency, cost optimization, and real-world results we could trust and build on."
AI output can vary depending on how the work is done, which can create significant issues for these types of high-stakes, multi-phase projects. Structured, repeatable workflows help reduce that variability so teams can deliver reliable, auditable results at enterprise scale.
IBM Bob now has pre-built workflows available that teams can customize and extend for their own environments to ensure outcomes are consistent and auditable, regardless of who runs it. IBM Bob Premium Packages for IBM Z, IBM i, and Java Modernization, are each opinionated workflows built on decades of IBM's domain experience that optimize AI for enterprise teams that need to do large-scale modernization.
What's New In IBM Bob:
Built-in usage visibility and cost optimization: Users can now access Bobalytics, a new feature that helps them monitor consumption, allocate resources and maintain oversight so they can scale AI according to their internal mandates. Parallel, model-native tool calling: Bob now allows models to request several tools in one turn and run them together. Subagents manage context at scale: Every exploratory step an AI takes, whether it's file reads, searches, or function traces, can bloat the context window and drive up cost. Now Bob subagents handle complex work in an isolated context, to deliver fast responses while helping manage cost. The latest version of IBM Bob is available for download at bob.ibm.com/download and for more details on the new capabilities and features, visit: https://bob.ibm.com/blog/bob-v2-release-announcement.
Now Available: IBM Bob Premium Packages
IBM has spent decades at the center of enterprise modernization across mainframes, IBM i systems, and Java codebases that global businesses run on. Bob's first three premium packages translate IBM's institutional knowledge into AI-native workflows that are structured, repeatable, auditable and purpose-built for the environments other tools weren't designed to handle.
Premium packages available now include:
IBM Z: Mainframe environments sit at the core of global banking, insurance and commerce, and have historically been the hardest places for AI to help. Bob now addresses this by bringing AI-native application modernization to IBM Z for the first time with COBOL and PL/I modernization and JCL analysis. For more details on Premium Package for IBM Z, visit: https://www.ibm.com/new/announcements/announcing-the-ibm-bob-premium-package-for-z IBM i: IBM i has powered mission-critical operations at enterprises worldwide for decades. Bob is bringing AI-native development to these environments for the first time, with remote file system integration, IBM i-specific modes and tools, and workflows built around the operational patterns of IBM i shops. For more details on Premium Package for IBMI i, visit: https://www.ibm.com/new/announcements/introducing-the-ibm-bob-premium-package-for-i Java Modernization: Enterprise Java portfolios remain some of the largest and most complex modernization challenges in today's software landscape. Bob delivers AI-guided workflows for Java modernization, including migration to Java 25, large-scale refactoring and dependency analysis at scale, in a structured and repeatable manner. For more details on Premium Package for Java Modernization, visit: https://www.ibm.com/new/announcements/announcing-ibm-bob-premium-package-for-java-modernization About IBM
IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Thousands of governments and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM's hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM's breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM's long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information.
Media contact:
Rebecca Neufeld
IBM
[email protected]
1
GitLab. (2026). The 2026 AI Accountability Report.
UnitedHealth zvýšil výhled zisku na více než 17,35 USD na akcii z 17,10 USD. V prvním čtvrtletí tržby vzrostly o 2 % a poměr nákladů na péči klesl na 83,9 %.
UnitedHealth Group (UNH 0.60%) has been one of the best buys in the healthcare sector over the past two months, with shares rising roughly 57% since the end of March.
The stock price of the nation's largest health insurer is now up 29% year to date and 38% over the past 12 months. It is an impressive bounce-back, considering shares had fallen to a nearly seven-year low of $234.60 per share on Aug. 1 last year.
One year earlier, on Aug. 1, 2024, UnitedHealth traded at $572 per share and reached an all-time closing high of $625 per share on Nov. 11, 2024. From that high, the stock price plummeted a staggering 62% over the next nine months.
Image source: Getty Images.
What brought on UnitedHealth's 61% drop? The precipitous fall has been well documented both on The Motley Fool and elsewhere. It was a confluence of factors that included the shocking murder of Brian Thompson, CEO of the UnitedHealthcare arm, on Dec. 4, 2024.
But at the same time, UnitedHealth's earnings started tanking as the firm was hit by a huge increase in Medicare Advantage costs, driven by a surge in elective surgeries and procedures and by patients likely holding off on procedures since the pandemic. This took a huge bite out of earnings.
Also, its Optum division took a hit due in large part to Medicare funding reductions. On top of that, UnitedHealth had been under investigation by the Justice Department for antitrust concerns and its billing practices.
Finally, amid the sinking ship, the CEO of UnitedHealth Group, Andrew Witty, abruptly resigned in May 2025 after four years serving in the role. It made matters worse that the company suspended its guidance, creating massive doubt and uncertainty for investors.
How UNH bounced back After UNH hit rock bottom last August, it slowly started climbing back up. It was partly because the stock was so cheap. After losing some 60% of its value, its P/E ratio plummeted from about 33 to around 13 last June.
One bright spot was that UNH was able to maintain its dividend and even raised it for the 16th straight year. Investors looking for a cheap, high-yield dividend stock found one in UNH.
The company also made a pivot, focusing less on new enrollments, exiting some markets, and repricing plans to improve profitability.
That pivot started to show in its Q1 earnings report. Revenue rose 2% while earnings fell 1% year over year, but earnings were up significantly from the December quarter. Also, its medical cost ratio (MCR) dropped to 83.9%, down 90 basis points year over year. This is a measure of efficiency, as it means UNH spent less on healthcare for every dollar collected in premiums.
Today's Change
(
-0.60
%) $
-2.59
Current Price
$
425.60
The company also raised its earnings guidance for this fiscal year to greater than $17.35 per share, up from the previous guidance of $17.10. That would be up from $13.23 per share in 2025.
The strong earnings were one tailwind, but the company also received good news from the federal government, which boosted Medicare Advantage plan rates by 2.48% for 2027. Those rates should directly benefit UnitedHealth by providing it with more money to cover medical costs, potentially increasing profits.
Should you buy UnitedHealth stock? So UnitedHealth has some momentum heading into the second-quarter earnings season, but the fact is, the recent surge has raised UNH's valuation. The P/E ratio is now 32, its highest since March 2025, when the stock price started tanking. There were many other factors at play a year ago that waylaid UNH stock, but the only other time the P/E ratio has been this elevated was around its 2024 peak.
While things are improving, UnitedHealth does not have the kind of earnings power to carry that high multiple. For that reason, I don't think UNH is a particularly good deal right now after this big run-up.
Čipy se po dvou prudkých výprodejích odrážejí zpět, když Micron před otevřením trhu přidal 3,5 % a AMD s Intelem přes 2,5 %. Analytici dál věří v poptávku po AI a zvyšují cílové ceny.
Chip stocks were set for a rebound on Thursday as investors stepped back into the AI hardware trade after two brutal sessions of profit-taking.
Micron rose 3.5% in premarket trading to $982.05, while AMD and Intel also gained over 2.5% after recent Wall Street target hikes helped restore some confidence in the sector.
The bounce follows a sharp selloff across Korea, Japan and the US, where investors briefly questioned whether the AI chip rally had run too far, too fast.
The reversal began after one of the sharpest global chip selloffs of the year.
Samsung Electronics reported preliminary second-quarter operating profit of 89.4 trillion won on Tuesday, with sales of about 171 trillion won, confirming a record quarter driven by AI memory demand.
But instead of rallying, Korean chip stocks sold off as investors treated the results as a “sell-the-news” moment.
South Korea’s Kospi fell into technical bear-market territory on Wednesday, down 22.8% from its June 22 peak.
Samsung lost 6.3% and SK Hynix dropped 5.7% in that session, extending a two-day rout tied to fears about stretched AI valuations, higher oil prices and interest-rate risk.
The earlier selling was even more dramatic as the Kospi ended 7.9% lower last week, with SK Hynix down 14.6%, Samsung off 9.1% and Japan’s Kioxia tumbling more than 13.5% as the memory trade unwound.
By Thursday, dip-buying had returned. Kioxia rose 8.3% in Japan, while Samsung and SK Hynix also gained as investors rotated back into memory names ahead of SK Hynix’s US listing.
The reason the rebound has traction is that analysts have not treated the pullback as a break in the AI cycle.
Bank of America’s Vivek Arya reiterated a Buy rating on Micron and kept a $1,550 price target.
Arya argued that global cloud and AI infrastructure spending could reach $1.5 trillion by 2027, with 35%-40% directed toward memory components.
His view is that investors are underestimating how memory is shifting from a deeply cyclical product into a strategic AI resource.
UBS also stayed bullish on memory. The firm raised its DRAM contract-price forecasts, with DDR prices now expected to rise 32% quarter-on-quarter in the third quarter, nearly double its earlier 17% forecast.
AMD has its own bull case as Goldman Sachs analyst James Schneider raised his AMD target to $640 from $450, citing strong AI demand and the rising role of high-performance CPUs in agentic AI workloads.
Intel’s rebound story is more about turnaround as HSBC analyst Frank Lee doubled his Intel target to $200 from $100, saying server CPU growth and the foundry business could deliver more value than investors expect.
HSBC expects design commitments in Intel Foundry to begin in the second half of 2026.
Also read- Intel, AMD stocks outperformed Nvidia in H1: what's next?
The bullish notes do not remove the risks and Intel is the clearest example of the same phenomenon.
HSBC’s $200 target is far above broader Street expectations, and the thesis depends heavily on foundry customers turning early engagement into real design commitments.
There is also a broader valuation issue as Bank of America’s bubble-risk warning for technology and semiconductor stocks earlier this month showed that even bullish analysts are watching how crowded the trade has become.
The next tests arrive quickly. SK Hynix’s Nasdaq ADRs are due to begin trading on July 10, after Reuters reported that the $28 billion US share sale was more than seven times oversubscribed.
That debut will be a real-time measure of investor appetite for AI memory exposure.
Honeywell Aerospace chystá nové produkty bez ITAR pro evropskou obranu, protože roste poptávka po dílech bez amerických exportních omezení. Firma zároveň vyvíjí technologie bez ITAR i pro partnery v Asii a Tichomoří.
Item 1 of 2 Honeywell Aerospace President and CEO Jim Currier speaks to employees, investors and members of the media at Honeywell Aerospace?s Inaugural Investor Day at Caesars Republic in Scottsdale, Arizona, U.S. June 3, 2026. REUTERS/Caitlin O'Hara/File Photo
[1/2]Honeywell Aerospace President and CEO Jim Currier speaks to employees, investors and members of the media at Honeywell Aerospace?s Inaugural Investor Day at Caesars Republic in Scottsdale, Arizona,... Purchase Licensing Rights, opens new tab Read more
SummaryCompaniesRising European defense spending is driving demand for parts without export roadblocksEuropean countries concerned Washington could block re-export of sensitive US componentsNew Honeywell Aero product announcement expected at Farnborough Airshow, source saysHoneywell Aero also developing non-ITAR technologies for Asia-Pacific partners like Japan and South KoreaJuly 9 (Reuters) - U.S. supplier Honeywell Aerospace (HONA.O), opens new tab is looking to add more products designed without restricted U.S. technologies as mounting European defense spending drives demand for parts free from possible export roadblocks.
NATO leaders have unveiled arms deals worth tens of billions of dollars at a gathering in Turkey this week, as they face U.S. demands to spend more to defend Europe and due to pressure from Russia's war in Ukraine.
The Reuters Iran Briefing newsletter keeps you informed with the latest developments and analysis of the Iran war. Sign up here.
Some European defense companies and North American suppliers are also expected to discuss demand for parts not governed by U.S. International Traffic in Arms Regulations (ITAR) at the world's largest air show later this month.
There is increasing demand among European countries for ITAR-free systems due to concerns over Washington potentially blocking the re-export of sensitive U.S. components embedded in foreign weapons, according to defense officials and industry executives.
Honeywell Aerospace is set to announce a new ITAR-free product for the international defense sector at the Farnborough Airshow in Britain later this month, a source told Reuters.
The Arizona-based company declined to comment on an announcement. But it has tasked a combined 1,000 engineers in Poland and the Czech Republic to design ITAR-free technologies, its CEO Jim Currier told Reuters in an interview in late June.
"Part of it is looking, acting, feeling and speaking like a European company," he said of doing business in Europe.
"Their main mantra, and drive and edict is to design non-ITAR technology for ... local strategy," Currier said of the engineers at the company's European subsidiary.
It comes as U.S. companies such as dronemakers have been expanding in Europe, while the U.S. this week floated a new missile maintenance facility on the continent and two defense contractors discussed building ATACMS ballistic missiles for the first time in Germany.
INTERNATIONAL EXPANSIONHoneywell Aerospace sees international exposure growing for its defense business, which accounts for about 40% of company revenue and includes navigation systems and actuators for missiles. Last year, international sales accounted for about 30% of the company's defense business, up from around 18% in 2020, Honeywell Aerospace said.
Currier said Honeywell Aerospace was using the company's global presence to scale ITAR-free navigational technology from its 2024 acquisition of Italy's Civitanavi.
"That has been the playbook. We are developing non-ITAR technologies for use in the EU and overseas for our partners in the Asia-Pacific region, like Japan and Korea," he said.
While European demand for ITAR-free components and parts has existed for years, geopolitical tensions between the U.S. and its NATO allies are underpinning greater calls for the technology.
The Canadian government has said it was made aware during last year's Paris Air Show of greater demand from European defense firms for North American suppliers free from U.S. ITAR restrictions, and such demand has led Canada to attempt further integration into European supply chains.
Michael Iacovelli, CEO of Toronto-area aerospace and defense components supplier Ben Machine Products, said more than half of its work is now required by clients to be ITAR-free. In contrast, none of its work needed to be ITAR-free in 2018, he said.
Reporting by Allison Lampert in Montreal; Editing by Jamie Freed
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Akcie společností zaměřených na AI čipy ustoupily kvůli obavám ze zpomalení výdajů na infrastrukturu, ale firmy typu hyperscaler dál signalizují růst kapitálových výdajů. Bank of America očekává, že globální capex na cloud a AI datová centra v roce 2027 vzroste o 40 % až 50 % na zhruba 1,5 bilionu USD.
While temperatures have been scorching across much of the U.S., AI chip stocks have cooled off, with the sector facing increased selling pressure this summer. The dip appears largely centered on concerns that AI infrastructure spending could slow. However, hyperscalers have largely indicated that their capital expenditures will only increase next year, and Bank of America recently projected that worldwide, cloud and AI data center capex will jump by 40% to 50% year over year to around $1.5 trillion in 2027.
With data center infrastructure spending still booming, this pullback could be a great chance to scoop up these three AI semiconductor stocks.
1. Nvidia: Still leading the way
Today's Change
(
3.74
%) $
7.37
Current Price
$
204.30
Nvidia (NVDA +3.74%) remains the king of AI infrastructure, and following the pullback, it trades at just 15 times analysts' estimated earnings for its fiscal 2028 (which ends in January 2028). That's a bargain for a company that is still delivering rapid revenue growth, including 85% growth last quarter.
What I really like about Nvidia, though, is how the company has quietly transformed itself into a complete AI infrastructure package. The company's graphics processing units (GPUs) remain its biggest revenue driver, and its ubiquitous CUDA software platform provides a wide moat for its chips in AI model training.
However, the company also has a top-notch networking portfolio; its "acquisition" of Groq gave it a chip designed specifically for inference; and it's diving headfirst into the data center central processing unit (CPU) market, which is set to boom as the use of agentic AI takes off. This lets it offer complete end-to-end systems for specific AI tasks and should help drive continued strong growth.
At its current valuation, Nvidia is a stock to own.
2. AMD: Riding inference and agentic AI trends
Today's Change
(
0.37
%) $
1.91
Current Price
$
518.02
Advanced Micro Devices (AMD +0.37%) stock has been hot this year, but it, too, has pulled back from its highs. The exciting thing about AMD is that it is riding two of the most powerful trends in AI right now.
The first is inference, where its GPUs compete well against Nvidia's offerings, given their chiplet design, which allows them to be packaged with more memory. AMD has formed partnerships with OpenAI and Meta Platforms, and big orders for its newest GPUs should begin shipping soon. It's also been reported that it may have a deal with Anthropic.
On top of that, AMD is a leader in data center CPUs.
Because CPUs are the right hardware for managing AI agents, the number of CPUs used in AI data centers is expected to skyrocket. Where previously, the ratio of GPUs to CPUs in AI data center servers built for training stood at 8:1, experts foresee that ratio evolving to 1:1 with infrastructure designed to support agentic AI. AMD sees the total addressable market for data center CPUs growing at a 35% annualized rate to $120 billion by 2030.
Between its GPU and CPU opportunities, AMD looks poised for strong growth.
Image source: Getty Images.
3. Broadcom: The custom chip leader
Today's Change
(
5.00
%) $
18.53
Current Price
$
389.31
Broadcom (AVGO +5.00%) is another company on the verge of explosive revenue growth that has been caught in the AI infrastructure sell-off. The pullback in the stock has taken its valuation down to just 19 times analysts' earnings estimates for its fiscal 2027 (which ends in November 2027).
However, the company should see its custom chip revenue surge to well over $100 billion next year. That's more than the nearly $64 billion in total revenue it generated last year and five times the AI revenue it produced. The company's custom chip business is taking off with the success of Alphabet's Tensor Processing Units (TPUs), which it helped the search leader develop. That has led to other hyperscale customers turning toward its ASIC (application-specific integrated circuit) services to help them develop custom AI chips.
Broadcom has also been a leader in data center networking. This is a fast-growing business that can also tie directly into its custom chip business. Given the company's growth prospects, the stock is just too cheap at these levels.
Siemens a FuelCell Energy uzavřely memorandum o spolupráci na škálovatelných palivových článcích pro on-site výrobu elektřiny. Cílí na rychlé nasazení komerčních projektů nad 100 MW.
Collaboration advances on-site energy deployment through aligned electrical infrastructure and fuel cell technologies July 09, 2026 07:00 ET | Source: FuelCell Energy, Inc.; Siemens
WENDELL, N.C. and DANBURY, Conn., July 09, 2026 (GLOBE NEWSWIRE) -- Siemens and FuelCell Energy, Inc. (Nasdaq: FCEL) have announced a collaboration to accelerate the growth of fuel cell-based power generation. The agreement aligns electrical design and supply with fuel cell technologies to support deployment of distributed energy systems.
As part of the collaboration, formalized in a memorandum of understanding, Siemens will design and supply electrical balance of plant (EBOP) systems for fuel cell installations, supporting the rapid deployment of 100+ MW commercial projects.
Siemens’ expertise in EBOP design and integration supports its position as a premier provider of electrical infrastructure for fuel cell-based power solutions. A leading turnkey fuel cell power producer, FuelCell Energy designs, manufactures, operates, and services fuel cell power plants for a range of mission-critical applications globally, including data centers, industrial facilities, utilities, and other distributed generation customers.
The work includes joint project development spanning engineering, integration, and delivery of distributed energy systems incorporating fuel cells, battery energy storage, microgrid controls, and medium-voltage electrical equipment. The companies will evaluate opportunities to scale and deploy solutions that improve timelines, reduce costs, and increase deployments.
“The rapid growth of electrification and distributed energy is redefining how power must be delivered at scale,” said Kevin Brown, Head of Sustainability Solutions, Electrification and Automation, at Siemens Smart Infrastructure USA. “By combining FuelCell Energy’s fuel cell technology with Siemens’ electrical infrastructure, service, and integration expertise, we can deliver scalable, on-site power solutions for energy-intensive applications – helping customers deploy power faster, scale with confidence, and advance their transition to lower-emission, more resilient energy systems.”
FuelCell Energy’s Chief Product and Technology Officer, Shankar Achanta, said, “This collaboration with Siemens enables us to deliver what the market has been asking for—bringing generation and electrical infrastructure together into a single, scalable solution. For customers, that means reliable, on-site power that is faster to deploy and built to scale, beginning with the data centers driving today’s demand.”
Additional efforts include pilot projects and solution development initiatives to assess new applications for fuel cell systems and electrical infrastructure, including medium-voltage DC power delivery and modular electrical systems. The agreement defines a path to transition successful pilot outcomes into full-scale commercial deployments, including the identification of target markets and deployment approaches.
Press Contacts
About Siemens
Siemens Corporation is a U.S. subsidiary of Siemens AG, a leading technology company focused on industry, infrastructure, transport, and healthcare. The company’s purpose is to create technology to transform the everyday, for everyone. By combining the real and the digital worlds, Siemens empowers customers to accelerate their digital and sustainability transformations, making factories more efficient, cities more livable, and transportation more sustainable. A leader in industrial AI, Siemens leverages its deep domain know-how to apply AI – including generative AI – to real-world applications, making AI accessible and impactful for customers across diverse industries. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a leading global medical technology provider pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
In fiscal year 2025, which ended on September 30, 2025, the Siemens Group USA generated revenue of $24.427 billion with 25 manufacturing sites across the U.S. and more than 50,000 employees serving customers in all 50 states and Puerto Rico.
Siemens Smart Infrastructure (SI) is shaping the market for intelligent, adaptive infrastructure for today and the future. It addresses the pressing challenges of urbanization and climate change by connecting energy systems, buildings, and industries. SI provides customers with a comprehensive end-to-end portfolio from a single source – with products, systems, solutions, and services from the point of power generation all the way to consumption. With an increasingly digitalized ecosystem, it helps customers thrive and communities progress while contributing toward protecting the planet. To protect this journey, we foster holistic cybersecurity to ensure secure and reliable operations. Siemens Smart Infrastructure has its global headquarters in Zug, Switzerland, and its U.S. corporate headquarters in Peachtree Corners, Georgia, USA. As of September 30, 2025, the business had around 79,400 employees worldwide.
About FuelCell Energy
FuelCell Energy, Inc. (NASDAQ: FCEL) is an American clean energy technology company delivering continuous, scalable baseload power for mission-critical applications globally. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emissions power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems—backed by global fuel cell deployments approaching one gigawatt. Learn more at www.FuelCellEnergy.com.
President Donald Trump has been more involved in the stock market than past presidents.
He's made some timely calls, notably telling investors to buy stocks after the market meltdown in April when he announced high tariff rates on most of the country's major trading partners.
The Trump administration has also had the U.S. government take stakes in companies it deems imperative to national security. Some of the government's picks, like Intel, have turned into extraordinary investments.
Recently, Trump has been touting and buying Dell (DELL +3.69%) stock. Should you?
Image source: Joyce N. Bhoghosian.
Why does Trump like Dell? Michael and Susan Dell donated $6 billion to power the new Trump Accounts, which are tax-advantaged accounts that parents can use to start building savings for their children as soon as they are born.
Eligible newborn babies born between the start of 2025 and the end of 2028 can also receive a free $1,000 contribution to the accounts.
"Go out and buy a Dell computer," Trump, who made a similar pitch in May, said on July 6. "We're going to get him that money back one way or the other -- and then I'll ask for another $6 billion. ... We'll start the whole process all over again."
Although the U.S. government doesn't hold a stake in Dell, 2025 financial disclosures show that Trump made 24 trades in Dell last year, with $545,000 in net purchases.
Dell has benefited from the AI trade Trump's bullish calls may help Dell, but the company has already benefited immensely from its involvement in the artificial intelligence trade, with the stock up more than 230% this year.
Similar to other AI plays that have done well, Dell is a pick-and-shovel play. The company builds servers that house graphics processing units (GPUs). Dell's servers help the GPUs run properly by cooling them, managing power distribution, and connecting them to other GPUs and storage within data centers.
So, as GPU clusters scale, Dell sees more demand for its servers. In Dell's first fiscal quarter of 2027, which ended May 1, revenue surged by 88% year over year, while diluted earnings per share surged 282%. More than 37% of Dell's total first-quarter revenue came from AI servers alone.
Today's Change
(
3.69
%) $
15.41
Current Price
$
432.69
After the earnings report, Piper Sandler analyst James Fish raised his price target on Dell to $497, implying about 19% upside from the July 7 closing price of about $417.
"This was not just a one-quarter phenomenon either, as the team is seeing backlog and pipelines outpace sales growth, though admitting that some of this is due to net pull-in of demand given the ongoing supply chain issues across the space and raised pricing," Fish wrote in his research note at the time.
One issue with Dell is that it's not exactly a high-margin story. Even as revenue has surged, the company's gross margin has declined by more than 300 basis points from 21.1% a year ago to 17.8% in its first quarter.
Should you buy the stock? The company's valuation reflects some of the margin issues. Dell trades at about 21 times forward earnings and 1.6 times forward sales, which isn't low per se, but not nearly as high as some other high-flying AI stocks.
Dell also has a large personal computer business, which, while no longer the company's main focus, remains a segment that management hopes to rejuvenate. The company wants to offer products with greater variety in price points and features.
While I am wary of all companies whose stocks have ripped higher on the AI trade right now, Dell by no means trades at an outlandish valuation compared to others. However, if you do buy the stock, I would dollar-cost average to smooth out your cost basis over time, as AI names are likely to experience high volatility.
Ark Invest v červenci nakoupil akcie Kratos Defense za zhruba 9,1 milionu USD a pozice se vyšplhala na desátou největší v portfoliu ETF Ark. Kratos letos klesl o více než 33 %.
So far this month, Cathie Wood's various Ark exchange-traded funds (ETFs) have bought about $9.1 million worth of stock in Kratos Defense & Security Solutions (KTOS +0.08%). With her recent buying, the position has grown to be the tenth largest across all Ark Invest ETFs, worth just north of $110 million as of the time of this writing.
That's a lot of enthusiasm for a defense company whose shares are down more than 33% this year. Yet even after that decline, it still trades at nearly 300 times trailing earnings -- a hefty premium. If you're wondering what Wood is seeing that other investors are overlooking, here are three reasons why the stock may be a buy.
Image source: Getty Images.
Drones have proven their worth The Iran and Ukraine wars have shown the importance of drones, which have evolved from expensive supporting assets into the central drivers of attrition, surveillance, and strategy on the 21st-century battlefield. Drones that are (relatively) cheap have often defeated costly electronic defense systems, inverting the economics of air defense.
Kratos specializes in tech-driven defense hardware, including artificial intelligence-controlled combat drones priced at $3 million to $5 million, significantly less expensive than manned fighter jets, which cost more than $100 million apiece. The company had a $2 billion backlog of orders as of the end of the first quarter, and the Pentagon's fiscal 2027 budget request includes more than $70 billion specifically for military drones and anti-drone weapon systems, the technologies that Kratos directly addresses.
Today's Change
(
0.08
%) $
0.04
Current Price
$
50.38
Kratos's Valkyrie XQ-58A has established the company's competitive edge as a proven supplier in the evolving drone warfare landscape. It's designed to fly sorties in conjunction with crewed fighter jets, during which it can scout ahead, absorb enemy fire, and deploy weapons.
The company, recognizing the rising demand for drones from the Pentagon and America's international allies, announced on July 6 that it is building a 106,000-square-foot expansion of its Oklahoma City manufacturing plant to increase jet drone production.
Kratos is a key player in the drone trend Kratos is seen as an Nvidia equivalent in the drone warfare arena -- a key player in a field where artificial intelligence capabilities are redefining operational effectiveness. As the U.S. military increases its use of drone technology, it is looking for cost-effective solutions of a type that larger defense contractors have struggled to provide.
Kratos is expected to face increased competition from the likes of General Atomics, Anduril Industries, and Boeing, but its specialization in affordability and its rapid product development cycles give it a strategic edge. As military operations continue to adapt to the realities of modern warfare, companies that can deliver effective solutions at lower costs will likely capture larger portions of defense spending.
Kratos is already financially on solid ground For the first quarter, Kratos reported revenue of $371 million, up 22.6% year over year, while earnings per share rose by 133% to $0.07. The company is forecasting full-year revenue between $1.7 billion and $1.76 billion, up 29% at the midpoint. It also predicts that its adjusted earnings before interest, taxes, depreciation, and amortization will land between $170 million and $176 million, up 44% at the midpoint.
The company isn't just a drone manufacturer; it has landed several high-value contracts across its core divisions this year, spanning space systems, rocket propulsion, air defense, and unmanned aerial targets.
Its biggest contract came in March from the U.S. Space Force, a $468 million follow-on Other Transaction Agreement. Kratos will build the essential ground management software and system infrastructure to support the military's Resilient Missile Warning and Tracking satellite constellation in medium Earth orbit.
Buying at the right time Wood knows a good deal when she sees it, and many of her Kratos buys this year have come after the stock has fallen. Kratos operates at the nexus of the long-term trend toward the greater use of unmanned defense hardware.
The company's focus on low-cost manufacturing is endearing it to the Pentagon, and its expansion plans put it on track to scale up drone production. It's also important to note that it has a relatively broad product base, including counter-drone technology and infrastructure that connects orbital satellites to military networks. That diversity should serve the company well in the long run.
While its high price-to-earnings ratio is concerning, it is seen as a growth stock with great long-term potential.
PepsiCo ve 2Q zvýšilo tržby o 6,4 % na 24,18 mld. USD, ale organické tržby vzrostly jen o 2,4 % a mírně zaostaly za odhady. Firma zároveň potvrdila celoroční výhled organického růstu tržeb.
Americký výrobce nápojů a potravin PepsiCo zveřejnil výsledky hospodaření za druhé čtvrtletí roku fiskálního roku 2026, které skončilo 13. června 2026. Organické tržby vzrostly o 2,4 %, čímž mírně zaostaly za odhadem analytiků, přičemž segment potravin v Severní Americe organicky klesl o 2 %. Tržby a jádrový zisk na akcii odhady mírně překonaly a společnost potvrdila celoroční výhled organického růstu tržeb.
Výsledky společnosti PepsiCo (PEP) za 2Q FY 2026 2Q FY 2026 Konsensus 2Q FY 2026 2Q FY 2025 Tržby (mld. USD) 24,18 23,95 22,73 Provozní zisk (mld. USD) 4,02 4,06 1,79 Jádrový zisk na akcii (Core EPS, USD/akcie) 2,20 2,19 2,12 Výsledky za 2Q FY 2026 Tržby meziročně vzrostly o 6,4 % na 24,18 mld. USD a překonaly odhad 23,95 mld. USD. Organické tržby vzrostly o 2,4 % (odhad: +2,54 %), přičemž loňský výsledek byl +2,1 %.
Tržby PepsiCo ve 2Q FY 2026 dle segmentů
(mld. USD) Segment Tržby Konsensus Meziroční změna Nápoje Severní Amerika (PBNA) 7,24 7,20 +6,5 % Potraviny Severní Amerika (PFNA) 6,37 6,48 –1,7 % Evropa, Blízký východ a Afrika (EMEA) 4,98 4,89 +9,9 % Potraviny Latinská Amerika 2,94 2,86 +15 % Mezinárodní franšíza nápojů (IB Franchise) 1,52 1,46 +11 % Asie a Tichomoří 1,12 1,06 +12 % Z hlediska organického růstu tržeb si mezinárodní segmenty vedly výrazně lépe než Severní Amerika – mezinárodní franšíza nápojů vzrostla o 9 %, EMEA o 6 % a Latinská Amerika o 4 %. Potraviny v Severní Americe organicky klesly o 2 %, nápoje v Severní Americe vzrostly o 1 %.
Provozní zisk dosáhl 4,02 mld. USD, mírně pod odhadem 4,06 mld. USD. Jádrová provozní marže se meziročně mírně snížila o 40 bazických bodů na 16,8 %.
Výhled na FY 2026 Společnost potvrdila celoroční výhled a nadále očekává:
Organický růst tržeb +2 % až +4 % (odhad: +2,76 %) Růst jádrového zisku na akcii v konstantních měnách +4 % až +6 % Firma zároveň očekává, že ve fiskálním roce 2026 navrátí akcionářům přibližně 8,9 mld. USD, z toho dividendy 7,9 mld. USD a zpětné odkupy akcií 1,0 mld. USD.
Komentář vedení „Výsledky druhého čtvrtletí přinesly silný organický růst objemů i tržeb v segmentech globálních potravin a nápojů. Od začátku roku vzrostl globální organický objem PepsiCo nejvyšším tempem od roku 2022, a to díky síle mezinárodního byznysu a pokračující evoluce portfolia," uvedl předseda představenstva a generální ředitel Ramon Laguarta. „Do budoucna budeme nadále plnit naše strategické priority se zaměřením na akceleraci růstu tržeb – včetně přepozicování vybraných globálních značek, inovací v oblasti funkčních a nových produktů a investic do cenové dostupnosti. Zároveň zvyšujeme produktivitu napříč celou organizací s cílem zlepšit provozní páku," dodal Laguarta.
Akcie PepsiCo Akcie PepsiCo (PEP) v předburzovní fázi obchodování rostou o 1,08 % na 144,03 USD.
Akcie PepsiCo Inc (PEP) před výsledky uzavřely na 142,51 USD Ukazatel Ukazatel Kapitalizace (mld. USD) 194,5 P/E 17,3 Vývoj za letošní rok (%) -0,7 Očekávané P/E 16,6 52týdenní minimum (USD) 133,0 Prům. cílová cena (USD) 165,4 52týdenní maximum (USD) 171,5 Dividendový výnos (%) 4,0 Zdroj: PepsiCo, Bloomberg
Natera oznámila, že Signatera získala certifikaci jako zařízení třídy C podle nařízení EU IVDR jako první personalizovaný MRD test pro solidní nádory v EU. Certifikace má usnadnit zavádění nových studií a udržet dostupnost v EU po roce 2028.
Signatera is the first personalized molecular residual disease (MRD) test for solid tumors to receive IVDR certification in the EU
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR).
The IVDR represents one of the world’s most rigorous regulatory frameworks for in vitro diagnostic medical devices, replacing the outgoing In Vitro Diagnostic Medical Devices Directive (IVDD). To obtain certification, the Signatera platform — including the assay, specimen collection kit, and associated software — underwent a comprehensive review against some of the most stringent standards in the medical industry, including evidence of analytical and clinical validity, as well as quality system management.
IVDR certification reduces the lead time and regulatory overhead for launching new clinical trials, and it ensures that Natera can continue offering Signatera to EU patients after the IVDD transition deadline in 2028.
Under this certification, Signatera is indicated for use in the adjuvant and surveillance settings across gastrointestinal malignancies, genitourinary malignancies, non-small cell lung cancer, head and neck cancer, breast cancer, skin cancer, gynecological malignancies, diffuse large B-cell lymphoma, indolent non-Hodgkin's lymphomas, and pan-cancer immunotherapy monitoring.
Certification was supported by extensive clinical and analytical evidence demonstrating Signatera’s performance across multiple tumor types and clinical settings. It follows two significant regulatory milestones for the Signatera portfolio: in June 2026, Signatera received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for patients with colorectal cancer; and in May 2026, the U.S. Food and Drug Administration approved Signatera™ CDx as a companion diagnostic for patients with muscle-invasive bladder cancer.
“MRD testing is redefining how we assess recurrence risk and guide treatment decisions for patients with cancer,” said Julien Taieb, M.D., Ph.D., head of the gastroenterology and gastrointestinal oncology department at the Université Paris-Cité. “This certification for Signatera is an important milestone as it will enhance access to personalized MRD testing for patients across Europe within a more rigorous regulatory framework.”
“Achieving IVDR certification is a key milestone in Natera’s plan to bring Signatera MRD testing to Europe,” said Solomon Moshkevich, president, clinical diagnostics at Natera. “Backed by extensive clinical evidence across multiple cancer types, this builds on our recent regulatory approvals in both the United States and Japan.”
About Natera
Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 400 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California, and through Foresight Diagnostics, its subsidiary, operates an ISO 27001-certified and CAP-accredited laboratory certified under CLIA in Boulder, Colorado. For more information, visit www.natera.com.
Forward-Looking Statements
All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera’s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera’s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to our efforts to develop and commercialize new product offerings, whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera’s recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.
